0001171843-18-005976.txt : 20180810 0001171843-18-005976.hdr.sgml : 20180810 20180810081623 ACCESSION NUMBER: 0001171843-18-005976 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 77 CONFORMED PERIOD OF REPORT: 20180630 FILED AS OF DATE: 20180810 DATE AS OF CHANGE: 20180810 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STR HOLDINGS, INC. CENTRAL INDEX KEY: 0001473597 STANDARD INDUSTRIAL CLASSIFICATION: UNSUPPORTED PLASTICS FILM & SHEET [3081] IRS NUMBER: 271023344 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34529 FILM NUMBER: 181007050 BUSINESS ADDRESS: STREET 1: 10 WATER STREET CITY: ENFIELD STATE: CT ZIP: 06082 BUSINESS PHONE: 860 272 4235 MAIL ADDRESS: STREET 1: 10 WATER STREET CITY: ENFIELD STATE: CT ZIP: 06082 FORMER COMPANY: FORMER CONFORMED NAME: STR Holdings, Inc. DATE OF NAME CHANGE: 20091106 FORMER COMPANY: FORMER CONFORMED NAME: STR Holdings (New) LLC DATE OF NAME CHANGE: 20091001 10-Q 1 f10q_081018p.htm FORM 10-Q

 

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(mark one)

 

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended June 30, 2018

 

Or

 

oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from             to             

 

Commission file number 001–34529

 

STR Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware 27–1023344
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
   
10 Water Street, Enfield, Connecticut 06082
(Address of principal executive offices) (Zip Code)

 

(860) 272–4235

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES x NO o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S–T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES x NO o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non–accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b–2 of the Exchange Act.

 

Large accelerated filer o   Accelerated filer o
     
Non–accelerated filer o   Smaller reporting company x
    Emerging growth company o

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b–2 of the Exchange Act). YES o NO x

 

At July 31, 2018, there were 20,101,221 shares of Common Stock, par value $0.01 per share, outstanding.

 

 

 

 

 
 

 

INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

STR Holdings, Inc. and Subsidiaries

Three and Six Months Ended June 30, 2018

 

  PAGE
NUMBER
PART I. FINANCIAL INFORMATION  
   
Item 1. Financial Statements 2
Condensed Consolidated Balance Sheets as of June 30, 2018 and December 31, 2017 (unaudited) 2
Condensed Consolidated Statements of Comprehensive (Loss) Income for the Three and Six Months Ended June 30, 2018 and 2017 (unaudited) 3
Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2018 and 2017 (unaudited) 4
Notes to Condensed Consolidated Financial Statements 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 16
Item 3. Quantitative and Qualitative Disclosures About Market Risk 25
Item 4. Controls and Procedures 25
   
PART II. OTHER INFORMATION  
   
Item 1. Legal Proceedings 26
Item 1A. Risk Factors 26
Item 5. Other Information 26
Item 6. Exhibits 27
SIGNATURE 28

 

 1 
 

 

PART I. FINANCIAL INFORMATION

 

Item 1.  Financial Statements

 

STR Holdings, Inc. and Subsidiaries

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)

All amounts in thousands except share and per share amounts

 

   June 30,
2018
  December 31,
2017
ASSETS          
CURRENT ASSETS          
Cash and cash equivalents   $11,710   $13,499 
Bank acceptance notes        904 
Accounts receivable, trade, less allowances for doubtful accounts of $1,734 and $1,725 in 2018 and 2017, respectively    1,588    1,199 
Inventories, net    1,357    1,110 
Prepaid expenses    859    748 
Other current assets    738    767 
Total current assets    16,252    18,227 
Property, plant and equipment, net    7,767    8,728 
Assets held for sale (Note 7)    6,155    6,155 
Other long-term assets    78    76 
Total assets   $30,252   $33,186 
LIABILITIES AND STOCKHOLDERS’ EQUITY          
CURRENT LIABILITIES          
Accounts payable   $1,451   $971 
Accrued liabilities (Note 8)    1,349    2,307 
Income taxes payable    898    896 
Due to factor    397    454 
Total current liabilities    4,095    4,628 
Deferred tax liabilities    969    698 
Total liabilities    5,064    5,326 
COMMITMENTS AND CONTINGENCIES (Note 9)          
Stockholders’ Equity          
Preferred stock, $0.01 par value, 20,000,000 shares authorized; no shares issued and outstanding         
Common stock, $0.01 par value, 200,000,000 shares authorized; 20,039,461 and 20,038,221 issued and outstanding, respectively, in 2018 and 19,919,529 and 19,918,289 issued and outstanding, respectively, in 2017    200    195 
Treasury stock, 1,240 shares at cost    (57)   (57)
Additional paid–in capital    232,315    232,149 
Accumulated deficit    (201,827)   (199,072)
Accumulated other comprehensive loss, net    (5,443)   (5,355)
Total stockholders’ equity    25,188    27,860 
Total liabilities and stockholders’ equity   $30,252   $33,186 

 

See accompanying notes to these condensed consolidated financial statements.

 

 

 2 
 

 

STR Holdings, Inc. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(unaudited)

All amounts in thousands except share and per share amounts

 

 

   Three Months Ended
June 30,
  Six Months Ended
June 30,
   2018  2017  2018  2017
Net sales   $2,515   $3,057   $6,261   $6,770 
Cost of sales    3,490    3,695    5,935    7,905 
Gross (loss) profit    (975)   (638)   326    (1,135)
Selling, general and administrative expenses    1,380    1,299    3,072    3,280 
Research and development expense    190    236    405    550 
Provision (recovery) for bad debt expense    67    (215)   6    (380)
Operating loss    (2,612)   (1,958)   (3,157)   (4,585)
Interest income (expense), net    16    (3)   15    (7)
Other income, net    183    1,632    1,203    1,206 
Loss on disposal of fixed assets    (383)   (16)   (383)   (13)
Foreign currency transaction loss    (106)   (64)   (162)   (75)
Loss before income tax expense (benefit)    (2,902)   (409)   (2,484)   (3,474)
Income tax expense (benefit)    172    (125)   271    (143)
Net loss   $(3,074)  $(284)  $(2,755)  $(3,331)
Other comprehensive (loss) income:                    
Foreign currency translation (net of tax effect of $(81), $205, $(36) and $257, respectively)    (542)   501    (88)   631 
Other comprehensive (loss) income    (542)   501    (88)   631 
Comprehensive (loss) income   $(3,616)  $217   $(2,843)  $(2,700)
Net loss per share (Note 3):                    
Basic   $(0.16)  $(0.02)  $(0.14)  $(0.18)
                     
Diluted   $(0.16)  $(0.02)  $(0.14)  $(0.18)
Weighted–average shares outstanding (Note 3):                    
Basic    19,669,353    18,913,427    19,607,204    18,839,391 
Diluted    19,669,353    18,913,427    19,607,204    18,839,391 

 

See accompanying notes to these condensed consolidated financial statements.

 

 3 
 

 

STR Holdings, Inc. and Subsidiaries

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

All amounts in thousands

 

   Six Months Ended
June 30,
   2018  2017
OPERATING ACTIVITIES          
Net loss   $(2,755)  $(3,331)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation    383    753 
Stock–based compensation expense    161    252 
Gain (loss) on disposal of property, plant and equipment    383    13 
Provision (recovery) for bad debt expense    6    (380)
Impairment of assets held for sale        267 
Proceeds from insurance claim        1,475 
Provision (recovery) for deferred taxes    271    (302)
Customer forfeiture of deposit    (940)    
Changes in operating assets and liabilities:          
Accounts receivable    (637)   1,010 
Inventories, net    (269)   (170)
Other current assets    860    1,624 
Accounts payable    244    (274)
Accrued liabilities    67    233 
Income taxes payable    4    2 
Other, net    150    (23)
Total net cash (used in) provided by operating activities    (2,072)   1,149 
           
INVESTING ACTIVITIES          
Capital investments    (36)   (410)
Proceeds from sale of fixed assets    238     
Total net cash provided by (used in) investing activities    202    (410)
           
FINANCING ACTIVITIES          
Factoring arrangement    (46)   111 
Total net cash (used in) provided by financing activities    (46)   111 
           
Effect of exchange rate changes on cash    127    175 
           
Net change in cash and cash equivalents    (1,789)   1,025 
Cash and cash equivalents, beginning of period    13,499    12,379 
Cash and cash equivalents, end of period   $11,710   $13,404 

 

See accompanying notes to these condensed consolidated financial statements.

 

 4 
STR Holdings, Inc. and Subsidiaries
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 1—BASIS OF PRESENTATION

 

The accompanying Condensed Consolidated Financial Statements and the related interim information contained within the notes to the Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information and quarterly reports on the Form 10-Q. Accordingly, they do not include all of the information and the notes required for complete financial statements. These Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2017, included in STR Holdings, Inc.’s (the “Company”) Annual Report on Form 10–K filed with the SEC on March 16, 2018. The unaudited interim Condensed Consolidated Financial Statements have been prepared on the same basis as the audited consolidated financial statements, and in the opinion of management, reflect all adjustments, consisting of only normal and recurring adjustments, necessary for the fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods presented. The results for the interim periods presented are not necessarily indicative of future results.

 

The year-end Condensed Consolidated Balance Sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP.

 

The preparation of the Condensed Consolidated Financial Statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management’s estimates.

 

NOTE 2—RECENT ACCOUNTING PRONOUNCEMENTS AND ADOPTION

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers” (Topic 606). This ASU is intended to clarify the principles for recognizing revenue by removing inconsistencies and weaknesses in revenue requirements; providing a more robust framework for addressing revenue issues; improving comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets; and providing more useful information to users of financial statements through improved revenue disclosure requirements. The provisions of this ASU are ultimately effective for interim and annual periods beginning after December 15, 2017. The standard shall be applied retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. During 2016, the FASB clarified the implementation guidance on principal versus agent, identifying performance obligations, licensing, and collectability.

 

The Company adopted the new revenue recognition standard (“ASC 606”) on January 1, 2018. Results for reporting periods beginning after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with ASC 605, Revenue Recognition. The application of the standard had no impact on the Company’s consolidated financial statements for any periods prior to 2018. The adoption of ASC 606 represents a change in accounting principle to more closely align revenue recognition with the delivery of the Company’s products, licenses and services. ASC 606 requires an entity to evaluate revenue recognition by identifying a contract with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations in the contract, and recognizing revenue when (or as) the entity satisfies a performance obligation.

 

Revenue is principally derived from the sale and licensing of highly engineered plastic sheet and film products. The Company receives specific purchase orders for the manufacture, sale and delivery of these products that identify the goods and/or services to be transferred, the price for those goods and other commercial terms of the order. The goods are generally purchased under EXW (or EX-Works) terms, meaning that the customer is responsible for arranging the shipping of the goods and title passes when the goods are picked up from the Company’s dock. Revenue is recognized upon the transfer of title, and there are no price concessions, volume discounts, rebates, refunds, credits, incentives, performance bonuses, royalties or other types of variable consideration.

 

In the specific case of the Equipment Purchase Agreement and a Technology License Agreement (the “Agreements”) signed on January 16, 2018 for an aggregate transaction price of $6,000, the Company will purchase from a third party specialized equipment (the “Equipment”) for the production of one of the Company’s proprietary encapsulants (the “Encapsulant”), resell the Equipment to the customer, install the Equipment at a facility of the customer and train the

 

 5 
STR Holdings, Inc. and Subsidiaries
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 2—RECENT ACCOUNTING PRONOUNCEMENTS AND ADOPTION (Continued)

 

customer’s personnel in the Equipment’s use. Under the license agreement, the Company has granted the customer the right to use the formula for the Encapsulant and certain of the Company’s production techniques to make or have made the Encapsulant for use in photovoltaic (PV) modules manufactured by the customer. For revenue recognition purposes, the Company defines the following three distinct major performance obligations of the Agreements and the corresponding transaction price allocated to those performance obligations:

 

  • Obligation 1 - $1,750 - Price Report, Formula and Sample
  • Obligation 2 - $2,000 - Equipment, including delivery & installation (incl. training)
  • Obligation 3 - $2,250 - License (perpetual)

Obligation 1 is considered to be separate and distinct from the other two obligations, in that the information provided under this obligation represents significant standalone value to the customer and the Company’s obligation to provide this information is separately identifiable from the other obligations in the agreements. Obligation 2 and Obligation 3 were also clearly identifiable, as defined by the Equipment Purchase Agreement (including delivery and installation by an agreed-upon date) and the license (“License”) granted pursuant to the Technology License Agreement (with an effective start date upon the receipt of an acceptance test payment).

 

The Company is applying a “cost-plus” approach to Obligation 1 and Obligation 2. As the Company had never before sold any type of license, had no established specific license pricing and had no knowledge of pricing for similar licenses, the Company is using the residual approach for Obligation 3. The License is perpetual, distinct and not combined with other goods and services, and is a right to use, rather than to access, functional intellectual property.

 

The Company also assessed whether it was acting in a principal or agent role in each performance obligation of the Agreements. In all obligations, the Company determined it was acting in the role of principal and therefore revenue is recognized on a gross basis.

 

As a result, the Company recognized $1,750 in the quarter ended March 31, 2018 upon the satisfaction of Obligation 1, its delivery of a price report, formula and sample. The total transaction price of the Agreements is expected to be recognized as revenue as follows:

 

    2018    2019(a)    Total 
Revenue expected to be recognized during the year ended December 31  $1,750   $4,250   $6,000 

 

(a)$2,000 upon installation of the Equipment and $2,250 upon acceptance and commencement of the License.

 

There are no new accounting pronouncements that the Company believes may have a material impact on its consolidated financial statements.

 

 6 
STR Holdings, Inc. and Subsidiaries
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 3—LOSS PER SHARE

 

The calculation of basic and diluted net loss per share for the periods presented is as follows:

 

   Three Months Ended
June 30,
  Six Months Ended
June 30,
   2018  2017  2018  2017
Basic and diluted net loss per share                    
Numerator:                    
Net loss   $(3,074)  $(284)  $(2,755)  $(3,331)
Denominator:                    
Weighted–average shares outstanding    19,669,353    18,913,427    19,607,204    18,839,391 
Add:                     
Dilutive effect of stock options                 
Dilutive effect of restricted common stock                 
Weighted–average shares outstanding with dilution    19,669,353    18,913,427    19,607,204    18,839,391 
                     
Net loss per share:                    
Basic   $(0.16)  $(0.02)  $(0.14)  $(0.18)
Diluted   $(0.16)  $(0.02)  $(0.14)  $(0.18)
                     

 

Due to the net loss for the three and six months ended June 30, 2018 and 2017, the computation of dilutive weighted-average common shares outstanding does not include any stock options or any shares of unvested restricted common stock as these potential awards are anti-dilutive.

 

Because the effect would be anti-dilutive, there were 1,121,332 stock options outstanding that were not included in the computation of diluted weighted-average shares outstanding for each of the three and six months ended June 30, 2018. Similarly, there were 1,121,332 stock options outstanding that were not included in the computation of diluted weighted-average shares outstanding for each of the three and six months ended June 30, 2017.

 

NOTE 4—BANK ACCEPTANCE NOTES

 

Customers in China may settle their accounts with bank acceptance notes, which are draft instruments that are guaranteed to be paid at maturity by the issuing bank. Upon receipt of the bank acceptance note, the Company can elect to hold the instrument until maturity and receive full face value, discount it with the bank for a fee, or transfer it at full face value to suppliers who will accept the note as settlement of the Company’s accounts payable balance with them.

 

Bank acceptance notes consist of the following:

 

   June 30,
2018
  December 31,
2017
Balance as of beginning of period   $904   $3,360 
Received from customers        1,985 
Converted to cash    (888)   (3,508)
Paid to suppliers        (1,162)
Foreign exchange impact    (16)   229 
Balance as of end of period   $   $904 

 

 7 
STR Holdings, Inc. and Subsidiaries
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 5—INVENTORIES

 

Inventories consist of the following:

 

   June 30,
2018
  December 31,
2017
Finished goods   $365   $340 
Raw materials    996    829 
Reserve    (4)   (59)
Inventories, net   $1,357   $1,110 

 

NOTE 6—LONG-LIVED ASSETS

 

Impairment Testing

 

In accordance with ASC 360-Property, Plant and Equipment, the Company assesses the impairment of its long-lived assets whenever changes in events or circumstances indicate that the carrying value of such assets may not be recoverable. During each reporting period, the Company assessed if the following factors were present, which would cause an impairment review: overall negative solar industry conditions; a significant or prolonged decrease in net sales generated under its trademarks; loss of a significant customer or a reduction in demand for customers’ products; a significant adverse change in the extent to or manner in which the Company used its trademarks or proprietary technology; such assets becoming obsolete due to new technology or manufacturing processes entering the markets or an adverse change in legal factors; and the market capitalization of the Company’s common stock.

 

At June 30, 2018 and December 31, 2017, the Company recorded valuation allowances against its deferred tax assets. The valuation allowances were recorded since the Company had three consecutive years of taxable losses and determined that its history of actual net losses was evidence that should be given more weight than future projections. The Company determined the recording of valuation allowances against deferred tax assets to be an indicator to test its long-lived assets, which consist solely of property, plant and equipment, for impairment. The Company assessed the specific recoverability of its property, plant and equipment using updated real estate appraisals and other data for its other fixed assets, mainly production equipment. Based upon this analysis, the Company believes its property, plant and equipment carrying value was recoverable and depreciable lives were appropriate as of June 30, 2018. Therefore no impairment was recorded in 2018. If the Company experiences a significant reduction in future sales volume, further average selling price (“ASP”) reductions, lower profitability, a cessation of operations at any of its facilities, or negative changes in U.S. or Spain real estate markets, the Company’s property, plant and equipment may be subject to future impairment or accelerated depreciation.

 

NOTE 7—ASSETS HELD FOR SALE

 

In July 2015, the Company announced a restructuring plan that included the closure of its Johor, Malaysia facility effective August 2, 2015. Subsequent to the announcement, the Company engaged advisors and was actively trying to sell its land-use right, building and other fixed assets located at the facility. During 2016, the Company entered into a definitive Purchase and Sale Agreement for the land-use right and the building for a purchase price of RM25,000. Closing of the transaction was subject to customary conditions to closing of transactions of this type, including the approval of the Johor Port Authority (“JPA”). On July 31, 2017, the Company received a notice from the purchaser purporting to terminate the agreement, alleging that the JPA was seeking to impose certain conditions on the approval of the transfer of the facility to the purchaser that it found unacceptable. The Company was not successful in removing those conditions, and the agreement terminated. The Company has re-launched the sale process for its Malaysia facility.

 

In accordance with ASC 360-Property, Plant and Equipment, the Company assessed the asset group attributed to the sale for impairment. Based upon the Company’s assessment of the status of the Malaysia property, plant and equipment, all of the requirements (including the held for sale requirements) set forth in ASC 360-10-45-9 were met and the assets were classified on the Condensed Consolidated Balance Sheet as of June 30, 2018 and December 31, 2017 as assets held for sale. An impairment loss of $267, related to the foreign currency fluctuation of the Ringgit, was recorded in the Company’s Condensed Consolidated Statement of Comprehensive (Loss) Income in other expense, net during the first half of 2017.

 

 8 
STR Holdings, Inc. and Subsidiaries
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 8—ACCRUED LIABILITIES

 

Accrued liabilities consist of the following:

 

   June 30,
2018
  December 31,
2017
Salaries and wages   $323   $239 
Accrued bonus    210    258 
Professional fees    285    319 
Restructuring severance and benefits (see Note 10)    102    87 
Environmental (see Note 9)    57    57 
Accrued franchise tax    79    90 
Client deposits    179    1,157 
Other    114    100 
Total accrued liabilities   $1,349   $2,307 

 

NOTE 9—COMMITMENTS AND CONTINGENCIES

 

The Company is a party to claims and litigation in the normal course of its operations. Management believes that the ultimate outcome of these matters will not have a material adverse effect on the Company’s financial position, results of operations, or cash flows.

 

Product Performance

 

The Company provides a short-term warranty that it has manufactured its products to the Company’s specifications. On limited occasions, the Company incurs costs to service its products in connection with specific product performance matters that do not meet the Company’s specifications. Anticipated future costs are recorded as part of cost of sales and accrued liabilities for specific product performance matters when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated.

 

On isolated occasions, the Company has also offered limited short-term performance warranties relating to its encapsulants not causing module power loss. The Company’s encapsulants are validated by long-term performance testing during product development prior to launch and during customer certification prior to mass production. The Company has operated its solar business since the 1970s and over 20 GW of solar modules incorporating its encapsulants have been installed in the field with no reported module power performance issues caused by the Company’s encapsulants and no related warranty claims to date. Based on this fact pattern, the Company has not accrued any warranty liability associated for this potential liability as its occurrence is deemed to be remote. If the Company was to ever receive a warranty claim for such matter, the Company would assess the need for a warranty accrual at that time.

 

The Company’s product performance liability that is recorded in accrued liabilities in the Condensed Consolidated Balance Sheets was $0 as of each June 30, 2018 and December 31, 2017.

 

Environmental

During 2010, the Company performed a Phase II environmental site assessment at its 10 Water Street, Enfield, Connecticut location. During its investigation, the site was found to contain a presence of volatile organic compounds. The Company has been in contact with the Department of Environmental Protection and has engaged a licensed contractor to remediate this circumstance. Based on ASC 450-Contingencies, the Company has accrued the estimated cost to remediate. The Company’s environmental liability that is recorded in accrued liabilities in the Condensed Consolidated Balance Sheets was $57 as of June 30, 2018 and December 31, 2017.

 

Solaria

 

In October 2016, a complaint was filed by Solaria Energia y Medio Ambiente S.A.U. (“Solaria”) against the Company and its Spanish subsidiary, Specialized Technology Resources España S.A.U. (“STR Spain”), in the Court of the First Instance No. 8 in Oviedo, Spain, relating to a product quality claim in connection with a non-encapsulant product that STR Spain

 

 9 
STR Holdings, Inc. and Subsidiaries
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 9—COMMITMENTS AND CONTINGENCIES (Continued)

 

purchased from a vendor in 2005 and 2006 and resold to Solaria. The Company stopped selling this product in 2006. Solaria is seeking approximately €3,300, plus interest, in damages.

 

A trial was held on April 6, 2017 in Oviedo, Spain, and the Company is currently awaiting a ruling from the court. The Company believes that it has product liability insurance coverage for claims of this nature, excluding the original product cost but including defense costs. The Company believes it has meritorious defenses and does not believe a loss is probable or can be reasonably estimated. As such, no accrual relating to this complaint was recorded as of June 30, 2018 and December 31, 2017.

 

NOTE 10—COST-REDUCTION ACTIONS

 

In March 2017 the Company made the decision to wind down its China manufacturing operations substantially by the end of the second quarter of 2017. The decision was consistent with ongoing efforts to reorganize its encapsulant business to better align with customer geography, to reduce losses related to unprofitable locations and to convert assets to cash for potential redeployment into more profitable endeavors. In connection with the restructuring, the Company does not expect any significant asset impairment charges and recorded $93 of severance charges and benefits in cost of sales and $48 of severance charges and benefits in selling, general and administrative expenses during the first six months of 2017 and $67 of severance charges during the first six months of 2018. The Company sold certain production and testing equipment from the China facility to its tolling partner in India during the third quarter of 2017.

 

In June 2018, the Company eliminated certain positions at its Spain facility, effective June 18, 2018. The Company recorded $588 of severance and benefits in cost of sales and $67 of severance and benefits in selling, general and administrative expenses during the second quarter of 2018.

 

The restructuring accrual consists of $102 for severance and benefits as of June 30, 2018. A rollforward of the severance and other exit cost accrual activity is as follows:

 

   June 30,
2018
  June  30,
2017
Balance as of beginning of year   $87   $269 
Additions    722    143 
Reductions    (707)   (177)
Reversals        (120)
Balance as of end of period   $102   $115 

 

NOTE 11—FAIR VALUE MEASUREMENTS

 

The Company measures certain financial assets and liabilities at fair value on a recurring basis in the financial statements. The hierarchy ranks the quality and reliability of inputs, or assumptions, used in the determination of fair value

and requires financial assets and liabilities carried at fair value to be classified and disclosed in one of the following three categories:

 

·Level 1-quoted prices (unadjusted) in active markets for identical assets and liabilities;
·Level 2-unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability; and
·Level 3-unobservable inputs that are not corroborated by market data.

 

 10 
STR Holdings, Inc. and Subsidiaries
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 11—FAIR VALUE MEASUREMENTS (Continued)

 

The following table provides the fair value measurements of applicable financial assets and liabilities as of June 30, 2018:

 

   Financial assets and liabilities at fair value
as of June 30, 2018
   Level 1  Level 2  Level 3
          
Money market funds (1)   $7,605   $   $ 
Bank acceptance notes (2)             
Non-recurring fair value measurements (3)            6,155 
Total   $7,605   $   $6,155 

 

The following table provides the fair value measurements of applicable financial assets and liabilities as of December 31, 2017:

 

   Financial assets and liabilities at fair value
as of December 31, 2017
   Level 1  Level 2  Level 3
          
Money market funds (1)   $6,688   $   $ 
Bank acceptance notes (2)    904         
Non-recurring fair value measurements (3)            6,155 
Total   $7,592   $   $6,155 

________________________

(1)Included in cash and cash equivalents on the Company’s Condensed Consolidated Balance Sheets. The carrying amount of money market funds is a reasonable estimate of fair value due to the short-term maturity.
(2)Refer to Note 4 for further information
(3)Included in assets held for sale on the Company’s Condensed Consolidated Balance Sheets. Refer to Note 7 for further information.

 

NOTE 12—FACTORING ARRANGEMENT

 

In October 2015, the Company’s wholly owned Spanish subsidiary, STR Spain, entered into a factoring agreement to sell, with recourse, certain European, U.S. and other foreign company-based receivables to Eurofactor Hispania S.A.U., who was later acquired by Credit Agricole Leasing and Factoring Sucursal en España during the first quarter of 2017. Under the current terms of the factoring agreement, the maximum amount of outstanding advances at any one time is €1,500 (approximately $1,752 as of June 30, 2018), which is subject to adjustment based on the level of eligible receivables, restrictions on concentrations of receivables and the historical performance of the receivables sold. The annual discount rate is 2% plus EURIBOR for Euro denominated receivables and 2% plus LIBOR for all other currencies. The term of the agreement is for one year, which will be automatically extended unless terminated by either party with 90 days prior written notice. As of June 30, 2018 and December 31, 2017 the Company has recorded $397 and $454, respectively, as due to factor on the Condensed Consolidated Balance Sheets.

 

NOTE 13—INCOME TAXES

 

On December 22, 2017, the Tax Cuts and Jobs Act (“TCJA”) was enacted into law in the United States. The legislation contains several key tax provisions including the reduction of the corporate income tax rate to 21% effective January 1, 2018, a one-time transition tax on foreign earnings which have not previously been subject to tax in the United States, as well as a variety of other changes, including limitation of the tax deductibility of interest expense, limitations for the deduction for net operating losses, new taxes on certain foreign-sourced earnings, and modification or repeal of many business deductions and credits.

 

The SEC staff issued SAB 118 which allows companies to record provisional amounts during a one-year measurement period. At December 31, 2017, the Company has not completed its accounting for the tax effects of the

 

 11 
STR Holdings, Inc. and Subsidiaries
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 13—INCOME TAXES (Continued)

 

enactment of the TCJA; however, the Company estimated what it believes to be the effects of the TCJA on its existing deferred tax balances and the one-time transition tax, and recorded a provisional estimate for these tax effects.

 

During the three and six months ended June 30, 2018, the Company did not record any measurement period adjustments to the provisional estimates recorded at December 31, 2017. Final accounting for these impacts is expected in the third quarter of 2018 subsequent to the Company’s completion of the 2017 tax return.

 

The TCJA subjects a U.S. shareholder to tax on global intangible low-taxed income (GILTI) earned by certain foreign subsidiaries for which an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or provide for the tax expense related to GILTI in the year the tax is incurred. Given the complexity of the GILTI provisions, the Company is still evaluating the effects of the GILTI provisions and has not yet determined its accounting policy. As of June 30, 2018, the Company does not anticipate a GILTI inclusion for the taxable year. The Company will continue to assess forthcoming guidance and accounting

interpretations on the effects of the TCJA and expects to complete its analysis within the measurement period in accordance with the SEC guidance.

 

During the three and six months ended June 30, 2018, the Company recorded an income tax expense of $172 and $271 resulting in an effective tax rate of (5.9%) and (10.9%), respectively. This effective tax rate for the three months ended June 30, 2018 differs from the U.S. statutory tax rate primarily due to the effect of taxes on foreign earnings.

 

There was no provision or benefit for federal, foreign or state income taxes for the three and six months ended June 30, 2017 other than income tax benefit of $125 and $143, respectively, resulting from an intra-period tax allocation between operations and other comprehensive income.

 

NOTE 14—STOCKHOLDERS’ EQUITY

 

Changes in stockholders’ equity for the six months ended June 30, 2018 are as follows:

 

   Common Stock  Treasury Stock  Additional
Paid–In
  Accumulated Other
Comprehensive
  Accumulated  Total
Stockholders’
   Issued  Amount  Acquired  Amount  Capital  Loss  Deficit  Equity
Balance at December 31, 2017    19,532,573   $195    1,240   $(57)  $232,149   $(5,355)  $(199,072)  $27,860 
Stock-based compensation    505,648    5            166            171 
Net loss                            (2,755)   (2.755)
Foreign currency translation, net of tax                        (88)       (88)
Balance at June 30, 2018    20,038,221   $200    1,240   $(57)  $232,315   $(5,443)  $(201,827)  $25,188 

 

Common Stock

 

The Company’s Board of Directors has authorized 200,000,000 shares of common stock, $0.01 par value. At June 30, 2018, there were 20,039,461 shares issued and 20,038,221 shares outstanding of common stock. Each share of common

stock is entitled to one vote per share.

 

NOTE 15—STOCK-BASED COMPENSATION

 

On November 6, 2009, the Company’s Board of Directors approved the Company’s 2009 Equity Incentive Plan (the “2009 Plan”), which became effective on the same day. Effective May 14, 2013, the 2009 Plan was amended to increase the number of shares subject to the 2009 Plan. As a result, a total of 4,133,133 shares of common stock were reserved for issuance under the 2009 Plan. The 2009 Plan is administered by the Board of Directors or any committee designated by the Board of Directors, which has the authority to designate participants and determine the number and type of awards to be granted, the time at which awards are exercisable, the method of payment and any other terms or conditions of the awards. The 2009 Plan provides for the grant of stock options, including incentive stock options and nonqualified stock options (collectively, “options”), stock appreciation rights, shares of restricted stock, or “restricted stock,” rights to dividend equivalents and other stock-based awards (collectively, the “awards”). The Board of Directors or the committee will, with regard to each award,

 

 12 
STR Holdings, Inc. and Subsidiaries
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 15—STOCK-BASED COMPENSATION (Continued)

 

determine the terms and conditions of the award, including the number of shares subject to the award, the vesting terms of the award, and the purchase price for the award. Awards may be made in assumption of or in substitution for outstanding awards previously granted by the Company or its affiliates, or a company acquired by the Company or with which it combines. Options outstanding generally vest over a three or four-year period and expire ten years from the date of grant. There were 431,131 shares available for grant under the 2009 Plan as of June 30, 2018.

 

The following table summarizes the options activity under the Company’s 2009 Plan for the six months ended June 30, 2018:

 

 

   Options Outstanding
   Number
of
Shares
  Weighted–
Average
Exercise
Price
  Weighted–
Average
Remaining
Contractual
Term
(in years)
  Weighted–
Average
Grant–Date
Fair Value
  Aggregate
Intrinsic
Value(1)
Balance at December 31, 2017    1,121,332   $1.52       $0.99   $(1,402)
Options granted       $       $   $ 
Exercised       $       $   $ 
Canceled/forfeited       $       $   $ 
Balance at June 30, 2018    1,121,332   $1.52    6.61   $0.99   $(1,402)
Vested and exercisable as of June 30, 2018    1,121,332   $1.52    6.61   $0.99   $(1,402)
Vested and exercisable as of June 30, 2018 and expected to vest thereafter    1,121,332   $1.52    6.61   $0.99   $(1,402)

 _________________

(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $0.27 of the Company’s common stock on June 30, 2018.

 

As of June 30, 2018, there was $0 of unrecognized compensation cost related to outstanding stock option awards. The Company did not receive any proceeds related to the exercise of stock options for the six months ended June 30, 2018.

 

The following table summarizes the restricted common stock activity of the Company for the six months ended June 30, 2018:

 

   Unvested
Restricted Shares
   Number of
Shares
  Weighted–
Average
Grant–Date
Fair Value
Unvested at December 31, 2017    385,716   $ 
Granted    119,932   $ 
Vested    (505,648)  $0.28 
Unvested at June 30, 2018       $ 
Expected to vest after June 30, 2018       $ 

 

Stock-based compensation expense was included in the following Condensed Consolidated Statements of Comprehensive Loss categories for operations:

 

   Three Months Ended
June 30,
  Six Months Ended
June 30,
   2018  2017  2018  2017
Selling, general and administrative expense   $88   $132   $161   $252 
Total stock-based compensation expense   $88   $132   $161   $252 

 

 13 
STR Holdings, Inc. and Subsidiaries
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 16—GEOGRAPHICAL INFORMATION

 

ASC 280-10-50 Disclosure about Segments of an Enterprise and Related Information establishes standards for the manner in which companies report information about operating segments, products, geographic areas and major customers. The method of determining what information to report is based on the way that management organizes the operating segment within the enterprise for making operating decisions and assessing financial performance. The Company focuses on the manufacturing, sale and licensing of highly engineered plastic sheet and film products to customers throughout the world. The Company procures raw materials from multiple similar vendors and expects similar long-term economic characteristics for its products.

 

Operations by Geographic Area

 

   Three Months Ended
June 30,
  Six Months Ended
June 30,
   2018  2017  2018  2017
Net Sales                    
Spain   $1,906   $2,042   $3,382   $3,754 
China        983    30    2,974 
India    478        904     
United States    131    32    1,945    42 
Total Net Sales   $2,515   $3,057   $6,261   $6,770 

 

Long-Lived Assets by Geographic Area

 

   June 30,
2018
  December 31,
2017
Long-Lived Assets          
United States   $1,237   $1,311 
Spain    6,454    7,141 
China    76    276 
Total Long-Lived Assets   $7,767   $8,728 

 

Foreign sales are based on the country in which the sales originated. Net sales to four of the Company’s major customers that exceeded 10% of the Company’s consolidated net sales for the three months ended June 30, 2018 were $1,401. Net sales to two of the Company’s major customers that exceeded 10% of the Company’s consolidated net sales for the six months ended June 30, 2018 were $1,444. Net sales to one of the Company’s major customers that exceeded 10% of the Company’s consolidated net sales for the three and six months ended June 30, 2018 were $683 and $1,330, respectively. Accounts receivable from two customers amounted to $1,072 and $70 as of June 30, 2018 and December 31, 2017, respectively.

 

NOTE 17—RELATED PARTY TRANSACTION

 

Huhui Supply Agreement

 

The Company’s Chinese subsidiary, Specialized Technology Resources Solar (Suzhou) Co. Ltd. (“STR China”) entered into a supply agreement (the “Huhui Supply Agreement”) dated as of December 31, 2014 with Zhangjiagang Huhui Segpv Co. Ltd ("Huhui"), a solar module manufacturer and an affiliate of Zhenfa. Pursuant to the Huhui Supply Agreement, STR China agreed to supply Huhui with the Company's encapsulant products and Huhui agreed (i) to purchase

not less than 535 MW worth of encapsulants (the “Minimum Amount”) during each contract year, (ii) to pay the Company a deposit equal to 10% of the Minimum Amount, and (iii) not to purchase encapsulant products from other encapsulant manufacturers. The initial term of the Huhui Supply Agreement was for one year; however, such initial term was extended due to failure by Huhui to purchase the Minimum Amount at the end of the first year anniversary of the effective date of the Huhui Supply Agreement. The Huhui Supply Agreement further provided that Huhui’s obligations were contingent (unless otherwise provided in the agreement) upon (i) the delivery by STR China of an initial shipment of products in accordance with the specifications and (ii) the qualification of the products by Huhui during a sample production run of not less than 30 days. As of December 31, 2017, Huhui had not commenced the sample production run. The Huhui Supply Agreement automatically renewed for additional one year terms if either party failed to notify the other party at least 90 days prior to the

 

 14 
STR Holdings, Inc. and Subsidiaries
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)
All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 17—RELATED PARTY TRANSACTION (Continued)

 

end of the then current term that it was electing to terminate the agreement. The Company believes that the terms and conditions set forth in the Huhui Agreement at that time were fair and reasonable to the Company. The Company received

$1,148 as a deposit from Huhui during the year ended December 31, 2015, which was included in accrued liabilities on the Condensed Consolidated Balance Sheets.

 

Huhui did not complete its 30 day production run as contemplated under the Supply Agreement and on March 27, 2018, following the approval of the Company’s Special Committee of Continuing Directors, STR China entered into an agreement to terminate the Supply Agreement (the “Termination Agreement”). Pursuant to the Termination Agreement,

Huhui agreed that STR China would retain the Deposit, and each of Huhui and STR China agreed to release the other from any liability or further obligations under the Supply Agreement. The Company recognized the full amount of the deposit as other income on the Condensed Consolidated Statement of Comprehensive Income (Loss).

 

 

 

 

 

 

 

 

 15 

 

 

Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis of the financial condition and results of our operations should be read together with our Condensed Consolidated Financial Statements and the related Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements, based on current expectations and related to future events and our future financial performance, that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under Item 1A,—Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2017, as amended by Form 10-K/A filed with the SEC on April 28, 2018.

 

Forward-Looking Statements

 

This Quarterly Report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to inherent risks and uncertainties. These forward-looking statements present our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business and are based on assumptions that we have made in light of our industry experience and perceptions of historical trends, current conditions, expected future developments and other factors management believes are appropriate under the circumstances. However, these forward-looking statements are not guarantees of future performance or financial or operating results. Forward-looking statements include, but are not limited to, the statements regarding the following: (1) incurring substantial losses for the foreseeable future and our inability to achieve or sustain profitability in the future; (2) the potential impact of pursuing strategic alternatives, including dissolution and liquidation of our Company, winding up our operations in China, restructuring our business to align with our customers’ geography; (3) our reliance on a single product line and any contemplated pursuits of new market sectors; (4) our securing net sales to new customers, growing net sales to existing key customers and increasing our market share; (5) customer concentration in our business and our relationships with and dependence on key customers; (6) the outsourcing arrangements and reliance on third parties for the manufacture of a portion of our encapsulants; (7) technological changes in the solar energy industry or our failure to develop and introduce or integrate new technologies could render our encapsulants uncompetitive or obsolete; (8) competition; (9) excess capacity in the solar supply chain; (10) demand for solar energy in general and solar modules in particular; (11) our operations and assets in China and India being subject to significant political and economic uncertainties; (12) limited legal recourse under the laws of China and India if disputes arise; (13) our ability to adequately protect our intellectual property, particularly during the outsource manufacturing of our products; (14) our lack of credit facility and our inability to obtain credit; (15) a significant reduction or elimination of government subsidies and economic incentives or a change in government policies that promote the use of solar energy; (16) volatility in commodity costs; (17) our customers’ financial profile causing additional credit risk on our accounts receivable; (18) our dependence on a limited number of third-party suppliers for raw materials for our encapsulants and other significant materials used in our process; (19) potential product performance matters and product liability; (20) our substantial international operations and shift of business focus to India; (21) the impact of changes in foreign currency exchange rates on financial results, and the geographic distribution of revenues; (22) losses of financial incentives from government bodies in certain foreign jurisdictions; (23) the ability to successfully complete our investment in Spain on a timely basis or within budget, if at all, or that we will be able to achieve our anticipated revenue, earnings or payback from this new investment; (24) that we will be able to timely collect the full amount of the insurance proceeds that we anticipate to support this project, or that we will be able to obtain the loan we have applied for from the regional government on favorable terms if at all and (25) the other risks and uncertainties described under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in subsequent periodic reports on Form 10-K, 10-Q and 8-K. You are urged to carefully review and consider the disclosure found in our filings, which are available on http://www.sec.gov or http://www.strsolar.com. Should one or more of these risks or uncertainties materialize, or should any of these assumptions prove to be incorrect, actual results may vary materially from those projected in these forward-looking statements. We undertake no obligation to publicly update any forward-looking statement contained in this Quarterly Report, whether as a result of new information, future developments or otherwise, except as may be required by law.

 

Overview

 

STR Holdings, Inc. and its subsidiaries (“we”, “us”, “our” or the “Company”) commenced operations in 1944 as a plastics and industrial materials research and development company. Based upon our expertise in polymer science, we evolved into a global provider of encapsulants to the solar industry. Encapsulant is a critical component used to protect and hold solar modules together.

 

We were the first to develop ethylene-vinyl acetate (“EVA”) based encapsulants for use in commercial solar module manufacturing. Our initial development effort was conducted while under contract to the predecessor of the U.S. Department of Energy in the 1970s. Since that time, we have expanded our solar encapsulant business, by investing in research and development and global production capacity.

 

 16 

 

 

Recent Developments

 

Wind-down of China Manufacturing Operations. Our business unit in China (“STR China”) incurred a loss of approximately $5.8 million during 2016, including a bad debt expense of $1.5 million. In October 2016, a fire destroyed one of our two China-based production lines and caused substantial damage to our building and some of our ancillary equipment. In light of continued poor financial results of STR China, as well as the effects of the fire, we conducted an orderly wind down of our China manufacturing operations to reduce operating losses related to this business unit. By the close of 2017, we effectively completed the wind down process, with only a small administrative team remaining in an office under a short-term lease.

 

India Tolling Plan. A review of our production in China revealed that our sales volume was shifting to customers in India. Moreover, our customers in India generally were more reliable in terms of payment and pricing than our customers in China. In conjunction with our wind down of manufacturing operations in China, we have entered into an agreement with a tolling partner in India. We sold our undamaged production line from STR China to this tolling partner and it is now in commercial operation making STR-formulated encapsulant products. By using a tolling partner, our goal is to continue to serve and grow our customer base in India without having to make a significant direct capital investment. We have not worked with our tolling partner in India prior to 2017 and we cannot ensure that the tolling partner will provide us with the support we anticipate or that we can otherwise successfully manage our collaboration with our tolling partner. If problems develop in our relationship with our India tolling partner, or if such party fails to perform as expected, it could lead to product defects, manufacturing and shipping delays, significant cost increases, changes in our strategies, and even failure of our initiatives, each of which may have a material adverse effect on our business, financial condition, and results of operations. We cannot assure that the India tolling plan will continue to be successful or that it is sustainable in the long term. We recently sold an additional production line to our tolling partner to enable the tolling partner to further increase its manufacturing capacity in India.

 

We continue to reorganize our encapsulant business to better align with customer geography, to reduce the cash burn related to unprofitable locations, to convert assets to cash for potential redeployment into more profitable endeavors and possible business opportunities in potentially more profitable parts of the solar supply-chain, and to evaluate other strategic alternatives.

 

High-End Food Packaging. In the fourth quarter of 2017, we initiated a significant investment through our wholly-owned subsidiary in Spain to enter the high-end food packaging business. This investment, which leverages our plastics expertise, includes the purchase of new, state-of-the-art plastics processing equipment and related building improvements along with the addition of experienced staff to pursue manufacturing and sales of high-end food packaging products. As anticipated, we have received and applied certain conditional insurance proceeds to this project (see “Manufacturing Facility Fire” below), helping to offset our net capital investment. These insurance proceeds are available to the Company only if we invest in new plastics manufacturing equipment. We have been advised by our insurer that our investment qualifies for reimbursement under the terms of our policy and, accordingly, they paid our U.S. entity the amount of $0.8 million in October 2017, to cover the cost of the deposit for the primary capital equipment. We expect them to reimburse our U.S entity for approximately an additional $1.8 million during 2018 as we continue to make qualifying capital investment under the packaging project. We have also applied for loans of up to €2.0 million from the regional government of Asturias, Spain to further support the project. Subject to the timely purchase and installation of equipment, we expect to begin production by 2019. The food packaging business is highly competitive having market participants with substantially more resources and experience than us. We will be a new entrant in this market and we cannot assure you that we will be successful in this new endeavor. In particular, we cannot assure that we will be able to successfully complete our investment in this new business on a timely basis or within budget, if at all, or that we will be able to achieve our anticipated revenue or earnings from this new investment. Nor can we assure that we will be able to timely collect the full amount of the insurance proceeds that we anticipate to support this project, or that we will be able to obtain the loan(s) we have applied for from the regional government on favorable terms if at all.

 

Alternative Transactions. In the event that we are not successful in restructuring our plastics manufacturing business, in entering into the high-end food packaging business, or in completing other strategic transactions, we also intend to consider alternatives, including without limitation, the acquisition of another business, the divestiture of all or certain of our assets, joint ventures and other transactions outside the ordinary course of business.

 

 17 

 

 

If we are unsuccessful in executing on our strategic plans to ultimately achieve profitability by reorganizing our plastics manufacturing business and entering the high-end packaging business, we may also decide to wind down or cease any or all of our operations.

 

In addition, any wind-down or dissolution may be a lengthy and complex process, yield unexpected results and delay any potential distributions to our stockholders. Such process may also require the further expenditure of our resources, such as legal, accounting and other professional fees and expenses and other related charges, which would decrease the amount of assets available for distribution to our stockholders.

 

Manufacturing Facility Fire. During the fourth quarter of 2016, we recorded a $0.9 million loss on disposal of fixed assets attributable to our Manufacturing Facility Fire. During 2017, STR China received interim payments totaling RMB12.7 million (approximately $1.9 million as of June 30, 2018) from our local China insurance carrier related to the existing fire insurance claim. During 2017, we also received $0.8 million in the U.S. under the master property insurance plan related to the same claim. These payments do not represent a final settlement, and we continue to work with our agents and the carrier to finalize the claim.

 

Equipment Purchase Agreement and Technology License Agreement. On January 16, 2018, we entered into an equipment purchase agreement and a technology license agreement (together, the “Agreements”) with a manufacturer of solar photovoltaic (PV) modules (the “Purchaser”).

 

Under the equipment purchase agreement, the Company will purchase from a third party specialized equipment (the “Equipment”) for the production of one of the Company’s proprietary encapsulants (the “Encapsulant”), resell the Equipment to the Purchaser, install the Equipment at a facility of the Purchaser and train Purchaser personnel in the Equipment’s use. Under the technology license agreement, the Company has granted the Purchaser the right to use the formula for the Encapsulant and certain of the Company’s production techniques to make or have made the Encapsulant for use in PV modules manufactured by the Purchaser. The license granted to the Purchaser pursuant to the technology license agreement is exclusive with respect to specified types of PV modules manufactured by the Purchaser, and nonexclusive as to all other types of PV modules. The Purchaser may also sublicense its rights under the technology license agreement to licensees of its PV module manufacturing processes.

 

Under the Agreements, the Purchaser will pay the Company an aggregate of $6.0 million. Billing and payment under the Agreements follows a schedule involving certain milestones relating to the qualification of the Encapsulant and installation, acceptance and operation of the Equipment. The Company received the initial payment of $1.8 million during the first quarter of 2018, with the balance to follow during the remainder of 2018 and 2019 as milestones occur. For revenue recognition purposes under ASC 606, $1.8 million was recorded as revenue during the first quarter of 2018 as initial performance obligations were satisfied, and the Company expects that the balance of the $6.0 million aggregate amount will be recognized as revenue when the remaining performance obligations are fulfilled. See Note 2 to the Consolidated Financial Statements.

 

The Company does not expect the Agreements to impact or otherwise displace any of its existing business in the solar encapsulant market.

 

2014 Transaction with Zhenfa

 

In 2014, we entered into certain definitive agreements with Zhenfa Energy Group Co., Ltd., a Chinese limited liability company (“Zhenfa”), and its indirect wholly owned subsidiary, Zhen Fa New Energy (U.S.) Co., Ltd., a Nevada corporation (“Zhenfa U.S.”).

 

Purchase Agreement

 

On August 11, 2014, we entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Zhenfa U.S., pursuant to which Zhenfa U.S. acquired approximately 51% of our then outstanding shares of common stock on December 15, 2014 (the “Closing Date”).

 

Sales Service Agreement

 

In connection with the execution of the Purchase Agreement, Specialized Technology Resources, Inc., our wholly owned subsidiary, entered into a sales service agreement (the "Sales Service Agreement") with Zhenfa, whereby Zhenfa agreed, among other things, to assist us in a number of endeavors, including, without limitation, marketing and selling our products in China, acquiring local raw materials, hiring and training personnel in China, and complying with Chinese law. The Sales Service Agreement became effective on the date of Closing, for an initial term of two years, and automatically renews for one year periods unless terminated earlier. The Sales Service Agreement may also be terminated by either party at such time as Zhenfa and its affiliates own less than 10% of our outstanding common stock.

 

 18 

 

 

As we have substantially discontinued operations in China, Zhenfa is not currently providing us with any material services under this agreement. Any activities with Zhenfa under the Sales Service Agreement are subject to the oversight of our Special Committee of Continuing Directors.

 

CRITICAL ACCOUNTING POLICIES

 

Our discussion and analysis of our financial condition and results of operations are based upon our interim Condensed Consolidated Financial Statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of these Condensed Consolidated Financial Statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, net sales and expenses, and related disclosures of contingent assets and liabilities. We continually evaluate our estimates, including those related to bad debts, valuation of inventory, long-lived assets, product performance matters, income taxes, stock–based compensation and deferred tax assets and liabilities. We base our estimates on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates. The accounting policies we believe to be most critical to understand our financial results and condition and that require complex and subjective management judgments are discussed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations-Critical Accounting Policies” in our Annual Report on Form 10–K filed with the Securities and Exchange Commission on March 16, 2018, as amended by Form 10-K/A filed with the SEC on April 28, 2018.

 

There have been no changes in our critical accounting policies during the quarter ended June 30, 2018.

 

RESULTS OF OPERATIONS

 

Condensed Consolidated Results of Operations

 

The following tables set forth our condensed consolidated results of operations for the three and six months ended June 30, 2018 and 2017:

 

   Three Months Ended
June 30,
  Six Months Ended
June 30,
   2018  2017  2018  2017
Net sales   $2,515   $3,057   $6,261   $6,770 
Cost of sales    3,490    3,695    5,935    7,905 
Gross (loss) profit    (975)   (638)   326    (1,135)
Selling, general and administrative expenses    1,380    1,299    3,072    3,280 
Research and development expense    190    236    405    550 
Provision (recovery) for bad debt expense    67    (215)   6    (380)
Operating loss    (2,612)   (1,958)   (3,157)   (4,585)
Interest income (expense), net    16    (3)   15    (7)
Other income, net (Note 8)    183    1,632    1,203    1,206 
Loss on disposal of fixed assets    (383)   (16)   (383)   (13)
Foreign currency transaction loss    (106)   (64)   (162)   (75)
Loss before income tax expense (benefit)    (2,902)   (409)   (2,484)   (3,474)
Income tax expense (benefit)    172    (125)   271    (143)
Net loss   $(3,074)  $(284)  $(2,755)  $(3,331)

 

Net Sales

 

   Three Months Ended June 30,  Six Months Ended June 30,
   2018  2017  Change  2018  2017  Change
   Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %  Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %
Net sales   $2,515    100.0%  $3,057    100.0%  $(542)   (17.7)%  $6,261    100.0%  $6,770    100.0%  $(509)   (7.5)%

 

 19 

 

 

The decrease in net sales for the three months ended June 30, 2018 compared to the corresponding period in 2017 was driven by an approximate 30% decrease in sales volume partially offset by a 16% increase in our average selling price (“ASP”).

 

The volume decline was primarily driven by a 21% decrease in Spain and a 100% decrease in China, partially offset by sales to customers in India through our tolling partner.

 

The decrease in net sales for the six months ended June 30, 2018 compared to the corresponding period in 2017 was driven by a $2.3 million reduction in encapsulant sales partially offset by recognition of $1.8 million related to completed performance obligations under the equipment purchase agreement and the technology license agreement. The decrease in encapsulant sales was primarily attributable to an approximate 45% decrease in sales volume that was partially offset by an approximate 21% increase in our ASP, relating to our discontinuance of our lower priced sales in China.

 

The volume decline was primarily driven by a 25% volume decrease in Spain and a 99% volume decrease in China, partially offset by sales to customers in India through our tolling partner. The increase in ASP was primarily attributable to our elimination of our lower priced and unprofitable sales in China.

 

On a sequential basis, net sales decreased by $1.2 million, or 32.9%, compared to the three months ended March 31, 2018. This decrease was primarily driven by recognition of $1.8 million related to completed performance obligations under the equipment purchase agreement and the technology license agreement during the first quarter, partially offset by a 24% increase in encapsulant sales volume and a 1% increase in ASP.

 

Cost of Sales

 

   Three Months Ended June 30,  Six Months Ended June 30,
   2018  2017  Change  2018  2017  Change
   Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %  Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %
Cost of sales   $3,490    138.8%  $3,695    120.9%  $(205)   (5.5)%  $5,935    94.8%  $7,905    116.8%  $(1,970)   (24.9)%

 

The decrease in our cost of sales for the three months ended June 30, 2018 compared to the corresponding period in 2017 was primarily driven by the 30% decrease in encapsulant sales volume partially offset by an approximate 15% increase in raw material cost per unit. The higher raw material cost per unit was primarily driven by a 6% increase in resin costs, as well as a 4% decrease in paperless sales mix. Direct labor increased by $0.3 million mainly due to $0.3 million of restructuring charges partially offset by the sales volume decrease. Overhead costs decreased by less than $0.1 million primarily due to continued cost-reduction actions.

 

The decrease in our cost of sales for the six months ended June 30, 2018 compared to the corresponding period in 2017 was primarily driven by the 45% decrease in encapsulant sales volume partially offset by an approximate 14% increase in raw material cost per unit. The higher raw material cost per unit was primarily driven by a 10% increase in resin costs, as well as a 5% decrease in paperless sales mix. Direct labor increased by $0.2 million mainly due to $0.3 million of restructuring charges partially offset by the sales volume decrease. Overhead costs decreased by $0.3 million primarily due to continued cost-reduction actions.

 

Gross (Loss) Profit

 

   Three Months Ended June 30,  Six Months Ended June 30,
   2018  2017  Change  2018  2017  Change
   Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %  Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %
Gross (loss) profit   $(975)   (38.8)%  $(638)   (20.9)%  $(337)   (52.8)%  $326    5.2%  $(1,135)   (16.8)%  $1,461    128.7%

 

Gross loss, as a percentage of net sales, declined for the three months ended June 30, 2018 compared to the corresponding period in 2017 mainly as a result of $0.6 million of restructuring charges related to eliminating certain positions at our Spain location, as well as a decrease in sales volume combined with an increase in raw material prices.

 

Gross profit (loss) as a percentage of net sales improved for the six months ended June 30, 2018 compared to the corresponding period in 2017 mainly as a result of recognition of $1.8 million related to completed performance obligations under the equipment purchase agreement and the technology license agreement. This was partially offset by $0.6 million of restructuring charges related to eliminating certain positions at our Spain facility, as well as a decrease in sales volume combined with an increase in raw material prices.

 

 20 

 

 

Selling, General and Administrative Expenses (“SG&A”)

 

   Three Months Ended June 30,  Six Months Ended June 30,
   2018  2017  Change  2018  2017  Change
   Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %  Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %
SG&A   $1,380    54.9%  $1,299    42.5%  $81    6.2%  $3,072    49.1%  $3,280    48.4%  $(208)   (6.3)%

 

SG&A increased by $0.1 million for the three months ended June 30, 2018 compared to 2017. This increase was primarily driven by a $0.3 million increase in restructuring expense partially offset by a $0.1 million decrease in professional fees.

 

SG&A decreased by $0.2 million for the six months ended June 30, 2018 compared to 2017. This decrease was primarily driven by $0.2 million in lower labor and benefits and a $0.1 million reduction in non-cash stock compensation expense partially offset by $0.2 million in increased restructuring expense.

 

Research and Development Expense (“R&D”)

 

   Three Months Ended June 30,  Six Months Ended June 30,
   2018  2017  Change  2018  2017  Change
   Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %  Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %
R&D   $190    7.6%  $236    7.7%  $(46)   (19.5)%  $405    6.5%  $550    8.1%  $(145)   (26.4)%

 

Research and development expense decreased by less than $0.1 million and $0.1 million for the three and six months ended June 30, 2018, respectively, compared to 2017, as we continued to economize these activities.

 

Provision (Recovery) for Bad Debt Expense

 

   Three Months Ended June 30,  Six Months Ended June 30,
   2018  2017  Change  2018  2017  Change
   Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %  Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %
Provision (recovery) for bad debt expense   $67    2.7%  $(215)   (7.0)%  $282    131.2%  $6    0.1%  $(380)   (5.6)%  $386    101.6%

 

The provision for bad debt expense recorded during the three and six months ended June 30, 2018 and June 30, 2017 primarily related the aging of accounts receivable under our policy, primarily in the U.S. The provision was partially offset by receiving cash for previously aged accounts receivable that were reserved for under our policy, primarily in China.

 

Other Income (Expense), net

 

   Three Months Ended June 30,  Six Months Ended June 30,
   2018  2017  Change  2018  2017  Change
   Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %  Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %
Other income (expense),  net   $183    7.3%  $1,632    53.4%  $(1,449)   (88.8)%  $1,203    19.2%  $1,206    17.8%  $(3)   (0.2)%

 

On March 27, 2018, following the approval of the Company’s Special Committee of Continuing Directors, STR China entered into an agreement to terminate the Huhui Supply Agreement (the “Termination Agreement”). Pursuant to the Termination Agreement, Huhui agreed that STR China would retain the deposit, and each of Huhui and STR China agreed to release the other from any liability or further obligations under the Supply Agreement. As a result of the Termination Agreement, we recorded other income of $1.0 million during the first quarter of 2018.

 

 21 

 

 

During the three months ended June 30, 2017, our China subsidiary received interim payments of $1.5 million from our local China insurance carrier related to the existing fire insurance claim. These payments do not represent a final settlement, and we continue to work with our agents and the carrier to finalize the claim.

 

In July 2015, we announced a restructuring plan that included the closure of our Malaysia facility, effective August 2, 2015. During 2016, we entered into a definitive Purchase and Sale Agreement for the land-use right and the building for a purchase price of RM25.0 million (approximately $6.2 million as of June 30, 2018). As a result of the pending sale (which was subject to the approval of the JPA), a gain on assets held for sale of $0.2 million and a loss on assets held for sale of $0.3 million, related to the foreign currency fluctuation of the Malaysian Ringgit, was recorded during the three and six months ended June 30, 2017, respectively. As noted above, this agreement terminated prior to the consummation of the sale. The Company has re-launched the sale process for its Malaysia facility.

 

Foreign Currency Transaction (Loss) Gain

 

   Three Months Ended June 30,  Six Months Ended June 30,
   2018  2017  Change  2018  2017  Change
   Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %  Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %
Foreign currency transaction (loss) gain   $(106)   (4.2)%  $(64)   (2.1)%  $(42)   (65.6)%  $(162)   (2.6)%  $(75)   (1.1)%  $(87)   (116.0)%

 

The foreign currency transaction impact was a loss of $0.1 million for each of the three months ended June 30, 2018 and June 30, 2017 period. Both amounts are primarily the result of volatility in the Euro spot exchange rate versus the U.S. Dollar.

 

The foreign currency transaction loss for the six months ended June 30, 2018 was $0.2 million compared to a loss of $0.1 million for the six months ended June 30, 2017.

 

Our primary foreign currency exposures are intercompany loans, U.S. dollar cash balances in foreign locations and some U.S. dollar denominated accounts receivable at our Spain and China facilities.

 

Income Tax Expense (Benefit)

 

   Three Months Ended June 30,  Six Months Ended June 30,
   2018  2017  Change  2018  2017  Change
   Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %  Amount  % of
Total
Net
Sales
  Amount  % of
Total
Net
Sales
  Amount  %
Income tax expense (benefit)   $172    6.8%  $(125)   (4.1)%  $297    237.6%  $271    4.3%  $(143)   (2.1)%  $414    289.5%

 

During the three and six months ended June 30, 2018, we recorded an income tax expense of $0.2 million and $0.3 million, resulting in an effective tax rate of (5.9%) and (10.9%), respectively. This effective tax rate for the three months ended June 30, 2018 differs from the U.S. statutory tax rate primarily due to the effect of taxes on foreign earnings.

 

During the three months ended June 30, 2018, the Company did not record any measurement period adjustments to the provisional estimates recorded at December 31, 2017 relating to the Tax Cuts and Jobs Act. Final accounting for these impacts is expected in the third quarter of 2018 subsequent to the Company’s completion of the 2017 tax return.

 

During the three and six months ended June 30, 2017, we recorded an income tax benefit of $0.1 million and $0.1 million, respectively, resulting in an effective tax rate of 30.6% and 4.1%, respectively. The income tax benefit was primarily related to the allocation of tax expense between operations and other comprehensive income when applying the exception to the ASC 740 intra-period allocation rule. The projected annual effective tax rate, excluding the intraperiod allocation, is 0.0% as compared to the U.S. federal statutory rate of 35.0%. The annual effective tax rate is principally driven by changes in valuation allowances.

 

Cost-Reduction Actions

 

On March 7, 2017 we made the decision to wind down our China manufacturing operations substantially by the end of the second quarter of 2017. The decision was consistent with ongoing efforts to reorganize our encapsulant business to better align with customer geography, to reduce losses related to unprofitable locations and to convert assets to cash for potential redeployment into more profitable endeavors. In connection with the restructuring, we do not expect any significant asset impairment charges and recorded $0.1 million of severance charges during the first six months of 2017 and the first six months of 2018. The Company sold certain production and testing equipment from the China facility to its tolling partner in India during the third quarter of 2017.

 

 22 

 

 

In June 2018, we eliminated certain positions at our Spain facility effective June 18, 2018. We recorded $0.6 million of severance and benefits in cost of sales and $0.1 million of severance and benefits in selling, general and administrative expenses during the second quarter of 2018.

 

A roll-forward of the severance and other exit cost accrual activity was as follows:

 

   June 30,
2018
  June  30,
2017
Balance as of beginning of year   $0.1   $0.3 
Additions    0.7    0.1 
Reductions    (0.7)   (0.2)
Reversals        (0.1)
Balance as of end of period   $0.1   $0.1 

 

The restructuring accrual consisted of $0.1 million and $0.1 million for severance and benefits as of June 30, 2018 and 2017, respectively.

 

Financial Condition, Liquidity and Capital Resources

 

We have funded our operations primarily through our earnings and existing cash balance. As of June 30, 2018, our principal source of liquidity was $11.7 million of cash. Our principal needs for liquidity have been, and for the foreseeable future we expect will continue to be, for working capital and capital investments. We are also seeking to sell our Johor, Malaysia facility, as discussed herein. With respect to China, evolving currency control regulations may limit our access to the $0.4 million of cash located in China as of June 30, 2018 for use outside the country. Although we believe that our timely available cash will be sufficient to meet our liquidity needs, including capital investments, through at least the next 12 months, if we are unable to collect our accounts receivable or fail to receive payment in a timely fashion, our financial condition and results of operations will be negatively affected.

 

Our wholly owned Spanish subsidiary, Specialized Technology Resources España S.A.U. (“STR Spain”), has a factoring agreement to sell, with recourse, certain European, U.S. and other foreign company-based receivables to Eurofactor Hispania S.A.U., who was later acquired by Credit Agricole Leasing & Factoring Sucursal en España during the first quarter of 2017. Under the current terms of the factoring agreement, the maximum amount of outstanding advances at any one time is €1.5 million (approximately $1.8 million as of June 30, 2018), which is subject to adjustment based on the level of eligible receivables, restrictions on concentrations of receivables and the historical performance of the receivables sold. The annual discount rate is 2% plus EURIBOR for Euro-denominated receivables and 2% plus LIBOR for all other currencies. The agreement renews annually unless terminated by either party with 90 days prior written notice. As of June 30, 2018, €1.2 million ($1.4 million as of June 30, 2018) was available under the factoring agreement based upon receivables outstanding.

 

In connection with our continued efforts to return our encapsulant business to profitability, on July 24, 2015, our Board approved a restructuring of our encapsulant business that included the shut-down of our Malaysia manufacturing facility, effective August 2, 2015. We are seeking to sell our Johor, Malaysia facility having already sold most of its production and ancillary equipment. In connection with the shut-down and potential sale of the Malaysia facility, we incurred approximately $1.3 million of associated non-recurring costs during the second half of 2015. In 2016, in connection with the potential sale of the Malaysia facility (specifically, the land-use right and building), an analysis of the asset group was performed and an impairment of assets held for sale of $1.7 million was recorded. As previously noted, we entered into an agreement to sell our rights to the facility for RM25.0 million (approximately $6.2 million as of June 30, 2018), however that agreement terminated during 2017 prior to consummation of the transaction. We have since re-launched the sale process for our Malaysia facility.

 

In the fourth quarter of 2017, the Company initiated a significant investment through STR Spain to enter the high-end food packaging business. This ongoing investment, which leverages our plastics expertise, includes the purchase of new, state-of-the-art plastics processing equipment and related building improvements along with the addition of experienced staff to pursue manufacturing and sales of high-end food packaging products. We have received and applied certain conditional insurance proceeds to this project, helping to offset our net capital investment. These insurance proceeds are available to the Company only if we invest in new plastics manufacturing equipment We have been advised by our insurer that our investment qualifies for reimbursement under the terms of our policy and, accordingly, they have paid our U.S. entity the amount of $0.8 million in October 2017, to cover the cost of the deposit for the primary capital equipment. We expect them to reimburse our U.S. entity for an additional approximately $1.8 million during 2018 as we continue to make qualifying capital investment under the packaging project. We have also applied for loans of up to $2.4 million from the regional government of Asturias, Spain to further support the project. Subject to the timely purchase and installation of equipment, we expect to begin production by 2019. The food packaging business is highly competitive having market participants with substantially more resources and experience than us. We will be a new entrant in this market and we cannot assure that we will be successful in this new endeavor. In particular, we cannot assure that we will be able to successfully complete our investment in this new business on a timely basis or within budget, if at all, or that we will be able to achieve our anticipated revenue or earnings from this new investment. Nor can we assure that we will be able to timely collect the full amount of the insurance proceeds that we anticipate to support this project, or that we will be able to obtain the loan(s) we have applied for from the regional government on favorable terms if at all.

 

 23 

 

 

We remain open to exploring possible business opportunities, alternate geographic markets, as well as other strategic alternatives. We cannot assure that we will be able to successfully pursue any such potential opportunities. If we are successful in pursuing any such opportunities, we may be required to expend significant funds, incur debt or other obligations or issue additional securities, any of which could significantly dilute our current stockholders and may negatively affect our operating results and financial condition. We cannot assure that any such strategic opportunities or related transactions, or any financing in connection therewith, would be available on favorable terms, if at all, or that we will realize any anticipated benefits from any such transactions that we complete. In the event that we are not successful in restructuring our encapsulant business or pursuing opportunities in the downstream solar market or other strategic transactions, we also intend to consider alternatives, including, without limitation, the acquisition of another business, the divestiture of all or certain of our assets, joint ventures and other transactions outside the ordinary course of business.

 

If we are not able to fund our working capital needs, we will have to slow our projected growth, which may further impede or delay our attempt to return to sustainable profitability. We expect to fund our cash requirements with our existing cash, leveraging our European factoring facility and other potential working capital financing arrangements.

 

Our cash and cash equivalents balance is located in the following geographies (dollars in thousands):

 

   June 30, 2018
United States   $10,002 
Spain    1,039 
Malaysia    206 
China    359 
Hong Kong    103 
India  1 
Consolidated   $11,710 

 

As noted above, due to, among other things, the difficulty repatriating cash to the U.S., we may have limited access to the $0.4 million of cash located in China for use outside the country.

 

We do not permanently re-invest our Malaysia subsidiary’s earnings. Based upon the Malaysia subsidiary’s liabilities to us, we expect the undistributed earnings of our Malaysia subsidiary will be repatriated to the U.S. in a tax-free manner. We do not permanently re-invest our Spain earnings, so this cash balance is available for dividend repatriation (less any applicable withholding taxes). We have not elected to permanently re-invest our Hong Kong and China earnings and plan to utilize our cash located in Hong Kong and China to fund working capital requirements and wind down costs. Our goal is to achieve and maintain self-sufficiency in each of our manufacturing locations to meet local cash requirements. We cannot assure that we will continue to fund the manufacturing operations in any location, if such operations would require investment of additional cash from other jurisdictions.

 

Cash Flows

 

Cash Flow from Operating Activities

 

Net cash used in operating activities was $2.0 million for the six months ended June 30, 2018 compared to net cash provided by operating activities of $1.1 million for the six months ended June 30, 2017. Net loss plus and minus non-cash adjustments declined by approximately $1.2 million for the six months ended June 30, 2018 compared to the same period in 2017. This decline was driven primarily by the receipt of the $1.5 million partial payment related to the insurance claim from the Manufacturing Facility Fire during 2017.

 

 24 

 

 

Cash Flow from Investing Activities

 

Net cash provided by investing activities was $0.2 million and net cash used in investing activities was $0.4 million for the six months ended June 30, 2018, respectively. We expect remaining 2018 consolidated capital expenditures to be approximately $4.0 million related to the high-end food packaging equipment.

 

Cash Flow from Financing Activities

 

Net cash used in financing activities was less than $0.1 million and net cash provided by financing activities was $0.1 million for the six months ended June 30, 2018 and 2017, respectively, primarily due to funds received by our Spanish subsidiary related to the factoring agreement.

 

Off-Balance Sheet Arrangements

 

We have no significant off-balance sheet financing arrangements.

 

Effects of Inflation

 

Inflation generally affects us by increasing costs of raw materials, labor and equipment. During the first six months of 2018, we were not materially affected by inflation.

 

Recently Issued Accounting Standards

 

There are no new accounting pronouncements that we believe may have an impact on our consolidated financial statements.

 

Item 3.    Quantitative and Qualitative Disclosures About Market Risk

 

We are not required to provide this Item 3 because we are a smaller reporting company.

 

Item 4.    Controls and Procedures

 

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports to the Securities Exchange Act of 1934, as amended (“Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chairman, President and Chief Executive Officer and our Vice President, Chief Financial Officer and Chief Accounting Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

 

As of June 30, 2018, we carried out an evaluation, under the supervision and with the participation of our management, including our Chairman, President and Chief Executive Officer and our Vice President, Chief Financial Officer and Chief Accounting Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that evaluation, our Chairman, President and Chief Executive Officer and our Vice President, Chief Financial Officer and Chief Accounting Officer concluded that our disclosure controls and procedures are effective.

 

Changes in Internal Control Over Financial Reporting

 

There have not been any changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the second fiscal quarter of our fiscal year ended December 31, 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 25 

 

 

PART II. OTHER INFORMATION

 

Item 1.    Legal Proceedings

 

From time to time, we are and have been a party to litigation that arises in the ordinary course of our business.

 

In October 2016, a complaint was filed by Solaria Energia y Medio Ambiente S.A. (“Solaria”) against the Company and its Spanish subsidiary, STR Spain, in the Court of the First Instance No. 8 in Oviedo, Spain, relating to a product quality claim in connection with a non-encapsulant product that STR Spain purchased from a vendor in 2005 and 2006 and resold to Solaria. The Company stopped selling this product in 2006. Solaria is seeking approximately €3.3 million (approximately $3.9 million as of June 30, 2018), plus interest, in damages. A trial was held on April 6, 2017, in Oviedo, Asturias, Spain. The Company is currently awaiting a ruling from the court.

 

In 2016, the Company filed suit against CEEG (Nanjing) Renewable Energy Co., Ltd. (“NRE”), the parent company of our former customer CSUN in Nanjing Jiangning District People’s Court, China. In a hearing held on August 10, 2016, the court found NRE delinquent in making payment against bona fide invoices dating back to April of 2015 and ordered NRE to pay the Company the amount of RMB8.0 million for encapsulant sold to CSUN, RMB0.1 million for court fees, RMB0.3 million for interest and RMB0.4 million for attorney fees. Following the subsequent failure of NRE to pay according to the order of the Nanjing Jiangning District People’s Court, the Company initiated enforcement proceedings in the enforcement department of Nanjing Jiangning District People’s Court and ultimately agreed to accept installment payments managed through the court, the first of which came due on February 28, 2018 and remains unpaid. The Company has since filed an application for the resumption of enforcement, for which the court has acknowledged receipt. The court has informed the Company that it will schedule another hearing to take further actions against NRE and its Chairman, Mr. Lu Tingxiu, to compel NRE to pay the Company according to the court order currently in force.

 

Item 1A.    Risk Factors

 

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2017, as amended by Form 10-K/A filed with the SEC on April 28, 2018, which could materially affect our business, financial position and results of operations. There have been no material changes to the risk factors as disclosed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2017, as amended by Form 10-K/A filed with the SEC on April 28, 2018.

 

Item 5.    Other Information

 

None.

 

 26 

 

 

Item 6.    Exhibits

 

10.1*   Amended and Restated 2009 Equity Incentive Plan
     
31.1   Certification of Chief Executive Officer pursuant to Rule 13a-14 Securities Exchange Act Rules 13a-14(a) and 15d-14(a), pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
     
31.2   Certification of Chief Financial Officer pursuant to Rule 13a-14 Securities Exchange Act Rules 13a-14(a) and 15d-14(a), pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
     
32.1   Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002.
     
32.2   Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002.
     
101.INS   XBRL Instance Document
     
101.SCH*   XBRL Taxonomy Extension Schema Document
     
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   XBRL Definition Linkbase Document
     
101.LAB   XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document

_______________________

 *Filed herewith.

 

Management contract or compensatory plan or arrangement.

 

 

 

 

 

 27 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  STR HOLDINGS, INC.  
  (Registrant)  
     
Date: August 10, 2018 /s/ Thomas D. Vitro  
  Name: Thomas D. Vitro  
  Title: Vice President, Chief Financial Officer and Chief Accounting Officer  
    (Duly Authorized Officer and Principal Financial Officer)  

 

 

 

 

 

 

 

 

 

 

 

 

 

28

 

 

EX-10.1 2 exh_101.htm EXHIBIT 10.1

Exhibit 10.1

 

 

STR Holdings, Inc.

2009 Equity Incentive Plan

(Amended and Restated dated as of February 20, 2018)

 

Article 1.               Establishment & Purpose

 

1.1  Establishment.  STR Holdings, Inc., a Delaware corporation (hereinafter referred to as the “Company”), establishes the 2009 Equity Incentive Plan (hereinafter referred to as the “Plan”) as set forth in this document.

 

1.2  Purpose of the Plan.  The purpose of this Plan is to attract, retain and motivate officers and employees of, consultants to, and non-employee directors providing services to the Company and its Subsidiaries and Affiliates, and to promote the success of the Company’s business by providing them with appropriate incentives and rewards either through a proprietary interest in the long-term success of the Company or compensation based on fulfilling their performance goals.

 

Article 2.               Definitions

 

Whenever capitalized in the Plan, the following terms shall have the meanings set forth below.

 

2.1          “Affiliate means any entity that the Company, either directly or indirectly, is in common control with, is controlled by or controls or any entity in which the Company has a substantial direct or indirect equity interest, as determined by the Board.

 

2.2          “Award means any Option, Stock Appreciation Right, Restricted Stock, Dividend Equivalent or Other Stock-Based Award that is granted under the Plan.

 

2.3          “Award Agreement means either (a) a written agreement entered into by the Company and a Participant setting forth the terms and provisions applicable to an Award granted under this Plan, or (b) a written statement issued by the Company to a Participant describing the terms and provisions of the actual grant of such Award.

 

2.4          “Beneficial Owner or Beneficial Ownership shall have the meaning ascribed to such term in Rule 13d-3 of the General Rules and Regulations under the Exchange Act.

 

2.5          “Board means the Board of Directors of the Company.

 

2.6          “Change of Control means the occurrence of any of the following events with respect to the Company, (i) any consolidation or merger with or into any other corporation, partnership, limited liability company or other entity in which the holders of capital stock of the Company immediately prior to such merger or consolidation no longer beneficially own, directly or indirectly, a majority of the outstanding capital stock or equity interest of the surviving corporation, partnership, limited liability company or other entity immediately after such merger or consolidation, (ii) the sale or transfer of the capital stock of the Company in which the holders of capital stock of the Company immediately prior to such sale or transfer no longer beneficially own, directly or indirectly, a majority of the outstanding capital stock or equity interest of the Company immediately after such sale or transfer, (iii) a sale or transfer of all or substantially all of the assets of the Company, or (iv) the license of all or substantially all of the assets of the Company where such license is substantially equivalent to a sale or transfer of all or substantially all of the assets of the Company.

  

2.7          “Code means the U.S. Internal Revenue Code of 1986, as amended from time to time.

 

2.8          “Committee means the Board, or any committee designated by the Board to administer this Plan.

 

2.9          “Company means STR Holdings, Inc., a Delaware corporation, and any successor thereto.

 

 

 

 

2.10        “Consultant means any person (other than an Employee or a Director) who is engaged by the Company, a Subsidiary or an Affiliate to render consulting or advisory services to the Company or such Subsidiary or Affiliate.

 

2.11        “Director means a member of the Board who is not an Employee.

 

2.12        “Dividend Equivalent means any right to a dividend equivalent granted from time to time under Article 6 of the Plan.

 

2.13        “Effective Date means the date set forth in Section 14.14.

 

2.14        “Employee means an officer or other employee of the Company, its Subsidiaries or an Affiliate, including a member of the Board who is such an employee.

 

2.15        “Exchange Act means the Securities Exchange Act of 1934, as amended from time to time.

 

2.16        “Fair Market Valuemeans, as of any date of determination (i)  if the Shares are listed on any established stock exchange or a national market system, its fair market value shall be the closing sales price for a share of such stock (or the closing bid, if no sales were reported) as quoted on such exchange or system for the last market trading day prior to the time of determination, as reported in The Wall Street Journal or such other source as the Board deems reliable; (ii)  if the Shares are regularly quoted by a recognized securities dealer but selling prices are not reported, its fair market value shall be the mean between the high bid and low asked prices for a Share on the last market trading day prior to the day of determination; or (iii) in the absence of an established market for the Shares, the fair market value thereof shall be determined in good faith by the Board through a reasonable application of a reasonable valuation method.

 

2.17        “Incentive Stock Optionmeans an Option intended to meet the requirements of an incentive stock option as defined in Section 422 of the Code and designated as an Incentive Stock Option.

 

2.18        “Nonqualified Stock Option means an Option that is not an Incentive Stock Option.

 

2.19        “Other Stock-Based Awardmeans any right granted under Article 10 of the Plan.

 

2.20        “Option means any stock option granted form time to time under Article 6 of the Plan.

 

2.21        “Option Pricemeans the purchase price per Share subject to an Option, as determined pursuant to Section 6.2 of the Plan.

 

2.22        “Participant means any eligible person as set forth in Section 4.1 to whom an Award is granted.

 

2.23        “Plan means the STR Holdings, Inc. Equity Incentive Plan.

 

2.24        “Restricted Stock” means any Award granted under Article 8.

 

2.25        “Restriction Period means the period during which Restricted Stock awarded under Article 8 of the Plan is subject to forfeiture.

 

2.26        “Servicemeans service as an Employee, Director or Consultant.

 

2.27        “Share means a share of common stock of the Company, par value $0.01 per share, or such other class or kind of shares or other securities resulting from the application of Section 12.1 hereof.

 

2.28        “Stock Appreciation Right means any right granted under Article 7.

 

2.29        “Subsidiary means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company (or any parent of the Company) if each of the corporations, other than the last corporation in each unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.

 

 

 

 

2.30        “Ten Percent Stockholder means a person who on any given date owns, either directly or indirectly (taking into account the attribution rules contained in Section 424(d) of the Code), stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or a Subsidiary or Affiliate.

 

Article 3.               Administration

 

3.1          Authority of the Committee.  The Plan shall be administered by the Committee, which shall have full power to interpret and administer the Plan and full authority to select the Directors, Employees and Consultants to whom Awards will be granted and determine the type and amount of Awards to be granted to each such Director, Employee or Consultant, the terms and conditions of Awards granted under the Plan and the terms of Award Agreements to be entered into with Participants.  Without limiting the generality of the foregoing, the Committee may, in its sole discretion, clarify, construe or resolve any ambiguity in, or interpret any provision of, any provision of the Plan or any Award Agreement, accelerate or waive vesting of Awards and exercisability of Awards, extend the term or period of exercisability of any Awards, modify the purchase price under any Award, or waive any terms or conditions applicable to any Award; provided that no action taken by the Committee shall adversely affect in any material respect the rights granted to any Participant under any outstanding Awards without the Participant’s written consent (other than pursuant to Article 11 or Article 12 hereof).  Awards may, in the discretion of the Committee, be made under the Plan in assumption of, or in substitution for, outstanding awards previously granted by the Company or its affiliates or a company acquired by the Company or with which the Company combines.  The Committee shall have full and exclusive discretionary power to adopt rules, forms, instruments, and guidelines for administering the Plan as the Committee deems necessary or proper.  All actions taken and all interpretations and determinations made by the Committee or by the Board (or any other committee or sub-committee thereof), as applicable, shall be final and binding upon the Participants, the Company, and all other interested individuals.

 

3.2          Delegation.  The Committee may delegate to one or more of its members, one or more officers of the Company or any of its Subsidiaries, and one or more agents or advisors such administrative duties or powers as it may deem advisable.

 

Article 4.               Eligibility and Participation

 

4.1          Eligibility.  Participants will consist of such Employees, Consultants, and Directors as the Committee in its sole discretion determines and whom the Committee may designate from time to time to receive awards under the Plan.  Designation of a Participant in any year shall not require the Committee to designate such person to receive an award in any other year or, once designated, to receive the same type or amount of award as granted to the Participant in any other year.

 

4.2          Types of Award.  Awards under the Plan may be granted in any one or a combination of:  (a) Options, (b) Stock Appreciation Rights, (c) Restricted Stock, (d) Dividend Equivalents and (e) Other Stock-Based Awards.  Awards granted under the Plan shall be evidenced by Award Agreements (which need not be identical) that provide additional terms and conditions associated with such Awards, as determined by the Committee in its sole discretion; provided, however, that in the event of any conflict between the provisions of the Plan and any such Award Agreement, the provisions of the Plan shall prevail.

 

Article 5.               Shares Subject to the Plan and Maximum Awards

 

5.1          Number of Shares Available for Awards.

 

(a)           General.  Subject to adjustment as provided in Section 5.1(b) and Article 12, the maximum number of Shares available for issuance to Participants pursuant to Awards under the Plan shall be 4,133,333 Shares.  The Shares available for issuance under the Plan may consist, in whole or in part, of authorized and unissued Shares or treasury Shares. The number of Shares available for granting Incentive Stock Options under the Plan shall not exceed 4,133,333 Shares, subject to adjustments provided in Article 12 hereof and subject to the provisions of Sections 422 or 424 of the Code or any successor provisions.  Any Shares delivered to the Company as part or full payment for the purchase price of an Award granted under this Plan or, to the extent the Committee determines that the availability of Incentive Stock Options under the Plan will not be compromised, to satisfy the Company’s withholding obligation with respect to an Award granted under this Plan, shall again be available for Awards under the Plan.  The maximum number of Shares that can be granted to any one Participant, in any calendar year, shall not exceed 1,333,333 Shares.

 

 

 

 

(b)           Additional Shares.  In the event that any outstanding Award expires, is forfeited, cancelled or otherwise terminated without consideration (i.e., Shares or cash) therefor, the Shares subject to such Award, to the extent of any such forfeiture, cancellation, expiration, termination or settlement for cash, shall again be available for Awards under the Plan. If the Committee authorizes the assumption under this Plan, in connection with any merger, consolidation, acquisition of property or stock, or reorganization, of awards granted under another plan, such assumption shall not reduce the maximum number of Shares available for issuance under this Plan.

 

Article 6.               Stock Options

 

6.1          Grant of Options.  The Committee is hereby authorized to grant Options to Participants.  Each Option shall permit a Participant to purchase from the Company a stated number of Shares at an Option Price established by the Committee, subject to the terms and conditions described in this Article 6 and to such additional terms and conditions, as established by the Committee, in its sole discretion, that are consistent with the provisions of the Plan.  Options shall be designated as either Incentive Stock Options or Nonqualified Stock Options, provided that Options granted to Directors and Consultants shall be Nonqualified Stock Options.  An Option granted as an Incentive Stock Option shall, to the extent it fails to qualify as an Incentive Stock Option, be treated as a Nonqualified Stock Option.  Neither the Committee nor the Company or any of its Affiliates shall be liable to any Participant or to any other person if it is determined that an Option intended to be an Incentive Stock Option does not qualify as an Incentive Stock Option.  Options shall be evidenced by Award Agreements which shall state the number of Shares covered by such Option.  Such agreements shall conform to the requirements of the Plan, and may contain such other provisions, as the Committee shall deem advisable.

 

6.2          Terms of Option Grant.  The Option Price shall be determined by the Committee at the time of grant, but shall not be less than 100% of the Fair Market Value of a Share on the date of grant.  In the case of any Incentive Stock Option granted to a Ten Percent Stockholder, the Option Price shall not be less than 110% of the Fair Market Value of a Share on the date of grant.

 

6.3          Option Term.  The term of each Option shall be determined by the Committee at the time of grant and shall be stated in the Award Agreement, but in no event shall such term be greater than ten years (or, in the case on an Incentive Stock Option granted to a Ten Percent Stockholder, five years).

 

6.4          Time of Exercise.  Options granted under this Article 6 shall be exercisable at such times and be subject to such restrictions and conditions as the Committee shall in each instance approve, which terms and restrictions need not be the same for each grant or for each Participant.

 

6.5          Method of Exercise.  Except as otherwise provided in the Plan or in an Award Agreement, an Option may be exercised for all, or from time to time any part, of the Shares for which it is then exercisable.  For purposes of this Article 6, the exercise date of an Option shall be the later of the date a notice of exercise is received by the Company and, if applicable, the date payment is received by the Company pursuant to clauses (i), (ii), (iii), (iv), or (v) in the following sentence. The aggregate Option Price for the Shares as to which an Option is exercised shall be paid to the Company in full at the time of exercise at the election of the Participant (i) in cash or its equivalent (e.g., by cashier’s check), (ii) to the extent permitted by the Committee, in Shares having a Fair Market Value equal to the aggregate Option Price for the Shares being purchased and satisfying such other requirements as may be imposed by the Committee, (iii) partly in cash and, to the extent permitted by the Committee, partly in such Shares, (iv) by reducing the number of Shares otherwise deliverable upon the exercise of the Option by the number of Shares having a Fair Market Value equal to the Option Price, or (v) if there is a public market for the Shares at such time, subject to such requirements as may be imposed by the Committee, through the delivery of irrevocable instructions to a broker to sell Shares obtained upon the exercise of the Option and to deliver promptly to the Company an amount out of the proceeds of such sale equal to the aggregate Option Price for the Shares being purchased.  The Committee may prescribe any other method of payment that it determines to be consistent with applicable law and the purpose of the Plan.

 

 

 

 

6.6          Limitations on Incentive Stock Options.  Incentive Stock Options may be granted only to employees of the Company or of a “parent corporation” or “subsidiary corporation” (as such terms are defined in Section 424 of the Code) at the date of grant.  The aggregate Fair Market Value (generally determined as of the time the Option is granted) of the Shares with respect to which Incentive Stock Options are exercisable for the first time by a Participant during any calendar year (under all plans of the Company and of any parent corporation or subsidiary corporation) shall not exceed one hundred thousand dollars ($100,000).  For purposes of the preceding sentence, Incentive Stock Options will be taken into account generally in the order in which they are granted.  No Incentive Stock Option may be exercised later than ten (10) years after the date it is granted.  Each provision of the Plan and each Award Agreement relating to an Incentive Stock Option shall be construed so that each Incentive Stock Option shall be an incentive stock option as defined in Section 422 of the Code, and any provisions of the Award Agreement thereof that cannot be so construed shall be disregarded.

 

Article 7.               Stock Appreciation Rights

 

7.1          Grant of Stock Appreciation Rights.  The Committee is hereby authorized to grant Stock Appreciation Rights to Participants, including a grant of Stock Appreciation Rights in tandem with any Option at the same time such Option is granted (a “Tandem SAR”).  Stock Appreciation Rights shall be evidenced by Award Agreements that shall conform to the requirements of the Plan and may contain such other provisions, as the Committee shall deem advisable.  Subject to the terms of the Plan and any applicable Award Agreement, a Stock Appreciation Right granted under the Plan shall confer on the holder thereof a right to receive, upon exercise thereof, the excess of (a) the Fair Market Value of a specified number of Shares on the date of exercise over (b) the grant price of the right as specified by the Committee on the date of the grant.  Such payment may be in the form of cash, Shares, other property or any combination thereof, as the Committee shall determine in its sole discretion.

 

7.2          Terms of Stock Appreciation Right.  Subject to the terms of the Plan and any applicable Award Agreement, the grant price (which shall not be less than 100% of the Fair Market Value of a Share on the date of grant), term, methods of exercise, methods of settlement, and any other terms and conditions of any Stock Appreciation Right shall be as determined by the Committee.  The Committee may impose such other conditions or restrictions on the exercise of any Stock Appreciation Right as it may deem appropriate.  Unless otherwise provided in the Award Agreement, no Stock Appreciation Right shall have a term of more than 10 years from the date of grant.

 

7.3          Tandem Stock Appreciation Rights and Options.  A Tandem SAR shall be exercisable only to the extent that the related Option is exercisable and shall expire no later than the expiration of the related Option.  Upon the exercise of all or a portion of a Tandem SAR, a Participant shall be required to forfeit the right to purchase an equivalent portion of the related Option (and, when a Share is purchased under the related Option, the Participant shall be required to forfeit an equivalent portion of the Stock Appreciation Right).

 

Article 8.               Restricted Stock

 

8.1          Grant of Restricted Stock.  An Award of Restricted Stock is a grant by the Company of a specified number of Shares to the Participant, which Shares may be subject to forfeiture upon the occurrence of specified events.  Participants shall be awarded Restricted Stock in exchange for consideration not less than the minimum consideration required by applicable law.  Restricted Stock shall be evidenced by an Award Agreement, which shall conform to the requirements of the Plan and may contain such other provisions, as the Committee shall deem advisable.

 

8.2          Terms of Restricted Stock Awards.  Each Award Agreement evidencing a Restricted Stock grant shall specify the period(s) of restriction, the number of Shares of Restricted Stock subject to the Award, the purchase price of such Shares of Restricted Stock, the performance, employment or other conditions (including the termination of a Participant’s Service whether due to death, disability or other cause) under which the Restricted Stock may become vested or may be forfeited to the Company and such other provisions as the Committee shall determine.  Upon determination of the number of Shares of Restricted Stock to be granted to the Participant and payment of any purchase price, the Committee shall direct that a certificate or certificates representing the number of Shares be issued to the Participant with the Participant designated as the registered owner. The certificate(s) representing such shares shall be legended as to sale, transfer, assignment, pledge or other encumbrances during the Restriction Period and deposited by the Participant, together with a stock power endorsed in blank, with the Company, to be held in escrow during the Restriction Period.  At the end of the Restriction Period, the restrictions imposed hereunder shall lapse with respect to the number of shares of Restricted Stock as determined by the Committee, and the legend shall be removed and such number of Shares delivered to the Participant (or, where appropriate, the Participant’s legal representative).

 

 

 

 

8.3          Voting and Dividend Rights.  Unless otherwise determined by the Committee and set forth in a Participant’s Award Agreement, Participants holding Restricted Stock granted hereunder shall have the right to exercise voting rights with respect to the Restricted Stock and shall have the right to receive dividends on such Restricted Stock.

 

8.4          Performance Goals.  The Committee may condition the grant of Restricted Stock or the expiration of the Restriction Period upon the Participant’s achievement of one or more performance goal(s) specified in the Award Agreement. If the Participant fails to achieve the specified performance goal(s), the Committee shall not grant the Restricted Stock to such Participant or the Participant shall forfeit the Award of Restricted Stock to the Company, as applicable, unless otherwise provided in the Participant’s Award Agreement or the applicable stockholders agreement.

 

8.5          Section 83(b) Election.  If a Participant makes an election pursuant to Section 83(b) of the Code concerning Restricted Stock, the Participant shall be required to promptly file a copy of such election with the Company.

 

Article 9.               Dividend Equivalents

 

The Committee may grant Dividend Equivalents to Participants based on the dividends declared on Shares that are subject to any Award.  The grant of Dividend Equivalents shall be treated as a separate Award.  Dividend Equivalents shall be credited to a notional account maintained by the Company, as of dividend payment dates during the period between the date the Award is granted and the date the Award is exercised, vested, expired, credited or paid.  Such Dividend Equivalents shall be converted to cash or Shares by such formula and at such time and subject to such limitations as may be determined by the Committee.  As determined by the Committee, Dividend Equivalents granted with respect to any Option or Stock Appreciation Right may be payable regardless of whether such Option or Stock Appreciation Right is subsequently exercised.

 

Article 10.            Other Stock-Based Awards

 

The Committee, in its sole discretion, may grant Awards of Shares and Awards that are valued, in whole or in part, by reference to, or are otherwise based on the Fair Market Value of, Shares (the “Other Stock-Based Awards”).  Such Other Stock-Based Awards shall be in such form, and dependent on such conditions, as the Committee shall determine, including, without limitation, the right to receive one or more Shares (or the equivalent cash value of such Shares) upon the completion of a specified period of service, the occurrence of an event and/or the attainment of performance objectives.  Other Stock-Based Awards may be granted alone or in addition to any other Awards granted under the Plan.  Subject to the provisions of the Plan, the Committee shall determine to whom and when Other Stock-Based Awards will be made, the number of Shares to be awarded under (or otherwise related to) such Other Stock-Based Awards; whether such Other Stock-Based Awards shall be settled in cash, Shares or a combination of cash and Shares; and all other terms and conditions of such Awards (including, without limitation, the vesting provisions thereof and provisions ensuring that all Shares so awarded and issued shall be fully paid and non-assessable).

 

 

 

 

Article 11.            Compliance with Section 409A of the Code

 

11.1        General.  To the extent that the Plan and/or Awards are subject to Section 409A of the Code, the Committee may, in its sole discretion and without a Participant’s prior consent, amend the Plan and/or Awards, adopt policies and procedures, or take any other actions (including amendments, policies, procedures and actions with retroactive effect) as are necessary or appropriate to (a) exempt the Plan and/or any Award from the application of Section 409A of the Code, (b) preserve the intended tax treatment of any such Award, or (c) comply with the requirements of Section 409A of the Code, Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the date of the grant (“Section 409A Guidance”).  This Plan shall be interpreted at all times in such a manner that the terms and provisions of the Plan and Awards are exempt from or comply with Section 409A Guidance.

 

11.2        Timing of Payment.  All Awards that would otherwise be subject to Section 409A of the Code shall be paid or otherwise settled on or as soon as practicable after the applicable vesting date and not later than the 15th day of the third month from the end of (i) the Participant’s tax year that includes the applicable payment or settlement date, or (ii) the Company’s tax year that includes the applicable payment or settlement date, whichever is later; provided, however, that the Committee reserves the right to delay payment or specify a compliant payment date with respect to any such Award under the circumstances set forth in Section 409A Guidance; provided, further, that notwithstanding any contrary provision in the Plan or Award Agreement, any payment(s) that are otherwise required to be made under the Plan to a “specified employee” (as defined under Section 409A of the Code) as a result of his or her separation from service (other than a payment that is not subject to Section 409A of the Code) shall be delayed for the first six (6) months following such separation from service (or, if earlier, the date of death of the specified employee) and shall instead be paid (in a manner set forth in the Award Agreement) on the payment date that immediately follows the end of such six-month period or as soon as administratively practicable thereafter.

 

Article 12.            Adjustments

 

12.1        Adjustments in Capitalization.  In the event of any corporate event or transaction (including, but not limited to, a change in the Shares of the Company or the capitalization of the Company) such as a merger, consolidation, reorganization, recapitalization, separation, stock dividend, stock split, reverse stock split, split up, spin-off, combination of Shares, exchange of Shares, dividend in kind, extraordinary cash dividend, or other like change in capital structure (other than normal cash dividends) to stockholders of the Company, or any similar corporate event or transaction, the Committee, to prevent dilution or enlargement of Participants’ rights under the Plan, shall substitute or adjust, in its sole discretion, (a) the number and kind of Shares or other securities that may be issued under the Plan, the number and kind of Shares or other securities subject to outstanding Awards, and/or where applicable, the exercise price, base value or purchase price applicable to such Awards; (b) grant a right to receive one or more payments of securities, cash and/or property (which right may be evidenced as an additional Award under this Plan) in respect of any outstanding Award, or (c) provide for the settlement of any outstanding Award (other than a Stock Option or Stock Appreciation Right) in such securities, cash and/or other property as would have been received had the Award been settled in full immediately prior to such corporate event or transaction; provided, however, that in the case of an adjustment made in accordance with (b) or (c) above, the right to any securities, cash and/or property may be issued subject to the same vesting schedule as the outstanding Award being adjusted; and provided, further, that any adjustment pursuant to this Section 12.1 shall comply with Section 409A of the Code, to the extent applicable.  Should the vesting of any Award be conditioned upon the Company’s attainment of performance conditions, the Board may make such adjustments to the terms and conditions of such Awards and the criteria therein to recognize unusual and nonrecurring events affecting the Company or in response to changes in applicable laws, regulations or accounting principles.

 

12.2        Change of Control.  Upon the occurrence of a Change of Control after the Effective Date, unless otherwise specifically prohibited under applicable laws or by the applicable rules and regulations of any governing governmental agencies or national securities exchanges, or unless the Committee shall determine otherwise in the Award Agreement, the Committee is authorized (but not obligated) to make adjustments in the terms and conditions of outstanding Awards, including without limitation the following (or any combination thereof): (i) continuation or assumption of such outstanding Awards under the Plan by the Company (if it is the surviving company or corporation) or by the surviving company or corporation or its parent; (ii) substitution by the surviving company or corporation or its parent of awards with substantially the same terms for such outstanding Awards; (iii) accelerated exercisability, vesting and/or lapse of restrictions under all then outstanding Awards immediately prior to the occurrence of such event; (iv) upon written notice, provided that any outstanding Awards must be exercised, to the extent then exercisable, within fifteen days immediately prior to the scheduled consummation of the event, or such other period as determined by the Committee (in either case contingent upon the consummation of the event), and at the end of such period, such Awards shall terminate to the extent not so exercised within the relevant period; and (v) cancellation of all or any portion of outstanding Awards for fair value (as determined in the sole discretion of the Committee) which, in the case of Options and Stock Appreciation Rights, may equal the excess, if any, of the value of the consideration to be paid in the Change of Control transaction to holders of the same number of Shares subject to such Options or Stock Appreciation Rights (or, if no such consideration is paid, Fair Market Value of the Shares subject to such outstanding Awards or portion thereof being canceled) over the aggregate Option Price or grant price, as applicable, with respect to such Awards or portion thereof being canceled.

 

 

 

 

Article 13.            Duration, Amendment, Modification, Suspension, and Termination

 

13.1        Duration of the Plan.  Unless sooner terminated as provided in Section 13.2, the Plan shall terminate on the tenth (10th) anniversary of the Effective Date.

 

13.2        Amendment, Modification, Suspension, and Termination of Plan.  The Board may amend, alter, suspend, discontinue, or terminate the Plan or any portion thereof or any Award (or Award Agreement) thereunder at any time; provided that, subject to Article 11, no such amendment, alteration, suspension, discontinuation or termination shall be made (i) without stockholder approval if such approval is necessary to comply with any tax or regulatory requirement applicable to the Plan and (ii) without the consent of the Participant, if such action would materially diminish any of the rights of any Participant under any Award theretofore granted to such Participant under the Plan; provided, however, the Committee may amend the Plan, any Award or any Award Agreement in such manner as it deems necessary to comply with applicable laws.

 

Article 14.            General Provisions

 

14.1        No Right to Service. The granting of an Award under the Plan shall impose no obligation on the Company, any Subsidiary or any Affiliate to continue the Service of a Participant and shall not lessen or affect any right that the Company, any Subsidiary or any Affiliate may have to terminate the Service of such Participant. No Participant or other person shall have any claim to be granted any Award, and there is no obligation for uniformity of treatment of Participants, or holders or beneficiaries of Awards. The terms and conditions of Awards and the Committee’s determinations and interpretations with respect thereto need not be the same with respect to each Participant (whether or not such Participants are similarly situated).

  

14.2        Settlement of Awards; No Fractional Shares.  Each Award Agreement shall establish the form in which the Award shall be settled.  No fractional Shares shall be issued or delivered pursuant to the Plan or any Award.  The Committee shall determine whether cash, Awards, other securities or other property shall be issued or paid in lieu of fractional Shares or whether such fractional Shares or any rights thereto shall be rounded, forfeited or otherwise eliminated.

 

14.3        Tax Withholding.  The Company shall have the power and the right to deduct or withhold, or require a Participant to remit to the Company, the minimum statutory amount to satisfy federal, state, and local taxes, domestic or foreign, required by law or regulation to be withheld with respect to any taxable event arising as a result of the Plan.  With respect to required withholding, Participants may elect, subject to the approval of the Committee, to satisfy the withholding requirement, in whole or in part, by having the Company withhold Shares or by delivering Shares to the Company, having a Fair Market Value on the date the tax is to be determined equal to the minimum statutory total tax that could be imposed on the transaction.

 

14.4        No Guarantees Regarding Tax Treatment.  Participants (or their beneficiaries) shall be responsible for all taxes with respect to any Awards under the Plan.  The Committee and the Company make no guarantees to any person regarding the tax treatment of Awards or payments made under the Plan.  Neither the Committee nor the Company has any obligation to take any action to prevent the assessment of any excise tax on any person with respect to any Award under Section 409A of the Code or otherwise and none of the Company, any of its Subsidiaries or Affiliates, or any of their employees or representatives shall have any liability to a Participant with respect thereto.

 

 

 

 

14.5        Non-Transferability of Awards.  Except as provided by the terms of any applicable stockholders agreement or unless otherwise determined by the Committee, an Award shall not be transferable or assignable by the Participant except in the event of his death (subject to the applicable laws of descent and distribution) and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company or any Affiliate.  An award exercisable after the death of a Participant may be exercised by the legatees, personal representatives or distributees of the Participant. Any permitted transfer of the Awards to heirs or legatees of the Participant shall not be effective to bind the Company unless the Committee shall have been furnished with written notice thereof and a copy of such evidence as the Committee may deem necessary to establish the validity of the transfer and the acceptance by the transferee or transferees of the terms and conditions hereof.

 

14.6        Conditions and Restrictions on Shares.  The Committee may impose such other conditions or restrictions on any Shares received in connection with an Award as it may deem advisable or desirable.  These restrictions may include, but shall not be limited to, a requirement that the Participant hold the Shares received for a specified period of time or a requirement that a Participant represent and warrant in writing that the Participant is acquiring the Shares for investment and without any present intention to sell or distribute such Shares.  The certificates for Shares may include any legend which the Committee deems appropriate to reflect any conditions and restrictions applicable to such Shares.

 

14.7        Shares Not Registered.  Shares and Awards shall not be issued under the Plan unless the issuance and delivery of such Shares and any Awards comply with (or are exempt from) all applicable requirements of law, including (without limitation) the Securities Act of 1933, as amended, the rules and regulations promulgated thereunder, State securities laws and regulations, and the regulations of any stock exchange or other securities market on which the Company’s securities may then be traded.  Except as set forth in an Award Agreement, the Company shall not be obligated to file any registration statement under any applicable securities laws to permit the purchase or issuance of any Shares or any Awards under the Plan, and accordingly any certificates for Shares or documents granting Awards may have an appropriate legend or statement of applicable restrictions endorsed thereon.  If the Company deems it necessary to ensure that the issuance of securities under the Plan is not required to be registered under any applicable securities laws, each Participant to whom such security would be purchased or issued shall deliver to the Company an agreement or certificate containing such representations, warranties and covenants as the Company which satisfies such requirements.

 

14.8        Rights as a Stockholder.  Except as otherwise provided herein or in the applicable Award Agreement, a Participant shall have none of the rights of a stockholder with respect to Shares covered by any Award until the Participant becomes the record holder of such Shares.

 

14.9        Severability.  If any provision of the Plan or any Award is or becomes or is deemed to be invalid, illegal, or unenforceable in any jurisdiction, or as to any person or Award, or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or deemed amended to conform to applicable laws, or if it cannot be so construed or deemed amended without, in the determination of the Committee, materially altering the intent of the Plan or the Award, such provision shall be stricken as to such jurisdiction, person, or Award, and the remainder of the Plan and any such Award shall remain in full force and effect.

 

14.10      Unfunded Plan.  Participants shall have no right, title, or interest whatsoever in or to any investments that the Company or any of its Subsidiaries may make to aid it in meeting its obligations under the Plan.  Nothing contained in the Plan, and no action taken pursuant to its provisions, shall create or be construed to create a trust of any kind, or a fiduciary relationship between the Company and any Participant, beneficiary, legal representative, or any other person.  To the extent that any person acquires a right to receive payments from the Company or any of its Subsidiaries under the Plan, such right shall be no greater than the right of an unsecured general creditor of the Company or a Subsidiary, as the case may be.  All payments to be made hereunder shall be paid from the general funds of the Company or a Subsidiary, as the case may be, and no special or separate fund shall be established and no segregation of assets shall be made to assure payment of such amounts.  The Plan is not subject to the U.S. Employee Retirement Income Security Act of 1974, as amended from time to time.

 

 

 

 

14.11      No Constraint on Corporate Action.  Nothing in the Plan shall be construed to (a) limit, impair, or otherwise affect the Company’s or its Subsidiary’s right or power to make adjustments, reclassifications, reorganizations, or changes of its capital or business structure, or to merge or consolidate, or dissolve, liquidate, sell, or transfer all or any part of its business or assets, or (b) limit the right or power of the Company or its Subsidiary to take any action which such entity deems to be necessary or appropriate.

 

14.12      Successors.  All obligations of the Company under the Plan with respect to Awards granted hereunder shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business or assets of the Company.

 

14.13      Governing Law.  The Plan and each Award Agreement shall be governed by the laws of the State of Delaware, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of the Plan to the substantive law of another jurisdiction.

 

14.14      Effective Date. The Plan shall be effective as of November 16, 2009 (the “Effective Date”), provided that the Plan is approved by the stockholders of the Company at an annual meeting or any special meeting of stockholders of the Company within 12 months of the Effective Date, and such approval of stockholders shall be a condition to the right of each Participant to receive any Award hereunder. Any Award granted under the Plan prior to such approval of stockholders shall be effective as of the date of grant, but no such Award may be exercised or settled and no restrictions relating to any Award may lapse prior to such stockholder approval, and if stockholders fail to approve the Plan as specified hereunder, any such Award shall be cancelled.

 

*                              *                              *

 

This Plan was duly adopted and approved by the Board of Directors of the Company at a meeting of the Board of Directors duly called and held on the 20th day of February, 2018.

 

STR HOLDINGS, INC.

 

 

/s/ Robert S. Yorgensen  
Name: Robert S. Yorgensen  
Title: President and Chief Executive Officer

 

 

 

EX-31.1 3 exh_311.htm EXHIBIT 31.1

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Robert S. Yorgensen, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of STR Holdings, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 10, 2018 /s/ Robert S. Yorgensen  
  Name: Robert S. Yorgensen  
  Title:

Chairman, President and Chief Executive Officer

(Principal Executive Officer)

 

EX-31.2 4 exh_312.htm EXHIBIT 31.2

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Thomas D. Vitro, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of STR Holdings, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 10, 2018 /s/ Thomas D. Vitro  
  Name: Thomas D. Vitro  
  Title:

Vice President, Chief Financial Officer and Chief Accounting Officer
(Principal Financial Officer and Principal Accounting Officer)

 

EX-32.1 5 exh_321.htm EXHIBIT 32.1

Exhibit 32.1

 

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chairman, President and Chief Executive Officer of STR Holdings, Inc. (the “Company”), does hereby certify that to my knowledge:

 

1.the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.the information contained in the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2018 fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 10, 2018 /s/ Robert S. Yorgensen  
  Name: Robert S. Yorgensen  
  Title:

Chairman, President and Chief Executive Officer

(Principal Executive Officer)

 

EX-32.2 6 exh_322.htm EXHIBIT 32.2

Exhibit 32.2

 

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Vice President, Chief Financial Officer and Chief Accounting Officer of STR Holdings, Inc. (the “Company”), does hereby certify that to my knowledge:

 

1.the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.the information contained in the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2018 fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 10, 2018 /s/ Thomas D. Vitro  
  Name: Thomas D. Vitro  
  Title:

Vice President, Chief Financial Officer and Chief Accounting Officer
(Principal Financial Officer and Principal Accounting Officer)

EX-101.INS 7 stri-20180630.xml XBRL INSTANCE FILE false --12-31 Q2 2018 2018-06-30 10-Q 0001473597 20101221 Yes Smaller Reporting Company STR HOLDINGS, INC. No No stri 79000 90000 1 397000 454000 1500000 1752000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12&#x2014;FACTORING</div> ARRANGEMENT</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 2015, </div>the Company&#x2019;s wholly owned Spanish subsidiary, STR Spain, entered into a factoring agreement to sell, with recourse, certain European, U.S. and other foreign company-based receivables to Eurofactor Hispania S.A.U., who was later acquired by Credit Agricole Leasing and Factoring Sucursal en Espa&ntilde;a during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> Under the current terms of the factoring agreement, the maximum amount of outstanding advances at any <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> time is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x20ac;1,500</div> (approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,752</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018), </div>which is subject to adjustment based on the level of eligible receivables, restrictions on concentrations of receivables and the historical performance of the receivables sold. The annual discount rate is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2%</div> plus EURIBOR for Euro denominated receivables and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2%</div> plus LIBOR for all other currencies. The term of the agreement is for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year, which will be automatically extended unless terminated by either party with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90</div> days prior written notice. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>the Company has recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$397</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$454,</div> respectively, as due to factor on the Condensed Consolidated Balance Sheets.</div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7&#x2014;ASSETS</div> HELD FOR SALE</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2015, </div>the Company announced a restructuring plan that included the closure of its Johor, Malaysia facility effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2, 2015. </div>Subsequent to the announcement, the Company engaged advisors and was actively trying to sell its land-use right, building and other fixed assets located at the facility. During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company entered into a definitive Purchase and Sale Agreement for the land-use right and the building for a purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">RM25,000.</div> Closing of the transaction was subject to customary conditions to closing of transactions of this type, including the approval of the Johor Port Authority (&#x201c;JPA&#x201d;). On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 31, 2017, </div>the Company received a notice from the purchaser purporting to terminate the agreement, alleging that the JPA was seeking to impose certain conditions on the approval of the transfer of the facility to the purchaser that it found unacceptable. The Company was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> successful in removing those conditions, and the agreement terminated. The Company has re-launched the sale process for its Malaysia facility.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">In accordance with ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">360</div>-Property, Plant and Equipment, the Company assessed the asset group attributed to the sale for impairment. Based upon the Company&#x2019;s assessment of the status of the Malaysia property, plant and equipment, all of the requirements (including the held for sale requirements) set forth in ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">360</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9</div> were met and the assets were classified on the Condensed Consolidated Balance Sheet as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> as assets held for sale. An impairment loss of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$267,</div> related to the foreign currency fluctuation of the Ringgit, was recorded in the Company&#x2019;s Condensed Consolidated Statement of Comprehensive (Loss) Income in other expense, net during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> half of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div></div> 888000 3508000 16000 -229000 1985000 1162000 4 2 1 2 1 -46000 111000 P1Y P1Y 1148000 0.1 535 P90D 0.99 0.99 0.99 0.99 P1Y P90D <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8&#x2014;ACCRUED</div> LIABILITIES</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Accrued liabilities consist of the following:</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">June&nbsp;30,<br /> 2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December&nbsp;31,<br /> 2017</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Salaries and wages </td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">323</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">239</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Accrued bonus </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">210</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">258</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Professional fees </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">285</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">319</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Restructuring severance and benefits (see Note 10) </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">102</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">87</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Environmental (see Note 9) </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Accrued franchise tax </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">79</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Client deposits </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">179</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,157</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Other </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">114</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 20pt">Total accrued liabilities </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,349</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,307</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div></div> 1451000 971000 1072000 70000 1588000 1199000 57000 57000 210000 258000 57000 57000 898000 896000 1349000 2307000 285000 319000 323000 239000 -5443000 -5355000 232315000 232149000 5000 166000 171000 88000 132000 161000 252000 88000 132000 161000 252000 1734000 1725000 1121332 1121332 1121332 1121332 30252000 33186000 16252000 18227000 6155000 6155000 11710000 13499000 12379000 13404000 7605000 6688000 -1789000 1025000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9&#x2014;COMMITMENTS</div> AND CONTINGENCIES</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">The Company is a party to claims and litigation in the normal course of its operations. Management believes that the ultimate outcome of these matters will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material adverse effect on the Company&#x2019;s financial position, results of operations, or cash flows.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Product Performance</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The Company provides a short-term warranty that it has manufactured its products to the Company&#x2019;s specifications. On limited occasions, the Company incurs costs to service its products in connection with specific product performance matters that do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> meet the Company&#x2019;s specifications. Anticipated future costs are recorded as part of cost of sales and accrued liabilities for specific product performance matters when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">On isolated occasions, the Company has also offered limited short-term performance warranties relating to its encapsulants <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> causing module power loss.&nbsp;The Company&#x2019;s encapsulants are validated by long-term performance testing during product development prior to launch and during customer certification prior to mass production. The Company has operated its solar business since the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1970s</div> and over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div> GW of solar modules incorporating its encapsulants&nbsp;have been installed in the field with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> reported module power performance issues caused by the Company&#x2019;s encapsulants and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> related warranty claims to date.&nbsp;Based on this fact pattern, the Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> accrued any warranty liability associated for this potential liability as its occurrence is deemed to be remote. If the Company was to ever receive a warranty claim for such matter, the Company would assess the need for a warranty accrual at that time.</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The Company&#x2019;s product performance liability that is recorded in accrued liabilities in the Condensed Consolidated Balance Sheets was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0</div></div> as of each <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Environmental</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2010,</div> the Company performed a Phase&nbsp;II environmental site assessment at its <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>&nbsp;Water&nbsp;Street, Enfield, Connecticut location. During its investigation, the site was found to contain a presence of volatile organic compounds. The Company has been in contact with the Department of Environmental Protection and has engaged a licensed contractor to remediate this circumstance. Based on ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">450</div>-Contingencies, the Company has accrued the estimated cost to remediate. The Company&#x2019;s environmental liability that is recorded in accrued liabilities in the Condensed Consolidated Balance Sheets was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57</div></div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Solaria</div></div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 2016, </div>a complaint was filed by Solaria Energia y Medio Ambiente S.A.U. (&#x201c;Solaria&#x201d;) against the Company and its Spanish subsidiary, Specialized Technology Resources Espa&ntilde;a S.A.U. (&#x201c;STR Spain&#x201d;), in the Court of the First Instance <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div> in Oviedo, Spain, relating to a product quality claim in connection with a non-encapsulant product that STR Spain</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></div> <!-- Field: Page; Sequence: 10 --> <div style=" font-size: 10pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; margin: 0pt 0">purchased from a vendor in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2006</div> and resold to Solaria. The Company stopped selling this product in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2006.</div> Solaria is seeking approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x20ac;3,300,</div> plus interest, in damages.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">A trial was held on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 6, 2017 </div>in Oviedo, Spain, and the Company is currently awaiting a ruling from the court. The Company believes that it has product liability insurance coverage for claims of this nature, excluding the original product cost but including defense costs. The Company believes it has meritorious defenses and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe a loss is probable or can be reasonably estimated. As such, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div></div> accrual relating to this complaint was recorded as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div></div> 0.01 0.01 200000000 200000000 20039461 19919529 20038221 19918289 200000 195000 -3616000 217000 -2843000 -2700000 3490000 3695000 5935000 7905000 0 0 179000 1157000 271000 -302000 969000 698000 383000 753000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15&#x2014;STOCK</div>-BASED COMPENSATION</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2009,</div> the Company&#x2019;s Board of Directors approved the Company&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2009</div> Equity Incentive Plan (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x201c;2009</div> Plan&#x201d;), which became effective on the same day. Effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2013,</div> the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2009</div> Plan was amended to increase the number of shares subject to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2009</div> Plan. As a result, a total of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,133,133</div> shares of common stock were reserved for issuance under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2009</div> Plan. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2009</div> Plan is administered by the Board of Directors or any committee designated by the Board of Directors, which has the authority to designate participants and determine the number and type of awards to be granted, the time at which awards are exercisable, the method of payment and any other terms or conditions of the awards. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2009</div> Plan provides for the grant of stock options, including incentive stock options and nonqualified stock options (collectively, &#x201c;options&#x201d;), stock appreciation rights, shares of restricted stock, or &#x201c;restricted stock,&#x201d; rights to dividend equivalents and other stock-based awards (collectively, the &#x201c;awards&#x201d;). The Board of Directors or the committee will, with regard to each award,</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <!-- Field: Page; Sequence: 13 --> <div style=" font-size: 10pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; margin: 0pt 0">determine the terms and conditions of the award, including the number of shares subject to the award, the vesting terms of the award, and the purchase price for the award. Awards <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be made in assumption of or in substitution for outstanding awards previously granted by the Company or its affiliates, or a company acquired by the Company or with which it combines. Options outstanding generally vest over a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div>-year period and expire <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> years from the date of grant. There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">431,131</div> shares available for grant under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2009</div> Plan as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018.</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The following table summarizes the options activity under the Company&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2009</div> Plan for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018:</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin-left: 0.5in; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="19" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Options&nbsp;Outstanding</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Number<br /> of<br /> Shares</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted&#x2013;<br /> Average<br /> Exercise<br /> Price</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted&#x2013;<br /> Average<br /> Remaining<br /> Contractual<br /> Term<br /> (in&nbsp;years)</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted&#x2013;<br /> Average<br /> Grant&#x2013;Date<br /> Fair&nbsp;Value</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Aggregate<br /> Intrinsic<br /> Value(1)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Balance at December&nbsp;31, 2017 </td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,121,332</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.52</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.99</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,402</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Options granted </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Exercised </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 20pt">Canceled/forfeited </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Balance at June&nbsp;30, 2018 </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,121,332</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.52</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.61</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.99</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,402</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Vested and exercisable as of June 30, 2018 </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,121,332</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.52</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.61</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.99</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,402</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Vested and exercisable as of June&nbsp;30, 2018 and expected to vest thereafter </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,121,332</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.52</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.61</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.99</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,402</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> </table> </div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;_________________</div> <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 3%; text-align: left"><div style="display: inline; font-size: 9pt">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>)</div></td> <td style="text-align: justify; width: 97%"><div style="display: inline; font-size: 9pt">The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.27</div> of the Company&#x2019;s common stock on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div></div></td> </tr> </table> <div style=" font-size: 10pt; margin: 0pt 0 0pt 0.5in">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0</div> of unrecognized compensation cost related to outstanding stock option awards. The Company did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> receive any proceeds related to the exercise of stock options for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018.</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The following table summarizes the restricted common stock activity of the Company for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018:</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Unvested<br /> Restricted&nbsp;Shares</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Number&nbsp;of<br /> Shares</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted&#x2013;<br /> Average<br /> Grant&#x2013;Date<br /> Fair&nbsp;Value</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Unvested at December&nbsp;31, 2017 </td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">385,716</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Granted </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">119,932</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Vested </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(505,648</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.28</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Unvested at June&nbsp;30, 2018 </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Expected to vest after June&nbsp;30, 2018 </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Stock-based compensation expense was included in the following Condensed Consolidated Statements of Comprehensive Loss categories for operations:</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin-left: 0.5in; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Three&nbsp;Months&nbsp;Ended<br /> June&nbsp;30,</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Six&nbsp;Months&nbsp;Ended<br /> June&nbsp;30,</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Selling, general and administrative expense </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">88</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">132</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">161</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Total stock-based compensation expense </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">88</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">132</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">161</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div></div> 6155000 6155000 -0.16 -0.02 -0.14 -0.18 -0.16 -0.02 -0.14 -0.18 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3&#x2014;LOSS</div> PER SHARE</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The calculation of basic and diluted net loss per share for the periods presented is as follows:</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin-left: 0.5in; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Three&nbsp;Months&nbsp;Ended<br /> June&nbsp;30,</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Six&nbsp;Months&nbsp;Ended<br /> June&nbsp;30,</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">Basic and diluted net loss per share</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 20pt">Numerator:</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Net loss </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,074</div></td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(284</div></td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,755</div></td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,331</div></td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Denominator:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Weighted&#x2013;average shares outstanding </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,669,353</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,913,427</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,607,204</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,839,391</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Add: </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt">Dilutive effect of stock options </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 30pt">Dilutive effect of restricted common stock </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 20pt">Weighted&#x2013;average shares outstanding with dilution </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,669,353</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,913,427</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,607,204</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,839,391</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Net loss per share:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Basic </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.16</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.14</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.18</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Diluted </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.16</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.14</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.18</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Due to the net loss for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the computation of dilutive weighted-average common shares outstanding does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include any stock options or any shares of unvested restricted common stock as these potential awards are anti-dilutive.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Because the effect would be anti-dilutive, there were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,121,332</div></div> stock options outstanding that were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> included in the computation of diluted weighted-average shares outstanding for each of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> Similarly, there were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,121,332</div></div> stock options outstanding that were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> included in the computation of diluted weighted-average shares outstanding for each of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div></div> 127000 175000 -0.059 -0.109 0.21 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11&#x2014;FAIR</div> VALUE MEASUREMENTS</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The Company measures certain financial assets and liabilities at fair value on a recurring basis in the financial statements. The hierarchy ranks the quality and reliability of inputs, or assumptions, used in the determination of fair value</div> <div style=" font-size: 10pt; margin: 0pt 0">and requires financial assets and liabilities carried at fair value to be classified and disclosed in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> of the following <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> categories:</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top"> <td style="width: 0.75in"></td> <td style="width: 0.25in"><div style="display: inline; font-family: Symbol">&middot;</div></td> <td>Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>-quoted prices (unadjusted) in active markets for identical assets and liabilities;</td> </tr> </table> <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top"> <td style="width: 0.75in"></td> <td style="width: 0.25in"><div style="display: inline; font-family: Symbol">&middot;</div></td> <td>Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>-unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> active, or inputs other than quoted prices that are observable for the asset or liability; and</td> </tr> </table> <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top"> <td style="width: 0.75in"></td> <td style="width: 0.25in"><div style="display: inline; font-family: Symbol">&middot;</div></td> <td>Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>-unobservable inputs that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> corroborated by market data.</td> </tr> </table> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <!-- Field: Page; Sequence: 11 --> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The following table provides the fair value measurements of applicable financial assets and liabilities as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018:</div></div> <div style=" font-size: 10pt; text-align: center; margin: 0pt 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin-left: 0.5in; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="11" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Financial&nbsp;assets&nbsp;and&nbsp;liabilities&nbsp;at&nbsp;fair&nbsp;value<br /> as&nbsp;of&nbsp;June&nbsp;30,&nbsp;2018</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Level&nbsp;1</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Level&nbsp;2</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Level&nbsp;3</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; text-align: right">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Money market funds (1) </td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 11%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,605</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 11%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 11%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Bank acceptance notes (2) </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Non-recurring fair value measurements (3) </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,155</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 20pt">Total </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,605</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,155</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The following table provides the fair value measurements of applicable financial assets and liabilities as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017:</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin-left: 0.5in; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="11" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Financial&nbsp;assets&nbsp;and&nbsp;liabilities&nbsp;at&nbsp;fair&nbsp;value<br /> as&nbsp;of&nbsp;December&nbsp;31,&nbsp;2017</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Level&nbsp;1</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Level&nbsp;2</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Level&nbsp;3</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; text-align: right">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Money market funds (1) </td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 11%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,688</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 11%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 11%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Bank acceptance notes (2) </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">904</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Non-recurring fair value measurements (3) </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,155</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 20pt">Total </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,592</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,155</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div> <div style=" font-size: 10pt; margin: 0pt 0">________________________</div> <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.25in"><div style="display: inline; font-size: 9pt">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>)</div></td> <td><div style="display: inline; font-size: 9pt">Included in cash and cash equivalents on the Company&#x2019;s Condensed Consolidated Balance Sheets. The carrying amount of money market funds is a reasonable estimate of fair value due to the short-term maturity.</div></td> </tr> </table> <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.25in"><div style="display: inline; font-size: 9pt">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>)</div></td> <td><div style="display: inline; font-size: 9pt">Refer to Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div> for further information</div></td> </tr> </table> <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.25in"><div style="display: inline; font-size: 9pt">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>)</div></td> <td><div style="display: inline; font-size: 9pt">Included in assets held for sale on the Company&#x2019;s Condensed Consolidated Balance Sheets. Refer to Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div> for further information.</div></td> </tr> </table></div> 7605000 6155000 7592000 6155000 -106000 -64000 -162000 -75000 940000 -383000 -13000 -383000 -16000 -383000 -13000 -975000 -638000 326000 -1135000 0 267000 267000 -3074000 -284000 -2755000 -3331000 -2902000 -409000 -2484000 -3474000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13&#x2014;INCOME</div> TAXES</div></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 22, 2017, </div>the Tax Cuts and Jobs Act (&#x201c;TCJA&#x201d;) was enacted into law in the United States. The legislation contains several key tax provisions including the reduction of the corporate income tax rate to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21%</div> effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018, </div>a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-time transition tax on foreign earnings which have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> previously been subject to tax in the United States, as well as a variety of other changes, including limitation of the tax deductibility of interest expense, limitations for the deduction for net operating losses, new taxes on certain foreign-sourced earnings, and modification or repeal of many business deductions and credits.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The SEC staff issued SAB <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">118</div> which allows companies to record provisional amounts during a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-year measurement period. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> completed its accounting for the tax effects of the</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <!-- Field: Page; Sequence: 12 --> <div style=" font-size: 10pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; margin: 0pt 0">enactment of the TCJA; however, the Company estimated what it believes to be the effects of the TCJA on its existing deferred tax balances and the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-time transition tax, and recorded a provisional estimate for these tax effects.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>the Company did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> record any measurement period adjustments to the provisional estimates recorded at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017. </div>Final accounting for these impacts is expected in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> subsequent to the Company&#x2019;s completion of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> tax return.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The TCJA subjects a U.S. shareholder to tax on global intangible low-taxed income (GILTI) earned by certain foreign subsidiaries for which an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or provide for the tax expense related to GILTI in the year the tax is incurred. Given the complexity of the GILTI provisions, the Company is still evaluating the effects of the GILTI provisions and has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet determined its accounting policy. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> anticipate a GILTI inclusion for the taxable year. The Company will continue to assess forthcoming guidance and accounting</div> <div style=" font-size: 10pt; margin: 0pt 0">interpretations on the effects of the TCJA and expects to complete its analysis within the measurement period in accordance with the SEC guidance.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>the Company recorded an income tax expense of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$172</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$271</div> resulting in an effective tax rate of (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.9%</div>) and (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10.9%</div>), respectively. This effective tax rate for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>differs from the U.S. statutory tax rate primarily due to the effect of taxes on foreign earnings.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">There was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div></div> provision or benefit for federal, foreign or state income taxes for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2017 </div>other than income tax benefit of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$125</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$143,</div> respectively, resulting from an intra-period tax allocation between operations and other comprehensive income.</div></div> 172000 271000 -125000 -143000 -125000 -143000 244000 -274000 637000 -1010000 4000 2000 67000 233000 269000 170000 -860000 -1624000 -150000 23000 16000 -3000 15000 -7000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5&#x2014;INVENTORIES</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Inventories consist of the following:</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">June&nbsp;30,<br /> 2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December&nbsp;31,<br /> 2017</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Finished goods </td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">365</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">340</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Raw materials </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">996</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">829</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Reserve </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(59</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 20pt">Inventories, net </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,357</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,110</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div></div> 365000 340000 1357000 1110000 996000 829000 4000 59000 5064000 5326000 30252000 33186000 4095000 4628000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4&#x2014;BANK</div> ACCEPTANCE NOTES</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Customers in China <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>settle their accounts with bank acceptance notes, which are draft instruments that are guaranteed to be paid at maturity by the issuing bank. Upon receipt of the bank acceptance note, the Company can elect to hold the instrument until maturity and receive full face value, discount it with the bank for a fee, or transfer it at full face value to suppliers who will accept the note as settlement of the Company&#x2019;s accounts payable balance with them.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">Bank acceptance notes consist of the following:</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">June 30,<br /> 2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br /> 2017</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Balance as of beginning of period </td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">904</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,360</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Received from customers </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,985</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Converted to cash </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(888</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,508</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Paid to suppliers </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,162</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Foreign exchange impact </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(16</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">229</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Balance as of end of period </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">904</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div></div> 0.02 0.02 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">June&nbsp;30,<br /> 2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December&nbsp;31,<br /> 2017</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">Long-Lived Assets</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 68%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">United States </td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,237</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,311</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Spain </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,454</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,141</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">China </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">76</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">276</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Total Long-Lived Assets </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,767</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,728</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div> 0 0 0 0 3300000 -46000 111000 202000 -410000 -2072000 1149000 -2755000 -3331000 -2755000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2&#x2014;RECENT</div> ACCOUNTING PRONOUNCEMENTS AND ADOPTION</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div>&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> &#x201c;Revenue from Contracts with Customers&#x201d; (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>). This ASU is intended to clarify the principles for recognizing revenue by removing inconsistencies and weaknesses in revenue requirements; providing a more robust framework for addressing revenue issues; improving comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets; and providing more useful information to users of financial statements through improved revenue disclosure requirements. The provisions of this ASU are ultimately effective for interim and annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> The standard shall be applied retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB clarified the implementation guidance on principal versus agent, identifying performance obligations, licensing, and collectability.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The Company adopted the new revenue recognition standard (&#x201c;ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606&#x201d;</div>) on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018. </div>Results for reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018 </div>are presented under ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,</div> while prior period amounts are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> adjusted and continue to be reported in accordance with ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605,</div>&nbsp;<div style="display: inline; font-style: italic;">Revenue Recognition</div>. The application of the standard had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impact on the Company&#x2019;s consolidated financial statements for any periods prior to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> The adoption of ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> represents a change in accounting principle to more closely align revenue recognition with the delivery of the Company&#x2019;s products, licenses and services. ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div> requires an entity to evaluate revenue recognition by identifying a contract with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations in the contract, and recognizing revenue when (or as) the entity satisfies a performance obligation.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Revenue is principally derived from the sale and licensing of highly engineered plastic sheet and film products. The Company receives specific purchase orders for the manufacture, sale and delivery of these products that identify the goods and/or services to be transferred, the price for those goods and other commercial terms of the order. The goods are generally purchased under EXW (or EX-Works) terms, meaning that the customer is responsible for arranging the shipping of the goods and title passes when the goods are picked up from the Company&#x2019;s dock. Revenue is recognized upon the transfer of title, and there are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> price concessions, volume discounts, rebates, refunds, credits, incentives, performance bonuses, royalties or other types of variable consideration.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">In the specific case of the Equipment Purchase Agreement and a Technology License Agreement (the &#x201c;Agreements&#x201d;) signed on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 16, 2018 </div>for an aggregate transaction price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6,000,</div> the Company will purchase from a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> party specialized equipment (the &#x201c;Equipment&#x201d;) for the production of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> of the Company&#x2019;s proprietary encapsulants (the &#x201c;Encapsulant&#x201d;), resell the Equipment to the customer, install the Equipment at a facility of the customer and train the</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <!-- Field: Page; Sequence: 6 --> <div style=" font-size: 10pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; margin: 0pt 0">customer&#x2019;s personnel in the Equipment&#x2019;s use. Under the license agreement, the Company has granted the customer the right to use the formula for the Encapsulant and certain of the Company&#x2019;s production techniques to make or have made the Encapsulant for use in photovoltaic (PV) modules manufactured by the customer. For revenue recognition purposes, the Company defines the following <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> distinct major performance obligations of the Agreements and the corresponding transaction price allocated to those performance obligations:</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <ul style="margin-top: 0in; list-style-type: disc"> <li style="margin: 0pt 0; font-size: 10pt">Obligation <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> - <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,750</div> - Price Report, Formula and Sample</li> <li style="margin: 0pt 0; font-size: 10pt">Obligation <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> - <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,000</div> - Equipment, including delivery &amp; installation (incl. training)</li> <li style="margin: 0pt 0; font-size: 10pt">Obligation <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> - <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,250</div> - License (perpetual)</li> </ul> <div style=" font-size: 10pt; margin: 0pt 0 0pt 0.5in"></div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Obligation <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> is considered to be separate and distinct from the other <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> obligations, in that the information provided under this obligation represents significant standalone value to the customer and the Company&#x2019;s obligation to provide this information is separately identifiable from the other obligations in the agreements. Obligation <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> and Obligation <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> were also clearly identifiable, as defined by the Equipment Purchase Agreement (including delivery and installation by an agreed-upon date) and the license (&#x201c;License&#x201d;) granted pursuant to the Technology License Agreement (with an effective start date upon the receipt of an acceptance test payment).</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The Company is applying a &#x201c;cost-plus&#x201d; approach to Obligation <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> and Obligation <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> As the Company had never before sold any type of license, had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> established specific license pricing and had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> knowledge of pricing for similar licenses, the Company is using the residual approach for Obligation <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.</div> The License is perpetual, distinct and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> combined with other goods and services, and is a right to use, rather than to access, functional intellectual property.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The Company also assessed whether it was acting in a principal or agent role in each performance obligation of the Agreements. In all obligations, the Company determined it was acting in the role of principal and therefore revenue is recognized on a gross basis.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">As a result, the Company recognized <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,750</div> in the quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2018 </div>upon the satisfaction of Obligation <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> its delivery of a price report, formula and sample. The total transaction price of the Agreements is expected to be recognized as revenue as follows:</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="width: 52%; font-size: 10pt; text-align: center; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 12%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: center">2018</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt; border-bottom: Black 1.1pt solid">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 12%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: center">2019(a)</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt; border-bottom: Black 1.1pt solid">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 12%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: center"><div style="display: inline; font-size: 10pt">Total</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Revenue expected to be recognized during the year ended December 31</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,750</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,250</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top"> <td style="width: 0.25in"></td> <td style="width: 0.25in">(a)</td> <td><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,000</div> upon installation of the Equipment and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,250</div> upon acceptance and commencement of the License.</td> </tr> </table> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">There are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> new accounting pronouncements that the Company believes <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>have a material impact on its consolidated financial statements.</div></div> 1237000 1311000 6454000 7141000 76000 276000 7767000 8728000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Unvested<br /> Restricted&nbsp;Shares</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Number&nbsp;of<br /> Shares</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted&#x2013;<br /> Average<br /> Grant&#x2013;Date<br /> Fair&nbsp;Value</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Unvested at December&nbsp;31, 2017 </td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">385,716</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Granted </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">119,932</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Vested </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(505,648</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.28</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Unvested at June&nbsp;30, 2018 </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Expected to vest after June&nbsp;30, 2018 </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div> 904000 3360000 904000 904000 -2612000 -1958000 -3157000 -4585000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1&#x2014;BASIS</div> OF PRESENTATION</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The accompanying Condensed Consolidated Financial Statements and the related interim information contained within the notes to the Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and the applicable rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) for interim financial information and quarterly reports on the Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q. Accordingly, they do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include all of the information and the notes required for complete financial statements. These Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>included in STR Holdings, Inc.&#x2019;s (the &#x201c;Company&#x201d;) Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10&#x2013;K</div> filed with the SEC on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 16, 2018. </div>The unaudited interim Condensed Consolidated Financial Statements have been prepared on the same basis as the audited consolidated financial statements, and in the opinion of management, reflect all adjustments, consisting of only normal and recurring adjustments, necessary for the fair presentation of the Company&#x2019;s financial position, results of operations and cash flows for the interim periods presented. The results for the interim periods presented are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of future results.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The year-end Condensed Consolidated Balance Sheet data was derived from audited financial statements, but does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include all disclosures required by GAAP.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The preparation of the Condensed Consolidated Financial Statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#x2019;s estimates.</div></div> 114000 100000 738000 767000 78000 76000 -542000 501000 -88000 631000 -88000 -81000 205000 -36000 257000 -542000 501000 -88000 631000 183000 1632000 1203000 1206000 707000 177000 36000 410000 0.01 0.01 20000000 20000000 0 0 0 0 859000 748000 1475000 25000000 238000 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6&#x2014;LONG</div>-LIVED ASSETS</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Impairment Testing</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">In accordance with ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">360</div>-Property, Plant and Equipment, the Company assesses the impairment of its long-lived assets whenever changes in events or circumstances indicate that the carrying value of such assets <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recoverable. During each reporting period, the Company assessed if the following factors were present, which would cause an impairment review: overall negative solar industry conditions; a significant or prolonged decrease in net sales generated under its trademarks; loss of a significant customer or a reduction in demand for customers&#x2019; products; a significant adverse change in the extent to or manner in which the Company used its trademarks or proprietary technology; such assets becoming obsolete due to new technology or manufacturing processes entering the markets or an adverse change in legal factors; and the market capitalization of the Company&#x2019;s common stock.</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>the Company recorded valuation allowances against its deferred tax assets. The valuation allowances were recorded since the Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> consecutive years of taxable losses and determined that its history of actual net losses was evidence that should be given more weight than future projections. The Company determined the recording of valuation allowances against deferred tax assets to be an indicator to test its long-lived assets, which consist solely of property, plant and equipment, for impairment. The Company assessed the specific recoverability of its property, plant and equipment using updated real estate appraisals and other data for its other fixed assets, mainly production equipment. Based upon this analysis, the Company believes its property, plant and equipment carrying value was recoverable and depreciable lives were appropriate as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018. </div>Therefore <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impairment was recorded in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> If the Company experiences a significant reduction in future sales volume, further average selling price (&#x201c;ASP&#x201d;) reductions, lower profitability, a cessation of operations at any of its facilities, or negative changes in U.S. or Spain real estate markets, the Company&#x2019;s property, plant and equipment <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be subject to future impairment or accelerated depreciation.</div></div> 7767000 8728000 6000 -380000 67000 -215000 904000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17&#x2014;RELATED</div> PARTY TRANSACTION</div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; text-decoration: underline;">Huhui Supply Agreement</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The Company&#x2019;s Chinese subsidiary, Specialized Technology Resources Solar (Suzhou) Co. Ltd. (&#x201c;STR China&#x201d;) entered into a supply agreement (the &#x201c;Huhui Supply Agreement&#x201d;) dated as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2014 </div>with Zhangjiagang Huhui Segpv Co. Ltd ("Huhui"), a solar module manufacturer and an affiliate of Zhenfa.&nbsp;Pursuant to the Huhui Supply Agreement,&nbsp;STR China&nbsp;agreed to supply Huhui with the Company's encapsulant products and Huhui agreed (i) to purchase</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">535</div> MW worth of encapsulants (the &#x201c;Minimum Amount&#x201d;)&nbsp;during each contract year, (ii) to pay the Company a deposit equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the Minimum Amount, and&nbsp;(iii)&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> to purchase encapsulant products from other encapsulant manufacturers. The initial term of the Huhui Supply Agreement was for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year; however, such initial term was extended due to failure by Huhui to purchase the Minimum Amount at the end of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> year anniversary of the effective date of the Huhui Supply Agreement. The Huhui Supply Agreement further provided that Huhui&#x2019;s obligations were contingent (unless otherwise provided in the agreement) upon (i) the delivery by STR China of an initial shipment of products in accordance with the specifications and (ii) the qualification of the products by Huhui during a sample production run of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30</div> days. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>Huhui had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> commenced the sample production run. The Huhui Supply Agreement automatically renewed&nbsp;for additional <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year terms if either party failed to notify the other party at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90</div> days prior to the</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <!-- Field: Page; Sequence: 15 --> <div style=" font-size: 10pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; margin: 0pt 0">end of the then current term that it was electing to terminate the agreement. The Company believes that the terms and conditions set forth in the Huhui Agreement at that time were fair and reasonable to the Company. The Company received</div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,148</div> as a deposit from Huhui during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2015, </div>which was included in accrued liabilities on the Condensed Consolidated Balance Sheets.</div> <div style=" font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Huhui did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> complete its <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30</div> day production run as contemplated under the Supply Agreement and on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 27, 2018, </div>following the approval of the Company&#x2019;s Special Committee of Continuing Directors, STR China entered into an agreement to terminate the Supply Agreement (the &#x201c;Termination Agreement&#x201d;). Pursuant to the Termination Agreement,</div> <div style=" font-size: 10pt; margin: 0pt 0">Huhui agreed that STR China would retain the Deposit, and each of Huhui and STR China agreed to release the other from any liability or further obligations under the Supply Agreement. The Company recognized the full amount of the deposit as other income on the Condensed Consolidated Statement of Comprehensive Income (Loss).</div></div> 190000 236000 405000 550000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10&#x2014;COST</div></div>-<div style="display: inline; font-weight: bold;">REDUCTION ACTIONS</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2017 </div>the Company made the decision to wind down its China manufacturing operations substantially by the end of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div>&nbsp;The decision was consistent with ongoing efforts to reorganize its encapsulant business to better align with customer geography, to reduce losses related to unprofitable locations and to convert assets to cash for potential redeployment into more profitable endeavors. In connection with the restructuring, the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect any significant asset impairment charges and recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$93</div> of severance charges and benefits in cost of sales and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$48</div> of severance charges and benefits in selling, general and administrative expenses during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$67</div> of severance charges during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> The Company sold certain production and testing equipment from the China facility to its tolling partner in India during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2018, </div>the Company eliminated certain positions at its Spain facility, effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 18, 2018. </div>The Company recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$588</div> of severance and benefits in cost of sales and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$67</div> of severance and benefits in selling, general and administrative expenses during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The restructuring accrual consists of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$102</div> for severance and benefits as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> A rollforward of the severance and other exit cost accrual activity is as follows:</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">June&nbsp;30,<br /> 2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">June &nbsp;30,<br /> 2017</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Balance as of beginning of year </td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">87</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">269</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Additions </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">722</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">143</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Reductions </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(707</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(177</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Reversals </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(120</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Balance as of end of period </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">102</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div></div> 722000 143000 102000 87000 269000 115000 -120000 102000 87000 -201827000 -199072000 1750000 1401000 1444000 683000 1330000 2515000 3057000 6261000 6770000 1906000 2042000 3382000 3754000 983000 30000 2974000 478000 904000 131000 32000 1945000 42000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Three&nbsp;Months&nbsp;Ended<br /> June&nbsp;30,</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Six&nbsp;Months&nbsp;Ended<br /> June&nbsp;30,</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">Net Sales</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 52%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Spain </td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,906</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,042</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,382</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,754</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">China </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">983</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,974</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">India </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">478</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">904</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">United States </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">131</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,945</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">42</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Total Net Sales </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,515</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,057</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,261</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,770</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div> 6000000 1750000 2000000 2250000 2000000 2250000 1750000 4250000 6000000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="width: 52%; font-size: 10pt; text-align: center; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 12%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: center">2018</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt; border-bottom: Black 1.1pt solid">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 12%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: center">2019(a)</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt; padding-bottom: 1.1pt; border-bottom: Black 1.1pt solid">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 12%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: center"><div style="display: inline; font-size: 10pt">Total</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left">Revenue expected to be recognized during the year ended December 31</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,750</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,250</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,000</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">June 30,<br /> 2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December 31,<br /> 2017</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Balance as of beginning of period </td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">904</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,360</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Received from customers </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,985</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Converted to cash </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(888</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,508</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Paid to suppliers </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,162</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Foreign exchange impact </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(16</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">229</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Balance as of end of period </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">904</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">June&nbsp;30,<br /> 2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December&nbsp;31,<br /> 2017</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Salaries and wages </td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">323</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">239</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Accrued bonus </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">210</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">258</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Professional fees </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">285</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">319</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Restructuring severance and benefits (see Note 10) </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">102</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">87</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Environmental (see Note 9) </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Accrued franchise tax </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">79</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Client deposits </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">179</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,157</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Other </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">114</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 20pt">Total accrued liabilities </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,349</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,307</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin-left: 0.5in; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Three&nbsp;Months&nbsp;Ended<br /> June&nbsp;30,</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Six&nbsp;Months&nbsp;Ended<br /> June&nbsp;30,</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">Basic and diluted net loss per share</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 20pt">Numerator:</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Net loss </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,074</div></td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(284</div></td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,755</div></td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="width: 10%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,331</div></td> <td style="width: 1%; border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Denominator:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Weighted&#x2013;average shares outstanding </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,669,353</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,913,427</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,607,204</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,839,391</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Add: </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 30pt">Dilutive effect of stock options </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 30pt">Dilutive effect of restricted common stock </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 20pt">Weighted&#x2013;average shares outstanding with dilution </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,669,353</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,913,427</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,607,204</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,839,391</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Net loss per share:</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Basic </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.16</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.14</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.18</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 30pt">Diluted </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.16</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.14</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.18</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin-left: 0.5in; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Three&nbsp;Months&nbsp;Ended<br /> June&nbsp;30,</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Six&nbsp;Months&nbsp;Ended<br /> June&nbsp;30,</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Selling, general and administrative expense </td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">88</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">132</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">161</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252</div></td> <td style="width: 1%; border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Total stock-based compensation expense </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">88</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">132</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">161</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin-left: 0.5in; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="11" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Financial&nbsp;assets&nbsp;and&nbsp;liabilities&nbsp;at&nbsp;fair&nbsp;value<br /> as&nbsp;of&nbsp;June&nbsp;30,&nbsp;2018</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Level&nbsp;1</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Level&nbsp;2</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Level&nbsp;3</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; text-align: right">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Money market funds (1) </td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 11%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,605</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 11%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 11%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Bank acceptance notes (2) </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Non-recurring fair value measurements (3) </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,155</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 20pt">Total </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,605</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,155</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin-left: 0.5in; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="11" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Financial&nbsp;assets&nbsp;and&nbsp;liabilities&nbsp;at&nbsp;fair&nbsp;value<br /> as&nbsp;of&nbsp;December&nbsp;31,&nbsp;2017</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Level&nbsp;1</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Level&nbsp;2</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Level&nbsp;3</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; text-align: right">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Money market funds (1) </td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 11%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,688</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 11%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 11%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Bank acceptance notes (2) </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">904</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Non-recurring fair value measurements (3) </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,155</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 20pt">Total </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,592</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,155</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">June&nbsp;30,<br /> 2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December&nbsp;31,<br /> 2017</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Finished goods </td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">365</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">340</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Raw materials </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">996</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">829</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Reserve </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(59</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 20pt">Inventories, net </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,357</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,110</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">June&nbsp;30,<br /> 2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">June &nbsp;30,<br /> 2017</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Balance as of beginning of year </td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">87</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 14%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">269</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Additions </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">722</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">143</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Reductions </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(707</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(177</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Reversals </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(120</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Balance as of end of period </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">102</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; margin-left: 0.5in; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="19" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Options&nbsp;Outstanding</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Number<br /> of<br /> Shares</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted&#x2013;<br /> Average<br /> Exercise<br /> Price</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted&#x2013;<br /> Average<br /> Remaining<br /> Contractual<br /> Term<br /> (in&nbsp;years)</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Weighted&#x2013;<br /> Average<br /> Grant&#x2013;Date<br /> Fair&nbsp;Value</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Aggregate<br /> Intrinsic<br /> Value(1)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Balance at December&nbsp;31, 2017 </td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,121,332</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.52</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.99</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,402</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Options granted </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Exercised </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 20pt">Canceled/forfeited </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Balance at June&nbsp;30, 2018 </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,121,332</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.52</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.61</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.99</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,402</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Vested and exercisable as of June 30, 2018 </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,121,332</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.52</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.61</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.99</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,402</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Vested and exercisable as of June&nbsp;30, 2018 and expected to vest thereafter </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,121,332</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.52</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.61</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.99</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">$</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,402</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Common&nbsp;Stock</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Treasury&nbsp;Stock</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center">Additional<br /> Paid&#x2013;In</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center">Accumulated Other<br /> Comprehensive</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center">Accumulated</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center">Total<br /> Stockholders&#x2019;</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Issued</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Acquired</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Capital</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Loss</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Deficit</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Equity</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Balance at December&nbsp;31, 2017 </td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 6%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,532,573</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 6%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">195</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 6%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,240</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 6%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(57</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 6%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">232,149</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 6%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,355</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 6%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(199,072</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 6%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27,860</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Stock-based compensation </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">505,648</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">166</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">171</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Net loss </td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,755</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2.755</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Foreign currency translation, net of tax </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(88</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(88</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Balance at June&nbsp;30, 2018 </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,038,221</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">200</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,240</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(57</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">232,315</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,443</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(201,827</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25,188</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16&#x2014;GEOGRAPHICAL</div> INFORMATION</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">280</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50</div> Disclosure about Segments of an Enterprise and Related Information establishes standards for the manner in which companies report information about operating segments, products, geographic areas and major customers. The method of determining what information to report is based on the way that management organizes the operating segment within the enterprise for making operating decisions and assessing financial performance. The Company focuses on the manufacturing, sale and licensing of highly engineered plastic sheet and film products to customers throughout the world. The Company procures raw materials from multiple similar vendors and expects similar long-term economic characteristics for its products.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: center; margin: 0pt 0"><div style="display: inline; font-weight: bold;">Operations by Geographic Area</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Three&nbsp;Months&nbsp;Ended<br /> June&nbsp;30,</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Six&nbsp;Months&nbsp;Ended<br /> June&nbsp;30,</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">2017</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">Net Sales</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 52%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Spain </td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,906</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,042</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,382</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 9%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,754</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">China </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">983</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,974</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">India </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">478</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">904</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">United States </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">131</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,945</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">42</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Total Net Sales </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,515</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,057</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,261</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,770</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-size: 10pt; text-align: center; margin: 0pt 0"><div style="display: inline; font-weight: bold;">Long-Lived Assets by Geographic Area</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">June&nbsp;30,<br /> 2018</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">December&nbsp;31,<br /> 2017</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">Long-Lived Assets</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 68%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">United States </td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,237</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 2%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,311</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Spain </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,454</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,141</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">China </td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">76</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">276</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Total Long-Lived Assets </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,767</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,728</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">Foreign sales are based on the country in which the sales originated. Net sales to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div> of the Company&#x2019;s major customers that exceeded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the Company&#x2019;s consolidated net sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,401.</div> Net sales to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> of the Company&#x2019;s major customers that exceeded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the Company&#x2019;s consolidated net sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,444.</div> Net sales to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div></div> of the Company&#x2019;s major customers that exceeded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the Company&#x2019;s consolidated net sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$683</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,330,</div> respectively. Accounts receivable from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> customers amounted to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,072</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$70</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively.</div></div> 1380000 1299000 3072000 3280000 93000 48000 67000 588000 67000 161000 252000 P3Y P4Y 119932 385716 505648 0.28 4133133 431131 1121332 1.52 -1402000 -1402000 1121332 1121332 1.52 1.52 -1402000 1121332 1.52 0.27 P10Y 1402000 P6Y222D P6Y222D P6Y222D 19532573 1240 20038221 1240 505648 25188000 27860000 195000 -57000 232149000 -5355000 -199072000 200000 -57000 232315000 -5443000 -201827000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14&#x2014;STOCKHOLDERS&#x2019;</div> EQUITY</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Changes in stockholders&#x2019; equity for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> are as follows:</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Common&nbsp;Stock</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="7" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Treasury&nbsp;Stock</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center">Additional<br /> Paid&#x2013;In</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center">Accumulated Other<br /> Comprehensive</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center">Accumulated</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center">Total<br /> Stockholders&#x2019;</td> </tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Issued</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Acquired</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Amount</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Capital</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Loss</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Deficit</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td colspan="3" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1.1pt solid">Equity</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">Balance at December&nbsp;31, 2017 </td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 6%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,532,573</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 6%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">195</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 6%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,240</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 6%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(57</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 6%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">232,149</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 6%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,355</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 6%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(199,072</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">)</td> <td style="width: 1%; font-size: 10pt">&nbsp;</td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td> <td style="width: 6%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27,860</div></td> <td style="width: 1%; font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Stock-based compensation </td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">505,648</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">166</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">171</div></td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Net loss </td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,755</div></td> <td style="font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt">&nbsp;</td> <td style="font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2.755</div></td> <td style="font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; padding-bottom: 1.1pt; text-indent: -10pt; padding-left: 10pt">Foreign currency translation, net of tax </td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(88</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 1.1pt">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(88</div></td> <td style="border-bottom: Black 1.1pt solid; font-size: 10pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Balance at June&nbsp;30, 2018 </td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,038,221</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">200</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,240</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(57</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">232,315</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,443</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(201,827</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">)</td> <td style="font-size: 10pt; padding-bottom: 2.5pt">&nbsp;</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25,188</div></td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">&nbsp;</td> </tr> </table> </div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Common Stock</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The Company&#x2019;s Board of Directors has authorized <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">200,000,000</div> shares of common stock, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01</div> par value. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018, </div>there were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,039,461</div> shares issued and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,038,221</div> shares outstanding of common stock. Each share of common</div> <div style=" font-size: 10pt; margin: 0pt 0">stock is entitled to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> vote per share.</div></div> 1240 1240 57000 57000 19669353 18913427 19607204 18839391 19669353 18913427 19607204 18839391 $2,000 upon installation of the Equipment and $2,250 upon acceptance and commencement of the License. The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $0.27 of the Company's common stock on June 30, 2018. Included in cash and cash equivalents on the Company's Condensed Consolidated Balance Sheets. The carrying amount of money market funds is a reasonable estimate of fair value due to the short-term maturity. Refer to Note 4 for further information Included in assets held for sale on the Company's Condensed Consolidated Balance Sheets. Refer to Note 7 for further information. xbrli:shares xbrli:pure utr:MWh iso4217:USD iso4217:MYR iso4217:USD xbrli:shares iso4217:EUR 0001473597 us-gaap:EmployeeStockOptionMember 2013-05-14 2013-05-14 0001473597 us-gaap:EmployeeStockOptionMember srt:MaximumMember 2013-05-14 2013-05-14 0001473597 us-gaap:EmployeeStockOptionMember srt:MinimumMember 2013-05-14 2013-05-14 0001473597 stri:HuhuiSupplyAgreementMember 2014-01-01 2014-12-31 0001473597 stri:HuhuiSupplyAgreementMember stri:ZhangjiagangHuhuiSegpvCoLtdMember 2014-01-01 2014-12-31 0001473597 us-gaap:AccruedLiabilitiesMember stri:HuhuiSupplyAgreementMember stri:ZhangjiagangHuhuiSegpvCoLtdMember 2015-01-01 2015-12-31 0001473597 stri:EurofactorHispaniaSauMember stri:FactoringAgreementToSellWithRecourseMember 2015-10-01 2015-10-01 0001473597 stri:EurofactorHispaniaSauMember stri:FactoringAgreementToSellWithRecourseMember 2015-10-01 2015-10-31 0001473597 stri:MalaysiaFacilityMember 2016-01-01 2016-06-30 0001473597 stri:SolariaEnergiaYMedioAmbienteSAMember us-gaap:DamagesFromProductDefectsMember 2016-10-01 2016-10-31 0001473597 2017-01-01 2017-06-30 0001473597 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-06-30 0001473597 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-06-30 0001473597 us-gaap:RestrictedStockMember 2017-01-01 2017-06-30 0001473597 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-06-30 0001473597 us-gaap:CostOfSalesMember us-gaap:FacilityClosingMember stri:JohorMalaysiaMember 2017-01-01 2017-06-30 0001473597 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-06-30 0001473597 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:FacilityClosingMember stri:JohorMalaysiaMember 2017-01-01 2017-06-30 0001473597 us-gaap:BankersAcceptanceMember 2017-01-01 2017-06-30 0001473597 country:CN 2017-01-01 2017-06-30 0001473597 country:ES 2017-01-01 2017-06-30 0001473597 country:IN 2017-01-01 2017-06-30 0001473597 country:US 2017-01-01 2017-06-30 0001473597 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-12-31 0001473597 2017-04-01 2017-06-30 0001473597 us-gaap:EmployeeStockOptionMember 2017-04-01 2017-06-30 0001473597 us-gaap:EmployeeStockOptionMember 2017-04-01 2017-06-30 0001473597 us-gaap:RestrictedStockMember 2017-04-01 2017-06-30 0001473597 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2017-04-01 2017-06-30 0001473597 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-04-01 2017-06-30 0001473597 country:CN 2017-04-01 2017-06-30 0001473597 country:ES 2017-04-01 2017-06-30 0001473597 country:IN 2017-04-01 2017-06-30 0001473597 country:US 2017-04-01 2017-06-30 0001473597 stri:PriceReportFormulaAndSampleMember 2018-01-01 2018-03-31 0001473597 2018-01-01 2018-06-30 0001473597 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-06-30 0001473597 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-06-30 0001473597 us-gaap:RestrictedStockMember 2018-01-01 2018-06-30 0001473597 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001473597 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-06-30 0001473597 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember stri:OneMajorCustomersMember 2018-01-01 2018-06-30 0001473597 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember stri:TwoMajorCustomersMember 2018-01-01 2018-06-30 0001473597 us-gaap:CostOfSalesMember us-gaap:FacilityClosingMember stri:JohorMalaysiaMember 2018-01-01 2018-06-30 0001473597 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-06-30 0001473597 us-gaap:BankersAcceptanceMember 2018-01-01 2018-06-30 0001473597 stri:MalaysiaFacilityMember 2018-01-01 2018-06-30 0001473597 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-06-30 0001473597 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-06-30 0001473597 us-gaap:CommonStockMember 2018-01-01 2018-06-30 0001473597 us-gaap:RetainedEarningsMember 2018-01-01 2018-06-30 0001473597 us-gaap:TreasuryStockMember 2018-01-01 2018-06-30 0001473597 country:CN 2018-01-01 2018-06-30 0001473597 country:ES 2018-01-01 2018-06-30 0001473597 country:IN 2018-01-01 2018-06-30 0001473597 country:US 2018-01-01 2018-06-30 0001473597 2018-04-01 2018-06-30 0001473597 us-gaap:EmployeeStockOptionMember 2018-04-01 2018-06-30 0001473597 us-gaap:EmployeeStockOptionMember 2018-04-01 2018-06-30 0001473597 us-gaap:RestrictedStockMember 2018-04-01 2018-06-30 0001473597 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-04-01 2018-06-30 0001473597 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember stri:FourMajorCustomersMember 2018-04-01 2018-06-30 0001473597 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember stri:OneMajorCustomersMember 2018-04-01 2018-06-30 0001473597 us-gaap:CostOfSalesMember us-gaap:FacilityClosingMember country:ES 2018-04-01 2018-06-30 0001473597 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-04-01 2018-06-30 0001473597 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:FacilityClosingMember country:ES 2018-04-01 2018-06-30 0001473597 country:CN 2018-04-01 2018-06-30 0001473597 country:ES 2018-04-01 2018-06-30 0001473597 country:IN 2018-04-01 2018-06-30 0001473597 country:US 2018-04-01 2018-06-30 0001473597 stri:EquityIncentivePlan2009Member 2013-05-14 0001473597 stri:EurofactorHispaniaSauMember stri:FactoringAgreementToSellWithRecourseMember stri:EuroInterbankOfferedRateEuriborMember 2015-10-31 0001473597 stri:EurofactorHispaniaSauMember stri:FactoringAgreementToSellWithRecourseMember us-gaap:LondonInterbankOfferedRateLIBORMember 2015-10-31 0001473597 2016-12-31 0001473597 us-gaap:BankersAcceptanceMember 2016-12-31 0001473597 2017-03-31 0001473597 2017-06-30 0001473597 us-gaap:BankersAcceptanceMember 2017-06-30 0001473597 2017-12-31 0001473597 us-gaap:EmployeeStockOptionMember 2017-12-31 0001473597 us-gaap:RestrictedStockMember 2017-12-31 0001473597 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2017-12-31 0001473597 stri:PhaseIIEnvironmentalSiteAssessmentMember 2017-12-31 0001473597 us-gaap:BankersAcceptanceMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001473597 us-gaap:BankersAcceptanceMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001473597 us-gaap:BankersAcceptanceMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001473597 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001473597 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001473597 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-12-31 0001473597 us-gaap:FairValueInputsLevel1Member 2017-12-31 0001473597 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsNonrecurringMember 2017-12-31 0001473597 us-gaap:FairValueInputsLevel2Member 2017-12-31 0001473597 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2017-12-31 0001473597 us-gaap:FairValueInputsLevel3Member 2017-12-31 0001473597 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2017-12-31 0001473597 us-gaap:BankersAcceptanceMember 2017-12-31 0001473597 stri:SolariaEnergiaYMedioAmbienteSAMember us-gaap:DamagesFromProductDefectsMember 2017-12-31 0001473597 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001473597 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001473597 us-gaap:CommonStockMember 2017-12-31 0001473597 us-gaap:RetainedEarningsMember 2017-12-31 0001473597 us-gaap:TreasuryStockMember 2017-12-31 0001473597 country:CN 2017-12-31 0001473597 country:ES 2017-12-31 0001473597 country:US 2017-12-31 0001473597 stri:DeliveryAndInstallationOfEquipmentAndTrainingMember 2018-01-16 0001473597 us-gaap:LicenseMember 2018-01-16 0001473597 stri:PriceReportFormulaAndSampleMember 2018-01-16 0001473597 2018-01-16 0001473597 2018-03-31 0001473597 2018-06-30 0001473597 us-gaap:EmployeeStockOptionMember 2018-06-30 0001473597 us-gaap:RestrictedStockMember 2018-06-30 0001473597 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-06-30 0001473597 stri:EurofactorHispaniaSauMember stri:FactoringAgreementToSellWithRecourseMember 2018-06-30 0001473597 stri:PhaseIIEnvironmentalSiteAssessmentMember 2018-06-30 0001473597 us-gaap:BankersAcceptanceMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001473597 us-gaap:BankersAcceptanceMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001473597 us-gaap:BankersAcceptanceMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001473597 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001473597 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001473597 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-06-30 0001473597 us-gaap:FairValueInputsLevel1Member 2018-06-30 0001473597 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsNonrecurringMember 2018-06-30 0001473597 us-gaap:FairValueInputsLevel2Member 2018-06-30 0001473597 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsNonrecurringMember 2018-06-30 0001473597 us-gaap:FairValueInputsLevel3Member 2018-06-30 0001473597 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2018-06-30 0001473597 us-gaap:BankersAcceptanceMember 2018-06-30 0001473597 stri:SolariaEnergiaYMedioAmbienteSAMember us-gaap:DamagesFromProductDefectsMember 2018-06-30 0001473597 stri:DeliveryAndInstallationOfEquipmentAndTrainingMember 2018-07-01 2018-06-30 0001473597 us-gaap:LicenseMember 2019-01-01 2018-06-30 0001473597 2018-07-01 2018-06-30 0001473597 2019-01-01 2018-06-30 0001473597 2018-06-30 0001473597 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001473597 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001473597 us-gaap:CommonStockMember 2018-06-30 0001473597 us-gaap:RetainedEarningsMember 2018-06-30 0001473597 us-gaap:TreasuryStockMember 2018-06-30 0001473597 country:CN 2018-06-30 0001473597 country:ES 2018-06-30 0001473597 country:US 2018-06-30 0001473597 2018-07-31 EX-101.SCH 8 stri-20180630.xsd XBRL SCHEMA FILE 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Basis of Presentation link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Recent Accounting Pronouncements and Adoption link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Loss Per Share link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Bank Acceptance Notes link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Inventories link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Long-lived Assets link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Assets Held for Sale link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Accrued Liabilities link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 9 - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 10 - Cost Reduction Actions link:calculationLink link:definitionLink link:presentationLink 016 - Document - Note 11 - Fair Value Measurements link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 12 - Factoring Arrangement link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 13 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 14 - Stockholders' Equity link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 15 - Stock-based Compensation link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 16 - Geographical Information link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 17 - Related Party Transaction link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 2 - Recent Accounting Pronouncements and Adoption (Tables) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 3 - Loss Per Share (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 4 - Bank Acceptance Notes (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 5 - Inventories (Tables) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 8 - Accrued Liabilities (Tables) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 10 - Cost Reduction Actions (Tables) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 11 - Fair Value Measurements (Tables) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 14 - Stockholders' Equity (Tables) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 15 - Stock-based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 16 - Geographical Information (Tables) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 2 - Recent Accounting Pronouncements and Adoption 1 (Details Textual) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 2 - Recent Accounting Pronouncements and Adoption 2 (Details Textual) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 2 - Recent Accounting Pronouncements and Adoption - Expected Recognition of Revenue (Details) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 3 - Loss Per Share (Details Textual) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 3 - Loss Per Share - Earnings (Loss) Per Share (Details) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 4 - Bank Acceptance Notes - Bank Acceptance Notes (Details) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 5 - Inventories - Inventories (Details) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 6 - Long-lived Assets (Details Textual) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 7 - Assets Held for Sale (Details Textual) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 8 - Accrued Liabilities - Accrued Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 9 - Commitments and Contingencies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 10 - Cost Reduction Actions (Details Textual) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 10 - Cost Reduction Actions - Schedule of Restructuring Costs (Details) link:calculationLink link:definitionLink link:presentationLink 046 - Disclosure - Note 11 - Fair Value Measurements - Fair Value Measurements of Financial Assets and Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 047 - Disclosure - Note 12 - Factoring Arrangement (Details Textual) link:calculationLink link:definitionLink link:presentationLink 048 - Disclosure - Note 13 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 049 - Disclosure - Note 14 - Stockholders' Equity (Details Textual) link:calculationLink link:definitionLink link:presentationLink 050 - Disclosure - Note 14 - Stockholders' Equity - Schedule of Changes in Stockholders' Equity (Details) link:calculationLink link:definitionLink link:presentationLink 051 - Disclosure - Note 15 - Stock-based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 052 - Disclosure - Note 15 - Stock-based Compensation - Summary of Stock Options Activity (Details) link:calculationLink link:definitionLink link:presentationLink 053 - Disclosure - Note 15 - Stock-based Compensation - Summary of Restricted Common Stock Activity (Details) link:calculationLink link:definitionLink link:presentationLink 054 - Disclosure - Note 15 - Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details) link:calculationLink link:definitionLink link:presentationLink 055 - Disclosure - Note 16 - Geographical Information (Details Textual) link:calculationLink link:definitionLink link:presentationLink 056 - Disclosure - Note 16 - Geographical Information - Schedule of Operations by Geographic Area (Details) link:calculationLink link:definitionLink link:presentationLink 057 - Disclosure - Note 16 - Reportable Segment and Geographical Information - Schedule of Long-lived Assets by Geographic Area (Details) link:calculationLink link:definitionLink link:presentationLink 058 - Disclosure - Note 17 - Related Party Transaction (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 9 stri-20180630_cal.xml XBRL CALCULATION FILE EX-101.DEF 10 stri-20180630_def.xml XBRL DEFINITION FILE EX-101.LAB 11 stri-20180630_lab.xml XBRL LABEL FILE Document And Entity Information us-gaap_IncomeTaxExpenseBenefitIntraperiodTaxAllocation Income Tax Expense (Benefit), Intraperiod Tax Allocation, Total Note To Financial Statement Details Textual Note 2 - Recent Accounting Pronouncements and Adoption stri_NotesReceivableConvertedToCash Converted to cash Represents the amount pertaining to conversion of notes to cash during the period. Note 3 - Loss Per Share Received from customers The amount pertaining to notes received from the customers for the services done by the entity during the period. Note 4 - Bank Acceptance Notes Note 5 - Inventories stri_NotesReceivablePaymentsToSuppliers Paid to suppliers Represents the amount pertaining to settlement of suppliers with the notes, which is received from the customers during the period. Note 8 - Accrued Liabilities us-gaap_PaymentsForRestructuring Reductions Note 10 - Cost Reduction Actions Note 11 - Fair Value Measurements Note 14 - Stockholders' Equity Note 15 - Stock-based Compensation Income Tax Disclosure [Text Block] Note 16 - Geographical Information Note 2 - Recent Accounting Pronouncements and Adoption - Expected Recognition of Revenue (Details) Note 3 - Loss Per Share - Earnings (Loss) Per Share (Details) Note 4 - Bank Acceptance Notes - Bank Acceptance Notes (Details) Other long-term assets us-gaap_ShareBasedCompensation Stock–based compensation expense Note 5 - Inventories - Inventories (Details) us-gaap_LiabilitiesCurrent Total current liabilities Note 8 - Accrued Liabilities - Accrued Liabilities (Details) Note 10 - Cost Reduction Actions - Schedule of Restructuring Costs (Details) Note 11 - Fair Value Measurements - Fair Value Measurements of Financial Assets and Liabilities (Details) Note 14 - Stockholders' Equity - Schedule of Changes in Stockholders' Equity (Details) Four Major Customers [Member] Represents information about the company's major customers during the period. Note 15 - Stock-based Compensation - Summary of Stock Options Activity (Details) Note 15 - Stock-based Compensation - Summary of Restricted Common Stock Activity (Details) Note 15 - Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details) Note 16 - Geographical Information - Schedule of Operations by Geographic Area (Details) Note 16 - Reportable Segment and Geographical Information - Schedule of Long-lived Assets by Geographic Area (Details) Notes To Financial Statements Notes To Financial Statements [Abstract] Environmental (see Note 9) Share-based Compensation, Stock Options, Activity [Table Text Block] Foreign currency translation (net of tax effect of $(81), $205, $(36) and $257, respectively) Foreign currency translation, net of tax Granted, Weighted-average grant-date fair value (in dollars per share) Vested, Weighted-average grant-date fair value (in dollars per share) Non-recurring fair value measurements us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Unvested, Weighted-average grant-date fair value (in dollars per share) Unvested, Weighted-average grant-date fair value (in dollars per share) Fair Value Assets Expected to vest, Number of shares (in shares) Unvested restricted shares, Number of shares (in shares) Unvested restricted shares, Number of shares (in shares) Vested and exercisable as of December 31, 2017 and expected to vest thereafter, Weighted–average remaining contractual term (Year) us-gaap_Depreciation Depreciation us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Granted, Number of shares (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Vested, Number of shares (in shares) Vested and exercisable as of December 31, 2017 and expected to vest thereafter, Number of shares (in shares) Nonvested Restricted Stock Shares Activity [Table Text Block] Vested and exercisable as of December 31, 2017 and expected to vest thereafter, Weighted-average exercise price (in dollars per share) Other comprehensive (loss) income: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Vested and exercisable as of December 31, 2017 and expected to vest thereafter, Aggregate intrinsic value us-gaap_AssetsCurrent Total current assets Vested and exercisable as of December 31, 2017, Weighted–average exercise price (in dollars per share) Vested and exercisable as of December 31, 2017, Weighted–average remaining contractual term (Year) Money market funds us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Vested and exercisable as of December 31, 2017, Aggregate intrinsic value us-gaap_ReceivablesFairValueDisclosure Bank acceptance notes Stockholders' Equity Note Disclosure [Text Block] Vested and exercisable as of December 31, 2017, Number of shares (in shares) Options outstanding, Weighted–average remaining contractual term (Year) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Options outstanding, Aggregate intrinsic value us-gaap_LoansReceivableBasisSpreadOnVariableRate Loans Receivable, Basis Spread on Variable Rate Options granted, Weighted–average Grant–date fair value (in dollars per share) Treasury stock, shares (in shares) Fair Value, Measurements, Nonrecurring [Member] Interest income (expense), net Common stock, $0.01 par value, 200,000,000 shares authorized; 20,039,461 and 20,038,221 issued and outstanding, respectively, in 2018 and 19,919,529 and 19,918,289 issued and outstanding, respectively, in 2017 Accrued Liabilities [Member] Measurement Frequency [Axis] Adjustments to reconcile net loss to net cash used in operating activities: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Options Outstanding, Weighted–average exercise price (in dollars per share) Options Outstanding, Weighted–average exercise price (in dollars per share) Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Recurring [Member] Common stock, authorized (in shares) Common Stock, Shares Authorized Common stock issued (in shares) Common Stock, Shares, Issued, Total Bankers Acceptance [Member] Canceled/forfeited, Weighted-average exercise price (in dollars per share) Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Options granted, Weighted–average exercise price (in dollars per share) Exercised, Weighted–average exercise price (in dollars per share) Accrued liabilities (Note 8) Total accrued liabilities Income taxes payable Malaysia Facility [Member] A facility located in Malaysia. Range [Domain] Maximum [Member] Minimum [Member] Accounts payable Product and Service [Axis] Other current assets us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Options Outstanding, Number of shares (in shares) Options Outstanding, Number of shares (in shares) Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Product and Service [Domain] Long-lived Assets Held for Sale Disclosure [Text Block] Disclosure of long lived assets held for sale. Disclosure may include the description of the facts and circumstances leading to the expected disposal, manner and timing of disposal, the carrying value of the assets held for sale, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss). Range [Axis] Price Report, Formula and Sample [Member] A price report, formula, and sample for one of the reporting entity's encapsulants. Accrued bonus Litigation Case [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Canceled/forfeited, Number of shares (in shares) Proceeds from sale of fixed assets Proceeds from Sale of Property, Plant, and Equipment, Total Litigation Case [Domain] Preferred stock, $0.01 par value, 20,000,000 shares authorized; no shares issued and outstanding us-gaap_OtherAccruedLiabilitiesCurrent Other Preferred stock, issued (in shares) Accrued franchise tax Represents accrued franchise tax. Salaries and wages us-gaap_PolicyTextBlockAbstract Accounting Policies Delivery and Installation of Equipment and Training [Member] The delivery of equipment, including installation and training to operate the equipment. Prepaid expenses Long-Lived Assets Property, Plant and Equipment Disclosure [Text Block] Geographical [Axis] Geographical [Domain] Preferred stock, authorized (in shares) Inventories, net Inventories, net us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Professional fees Preferred stock, par value (in dollars per share) Phase II Environmental Site Assessment [Member] Represents Phase II environmental site assessment. Net sales Revenue from Contract with Customer, Including Assessed Tax us-gaap_InventoryValuationReserves Reserve Fair Value, Inputs, Level 3 [Member] us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Capital investments Dilutive effect of share-based awards (in shares) Foreign currency transaction loss Finished goods Proceeds from insurance claim Fair Value Hierarchy and NAV [Domain] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Customer [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Customer [Domain] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Weighted–average shares outstanding (Note 3): Fair Value Hierarchy and NAV [Axis] us-gaap_LossContingencyAccrualAtCarryingValue Loss Contingency Accrual, Ending Balance CURRENT LIABILITIES Raw materials us-gaap_Assets Total assets Plan Name [Axis] Plan Name [Domain] us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total OPERATING ACTIVITIES Bank acceptance notes Balance as of beginning of period Balance as of end of period Statement [Line Items] us-gaap_AccountsReceivableGrossCurrent Accounts Receivable, Gross, Current Allowance for doubtful accounts Accounts receivable, trade, less allowances for doubtful accounts of $1,734 and $1,725 in 2018 and 2017, respectively us-gaap_LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value Johor, Malaysia [Member] Represents Johor, Malaysia. Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Additional paid–in capital AOCI Attributable to Parent [Member] Stockholders’ Equity Other income, net Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Segment Reporting Disclosure [Text Block] Equity Award [Domain] Client deposits CURRENT ASSETS us-gaap_IncomeLossFromContinuingOperations Net loss Net loss Fair Value Disclosures [Text Block] Award Type [Axis] Net loss us-gaap_NetIncomeLoss Net loss Net loss per share (Note 3): License [Member] us-gaap_Liabilities Total liabilities us-gaap_NetCashProvidedByUsedInFinancingActivities Total net cash (used in) provided by financing activities Restricted Stock [Member] stri_FactoringAgreementMaximumOutstandingAmount Factoring Agreement Maximum Outstanding Amount Represents information pertaining to factoring agreement maximum outstanding amount. COMMITMENTS AND CONTINGENCIES (Note 9) Factoring Agreement to Sell with Recourse [Member] Represents information pertaining to factoring agreement to sell with recourse. Eurofactor Hispania S.A.U [Member] Represents information pertaining to eurofactor Hispania S.A.U. us-gaap_OperatingIncomeLoss Operating loss Employee Stock Option [Member] us-gaap_NetCashProvidedByUsedInOperatingActivities Total net cash (used in) provided by operating activities us-gaap_NetCashProvidedByUsedInInvestingActivities Total net cash provided by (used in) investing activities Loss Contingency, Nature [Domain] stri_TermOfAgreement Term of Agreement Represents the term of the agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Effect of exchange rate changes on cash us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Net change in cash and cash equivalents Antidilutive Securities [Axis] Damages from Product Defects [Member] Antidilutive Securities, Name [Domain] us-gaap_GrossProfit Gross (loss) profit Cost of sales Counterparty Name [Axis] stri_WrittenNoticePeriodPriorToEndOfCurrentTerm Written Notice Period Prior to End of Current Term Represents information pertaining to written notice period prior to end of current term. Counterparty Name [Domain] Euro Interbank Offered Rate (EURIBOR) [Member] Represents the Interest rate at which a bank borrows funds from other banks in the Eurointerbank market. Loss Contingency Nature [Axis] Commitments and Contingencies Disclosure [Text Block] Property, plant and equipment, net stri_RelatedPartyTransactionMinimumSquareMetersTransaction Related Party Transaction, Minimum Square Meters Transaction Represents the information pertaining to minimum encapsulants transaction. Huhui Supply Agreement [Member] Represents information pertaining to Huhui supply agreement. Zhangjiagang Huhui Segpv Co Ltd [Member] Represents information pertaining to Zhangjiagang Huhui Segpv Co Ltd, an affiliate of Zhenfa. stri_RelatedPartyTransactionAutomaticRenewalAdditionalTerm Related Party Transaction, Automatic Renewal Additional Term The term of the related party automatic renewal in the absence of termination. stri_RelatedPartyTransactionDepositPercentageOnMinimumAmount Related Party Transaction, Deposit Percentage on Minimum Amount Represents the information pertaining to deposit percentage on minimum amount. stri_RelatedPartyTransactionClientDepositReceivedFromRelatedParty Related Party Transaction, Client Deposit Received from Related Party Represents the information pertaining to amount as a client deposit received from related party. stri_RelatedPartyTransactionNoticePeriodPriorToEndOfCurrentTerm Related Party Transaction, Notice Period Prior to End of Current Term Represents the information pertaining to notice period prior to end of current term. INVESTING ACTIVITIES stri_NumberOfMajorCustomers Number of Major Customers Represents the number of major customers accounting for 10% or more of the specified concentration risk benchmark, which includes, but not limited to, sales revenue, accounts receivable, etc. us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet Other, net Two Major Customers [Member] Represents information about the company's major customers during the period. Retained Earnings [Member] Earnings Per Share [Text Block] us-gaap_ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised One Major Customers [Member] Represents information about the company's major customers during the period. Treasury Stock [Member] us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable Income taxes payable Equity Incentive Plan 2009 [Member] Represents the 2009 Equity Incentive Plan which provides for the grant of stock-based awards. Excludes shares which may be purchased under an employee stock purchase plan. Additional Paid-in Capital [Member] Common Stock [Member] Related Party Transactions Disclosure [Text Block] Income tax expense (benefit) Income Tax Expense (Benefit), Total us-gaap_IncreaseDecreaseInAccruedLiabilities Accrued liabilities Equity Components [Axis] Equity Component [Domain] us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit), Total CHINA us-gaap_IncreaseDecreaseInAccountsPayable Accounts payable Environmental Remediation Contingency [Axis] Revenue expected to be recognized during the year ended December 31 Revenue, Remaining Performance Obligation, Amount Environmental Remediation Contingency [Domain] us-gaap_GainLossOnContractTermination Customer forfeiture of deposit Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Loss before income tax expense (benefit) Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block] SPAIN Cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cancelled/forfeited, Weighted–average Grant–date fair value (in dollars per share) The weighted-average grant-date fair value of exercisable stock options that are fully vested or expected to vest, as of the balance sheet date. Total stock-based compensation expense Options outstanding, Weighted–average Grant–date fair value (in dollars per share) The weighted-average grant-date fair value of option awards outstanding under the stock option plan. Vested and exercisable as of December 31, 2017 and expected to vest thereafter, Weighted–average Grant–date fair value (in dollars per share) As of the balance sheet date, the weighted-average grant date fair value for exercisable stock options that are fully vested or expected to vest. Balance Sheet Location [Axis] Balance Sheet Location [Domain] Foreign currency translation, tax effect Amendment Flag Accounting Policies [Abstract] us-gaap_ComprehensiveIncomeNetOfTax Comprehensive (loss) income Selling, General and Administrative Expenses [Member] Loss on disposal of fixed assets INDIA us-gaap_SharesOutstanding Balance at December 31, 2017 (in shares) Balance at end of period (in shares) Common stock, outstanding (in shares) Common Stock, Shares, Outstanding, Ending Balance Preferred stock, outstanding (in shares) Due to factor Due To Factor, Current Carrying value as of balance sheet date of current liabilities incurred due to factor. Current Fiscal Year End Date Cost of Sales [Member] Factoring arrangement Represents proceeds from (payments to) factoring agreement. Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date Income Statement Location [Axis] Income Statement Location [Domain] Type of Arrangement and Non-arrangement Transactions [Axis] stri_CommonStockVotingRightsNumber Common Stock, Voting Rights Number Represents the number of voting rights entitled per share of common stock owned. Document Type stri_NotesReceivableForeignExchangeImpact Foreign exchange impact Represents the amount pertaining to foreign exchange impact of notes, which is received from the customers during the period. Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Document Information [Line Items] Factoring Arrangement Disclosure [Text Block] Represents the entire disclosure for factoring arrangement. Document Information [Table] us-gaap_SeveranceCosts1 Severance Costs Entity Filer Category Entity Current Reporting Status us-gaap_RestructuringCharges Additions Entity Voluntary Filers Entity Well-known Seasoned Issuer London Interbank Offered Rate (LIBOR) [Member] Variable Rate [Domain] us-gaap_SharePrice Share Price Vested and exercisable as of December 31, 2017, Weighted–average Grant–date fair value (in dollars per share) The weighted-average grant-date fair value, as of the balance sheet date, of vested portions of options outstanding and currently exercisable under the stock option plan. us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Expected to vest, Weighted-average grant-date fair value (in dollars per share) The weighted average fair value of nonvested awards on equity-based plans excluding option plans outstanding as of the balance sheet date that are expected to vest after the balance sheet date. Solaria Energia y Medio Ambiente S.A. [Member] A litigation case involving Solaria Energia y Medio Ambiente S.A. Variable Rate [Axis] Weighted–average shares outstanding with dilution (in shares) Diluted (in shares) us-gaap_IncreaseDecreaseInAccountsReceivable Accounts receivable Stock-based compensation Impairment of assets held for sale Impairment of Long-Lived Assets to be Disposed of Entity Central Index Key Entity Registrant Name Entity [Domain] Customer Concentration Risk [Member] Asset Class [Axis] Legal Entity [Axis] Asset Class [Domain] Statement [Table] Scenario [Axis] Statement of Financial Position [Abstract] Diluted (in dollars per share) Scenario, Unspecified [Domain] Weighted–average shares outstanding (in shares) Basic (in shares) Accounts Payable and Accrued Liabilities Disclosure [Text Block] us-gaap_EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent, Total Basic (in dollars per share) Concentration Risk Type [Axis] Concentration Risk Type [Domain] us-gaap_TreasuryStockValue Treasury stock, 1,240 shares at cost stri_RelatedPartyTransactionAgreementTerm Related Party Transaction, Agreement Term The term of the related party transaction agreement. Statement of Cash Flows [Abstract] Entity Common Stock, Shares Outstanding (in shares) Income Statement [Abstract] us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other comprehensive (loss) income us-gaap_RestructuringReserve Restructuring Reserve, Ending Balance Balance as of beginning of year Balance Sales Revenue, Net [Member] Revenue from External Customers by Geographic Areas [Table Text Block] Long-lived Assets by Geographic Areas [Table Text Block] Accounts Receivable [Member] Schedule of Accrued Liabilities [Table Text Block] us-gaap_IncreaseDecreaseInOtherCurrentAssets Other current assets Reversals Investments [Domain] us-gaap_IncreaseDecreaseInInventories Inventories, net Trading Symbol Restructuring severance and benefits (see Note 10) Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Investment Type [Axis] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] us-gaap_GainLossOnDispositionOfAssets Gain (loss) on disposal of property, plant and equipment us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised Exercised, Number of shares (in shares) us-gaap_TableTextBlock Notes Tables Stock-based compensation (in shares) New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Type of Restructuring [Domain] Related Party [Axis] Facility Closing [Member] Related Party [Domain] Restructuring and Related Activities Disclosure [Text Block] Selling, general and administrative expenses Provision (recovery) for bad debt expense Restructuring Type [Axis] FINANCING ACTIVITIES Options granted, Number of shares (in shares) us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Arrangements and Non-arrangement Transactions [Domain] us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and stockholders’ equity us-gaap_DeferredTaxLiabilitiesNoncurrent Deferred tax liabilities UNITED STATES Related Party Transaction [Axis] Related Party Transaction [Domain] Accumulated deficit Research and development expense Accumulated other comprehensive loss, net Money Market Funds [Member] Assets held for sale (Note 7) us-gaap_AccrualForEnvironmentalLossContingencies Accrual for Environmental Loss Contingencies, Ending Balance Changes in operating assets and liabilities: us-gaap_StockholdersEquity Total stockholders’ equity Balance at December 31, 2017 Balance at end of period us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Inventory Disclosure [Text Block] Schedule of Inventory, Current [Table Text Block] Class of Stock [Axis] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Stockholders Equity [Table Text Block] Schedule of Restructuring Reserve by Type of Cost [Table Text Block] us-gaap_DeferredIncomeTaxExpenseBenefit Provision (recovery) for deferred taxes EX-101.PRE 12 stri-20180630_pre.xml XBRL PRESENTATION FILE GRAPHIC 13 str_logo.jpg GRAPHIC begin 644 str_logo.jpg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htm IDEA: XBRL DOCUMENT v3.10.0.1
Document And Entity Information - shares
6 Months Ended
Jun. 30, 2018
Jul. 31, 2018
Document Information [Line Items]    
Entity Registrant Name STR HOLDINGS, INC.  
Entity Central Index Key 0001473597  
Trading Symbol stri  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Well-known Seasoned Issuer No  
Entity Common Stock, Shares Outstanding (in shares)   20,101,221
Document Type 10-Q  
Document Period End Date Jun. 30, 2018  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q2  
Amendment Flag false  
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
CURRENT ASSETS    
Cash and cash equivalents $ 11,710 $ 13,499
Bank acceptance notes 904
Accounts receivable, trade, less allowances for doubtful accounts of $1,734 and $1,725 in 2018 and 2017, respectively 1,588 1,199
Inventories, net 1,357 1,110
Prepaid expenses 859 748
Other current assets 738 767
Total current assets 16,252 18,227
Property, plant and equipment, net 7,767 8,728
Assets held for sale (Note 7) 6,155 6,155
Other long-term assets 78 76
Total assets 30,252 33,186
CURRENT LIABILITIES    
Accounts payable 1,451 971
Accrued liabilities (Note 8) 1,349 2,307
Income taxes payable 898 896
Due to factor 397 454
Total current liabilities 4,095 4,628
Deferred tax liabilities 969 698
Total liabilities 5,064 5,326
COMMITMENTS AND CONTINGENCIES (Note 9)
Stockholders’ Equity    
Preferred stock, $0.01 par value, 20,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.01 par value, 200,000,000 shares authorized; 20,039,461 and 20,038,221 issued and outstanding, respectively, in 2018 and 19,919,529 and 19,918,289 issued and outstanding, respectively, in 2017 200 195
Treasury stock, 1,240 shares at cost (57) (57)
Additional paid–in capital 232,315 232,149
Accumulated deficit (201,827) (199,072)
Accumulated other comprehensive loss, net (5,443) (5,355)
Total stockholders’ equity 25,188 27,860
Total liabilities and stockholders’ equity $ 30,252 $ 33,186
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Allowance for doubtful accounts $ 1,734 $ 1,725
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, authorized (in shares) 20,000,000 20,000,000
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, authorized (in shares) 200,000,000 200,000,000
Common stock issued (in shares) 20,039,461 19,919,529
Common stock, outstanding (in shares) 20,038,221 19,918,289
Treasury stock, shares (in shares) 1,240 1,240
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Net sales $ 2,515 $ 3,057 $ 6,261 $ 6,770
Cost of sales 3,490 3,695 5,935 7,905
Gross (loss) profit (975) (638) 326 (1,135)
Selling, general and administrative expenses 1,380 1,299 3,072 3,280
Research and development expense 190 236 405 550
Provision (recovery) for bad debt expense 67 (215) 6 (380)
Operating loss (2,612) (1,958) (3,157) (4,585)
Interest income (expense), net 16 (3) 15 (7)
Other income, net 183 1,632 1,203 1,206
Loss on disposal of fixed assets (383) (16) (383) (13)
Foreign currency transaction loss (106) (64) (162) (75)
Loss before income tax expense (benefit) (2,902) (409) (2,484) (3,474)
Income tax expense (benefit) 172 (125) 271 (143)
Net loss (3,074) (284) (2,755) (3,331)
Other comprehensive (loss) income:        
Foreign currency translation (net of tax effect of $(81), $205, $(36) and $257, respectively) (542) 501 (88) 631
Other comprehensive (loss) income (542) 501 (88) 631
Comprehensive (loss) income $ (3,616) $ 217 $ (2,843) $ (2,700)
Net loss per share (Note 3):        
Basic (in dollars per share) $ (0.16) $ (0.02) $ (0.14) $ (0.18)
Diluted (in dollars per share) $ (0.16) $ (0.02) $ (0.14) $ (0.18)
Weighted–average shares outstanding (Note 3):        
Basic (in shares) 19,669,353 18,913,427 19,607,204 18,839,391
Diluted (in shares) 19,669,353 18,913,427 19,607,204 18,839,391
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited) (Parentheticals) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Foreign currency translation, tax effect $ (81) $ 205 $ (36) $ 257
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
OPERATING ACTIVITIES    
Net loss $ (2,755) $ (3,331)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 383 753
Stock–based compensation expense 161 252
Gain (loss) on disposal of property, plant and equipment 383 13
Provision (recovery) for bad debt expense 6 (380)
Impairment of assets held for sale 0 267
Proceeds from insurance claim 1,475
Provision (recovery) for deferred taxes 271 (302)
Customer forfeiture of deposit (940)
Changes in operating assets and liabilities:    
Accounts receivable (637) 1,010
Inventories, net (269) (170)
Other current assets 860 1,624
Accounts payable 244 (274)
Accrued liabilities 67 233
Income taxes payable 4 2
Other, net 150 (23)
Total net cash (used in) provided by operating activities (2,072) 1,149
INVESTING ACTIVITIES    
Capital investments (36) (410)
Proceeds from sale of fixed assets 238
Total net cash provided by (used in) investing activities 202 (410)
FINANCING ACTIVITIES    
Factoring arrangement (46) 111
Total net cash (used in) provided by financing activities (46) 111
Effect of exchange rate changes on cash 127 175
Net change in cash and cash equivalents (1,789) 1,025
Cash and cash equivalents, beginning of period 13,499 12,379
Cash and cash equivalents, end of period $ 11,710 $ 13,404
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 1 - Basis of Presentation
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
NOTE
1—BASIS
OF PRESENTATION
 
The accompanying Condensed Consolidated Financial Statements and the related interim information contained within the notes to the Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information and quarterly reports on the Form
10
-Q. Accordingly, they do
not
include all of the information and the notes required for complete financial statements. These Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended
December 31, 2017,
included in STR Holdings, Inc.’s (the “Company”) Annual Report on Form
10–K
filed with the SEC on
March 16, 2018.
The unaudited interim Condensed Consolidated Financial Statements have been prepared on the same basis as the audited consolidated financial statements, and in the opinion of management, reflect all adjustments, consisting of only normal and recurring adjustments, necessary for the fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods presented. The results for the interim periods presented are
not
necessarily indicative of future results.
 
The year-end Condensed Consolidated Balance Sheet data was derived from audited financial statements, but does
not
include all disclosures required by GAAP.
 
The preparation of the Condensed Consolidated Financial Statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management’s estimates.
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 2 - Recent Accounting Pronouncements and Adoption
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
New Accounting Pronouncements and Changes in Accounting Principles [Text Block]
NOTE
2—RECENT
ACCOUNTING PRONOUNCEMENTS AND ADOPTION
 
In
May 
2014,
the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
No.
 
2014
-
09,
“Revenue from Contracts with Customers” (Topic
606
). This ASU is intended to clarify the principles for recognizing revenue by removing inconsistencies and weaknesses in revenue requirements; providing a more robust framework for addressing revenue issues; improving comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets; and providing more useful information to users of financial statements through improved revenue disclosure requirements. The provisions of this ASU are ultimately effective for interim and annual periods beginning after
December 
15,
2017.
The standard shall be applied retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. During
2016,
the FASB clarified the implementation guidance on principal versus agent, identifying performance obligations, licensing, and collectability.
 
The Company adopted the new revenue recognition standard (“ASC
606”
) on
January 1, 2018.
Results for reporting periods beginning after
January 1, 2018
are presented under ASC
606,
while prior period amounts are
not
adjusted and continue to be reported in accordance with ASC
605,
 
Revenue Recognition
. The application of the standard had
no
impact on the Company’s consolidated financial statements for any periods prior to
2018.
The adoption of ASC
606
represents a change in accounting principle to more closely align revenue recognition with the delivery of the Company’s products, licenses and services. ASC
606
requires an entity to evaluate revenue recognition by identifying a contract with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations in the contract, and recognizing revenue when (or as) the entity satisfies a performance obligation.
 
Revenue is principally derived from the sale and licensing of highly engineered plastic sheet and film products. The Company receives specific purchase orders for the manufacture, sale and delivery of these products that identify the goods and/or services to be transferred, the price for those goods and other commercial terms of the order. The goods are generally purchased under EXW (or EX-Works) terms, meaning that the customer is responsible for arranging the shipping of the goods and title passes when the goods are picked up from the Company’s dock. Revenue is recognized upon the transfer of title, and there are
no
price concessions, volume discounts, rebates, refunds, credits, incentives, performance bonuses, royalties or other types of variable consideration.
 
In the specific case of the Equipment Purchase Agreement and a Technology License Agreement (the “Agreements”) signed on
January 16, 2018
for an aggregate transaction price of
$6,000,
the Company will purchase from a
third
party specialized equipment (the “Equipment”) for the production of
one
of the Company’s proprietary encapsulants (the “Encapsulant”), resell the Equipment to the customer, install the Equipment at a facility of the customer and train the
 
customer’s personnel in the Equipment’s use. Under the license agreement, the Company has granted the customer the right to use the formula for the Encapsulant and certain of the Company’s production techniques to make or have made the Encapsulant for use in photovoltaic (PV) modules manufactured by the customer. For revenue recognition purposes, the Company defines the following
three
distinct major performance obligations of the Agreements and the corresponding transaction price allocated to those performance obligations:
 
  • Obligation
    1
    -
    $1,750
    - Price Report, Formula and Sample
  • Obligation
    2
    -
    $2,000
    - Equipment, including delivery & installation (incl. training)
  • Obligation
    3
    -
    $2,250
    - License (perpetual)
Obligation
1
is considered to be separate and distinct from the other
two
obligations, in that the information provided under this obligation represents significant standalone value to the customer and the Company’s obligation to provide this information is separately identifiable from the other obligations in the agreements. Obligation
2
and Obligation
3
were also clearly identifiable, as defined by the Equipment Purchase Agreement (including delivery and installation by an agreed-upon date) and the license (“License”) granted pursuant to the Technology License Agreement (with an effective start date upon the receipt of an acceptance test payment).
 
The Company is applying a “cost-plus” approach to Obligation
1
and Obligation
2.
As the Company had never before sold any type of license, had
no
established specific license pricing and had
no
knowledge of pricing for similar licenses, the Company is using the residual approach for Obligation
3.
The License is perpetual, distinct and
not
combined with other goods and services, and is a right to use, rather than to access, functional intellectual property.
 
The Company also assessed whether it was acting in a principal or agent role in each performance obligation of the Agreements. In all obligations, the Company determined it was acting in the role of principal and therefore revenue is recognized on a gross basis.
 
As a result, the Company recognized
$1,750
in the quarter ended
March 31, 2018
upon the satisfaction of Obligation
1,
its delivery of a price report, formula and sample. The total transaction price of the Agreements is expected to be recognized as revenue as follows:
 
      2018       2019(a)      
Total
 
Revenue expected to be recognized during the year ended December 31   $
1,750
    $
4,250
    $
6,000
 
 
(a)
$2,000
upon installation of the Equipment and
$2,250
upon acceptance and commencement of the License.
 
There are
no
new accounting pronouncements that the Company believes
may
have a material impact on its consolidated financial statements.
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 3 - Loss Per Share
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Earnings Per Share [Text Block]
NOTE
3—LOSS
PER SHARE
 
The calculation of basic and diluted net loss per share for the periods presented is as follows:
 
    Three Months Ended
June 30,
  Six Months Ended
June 30,
    2018   2017   2018   2017
Basic and diluted net loss per share                                
Numerator:                                
Net loss   $
(3,074
)   $
(284
)   $
(2,755
)   $
(3,331
)
Denominator:                                
Weighted–average shares outstanding    
19,669,353
     
18,913,427
     
19,607,204
     
18,839,391
 
Add:                                
Dilutive effect of stock options    
     
     
     
 
Dilutive effect of restricted common stock    
     
     
     
 
Weighted–average shares outstanding with dilution    
19,669,353
     
18,913,427
     
19,607,204
     
18,839,391
 
                                 
Net loss per share:                                
Basic   $
(0.16
)   $
(0.02
)   $
(0.14
)   $
(0.18
)
Diluted   $
(0.16
)   $
(0.02
)   $
(0.14
)   $
(0.18
)
                                 
 
Due to the net loss for the
three
and
six
months ended
June 
30,
2018
and
2017,
the computation of dilutive weighted-average common shares outstanding does
not
include any stock options or any shares of unvested restricted common stock as these potential awards are anti-dilutive.
 
Because the effect would be anti-dilutive, there were
1,121,332
stock options outstanding that were
not
included in the computation of diluted weighted-average shares outstanding for each of the
three
and
six
months ended
June 
30,
2018.
Similarly, there were
1,121,332
stock options outstanding that were
not
included in the computation of diluted weighted-average shares outstanding for each of the
three
and
six
months ended
June 
30,
2017.
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 4 - Bank Acceptance Notes
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]
NOTE
4—BANK
ACCEPTANCE NOTES
 
Customers in China
may
settle their accounts with bank acceptance notes, which are draft instruments that are guaranteed to be paid at maturity by the issuing bank. Upon receipt of the bank acceptance note, the Company can elect to hold the instrument until maturity and receive full face value, discount it with the bank for a fee, or transfer it at full face value to suppliers who will accept the note as settlement of the Company’s accounts payable balance with them.
 
Bank acceptance notes consist of the following:
 
    June 30,
2018
  December 31,
2017
Balance as of beginning of period   $
904
    $
3,360
 
Received from customers    
     
1,985
 
Converted to cash    
(888
)    
(3,508
)
Paid to suppliers    
     
(1,162
)
Foreign exchange impact    
(16
)    
229
 
Balance as of end of period   $
    $
904
 
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 5 - Inventories
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Inventory Disclosure [Text Block]
NOTE
5—INVENTORIES
 
Inventories consist of the following:
 
    June 30,
2018
  December 31,
2017
Finished goods   $
365
    $
340
 
Raw materials    
996
     
829
 
Reserve    
(4
)    
(59
)
Inventories, net   $
1,357
    $
1,110
 
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 6 - Long-lived Assets
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Property, Plant and Equipment Disclosure [Text Block]
NOTE
6—LONG
-LIVED ASSETS
 
Impairment Testing
 
In accordance with ASC
360
-Property, Plant and Equipment, the Company assesses the impairment of its long-lived assets whenever changes in events or circumstances indicate that the carrying value of such assets
may
not
be recoverable. During each reporting period, the Company assessed if the following factors were present, which would cause an impairment review: overall negative solar industry conditions; a significant or prolonged decrease in net sales generated under its trademarks; loss of a significant customer or a reduction in demand for customers’ products; a significant adverse change in the extent to or manner in which the Company used its trademarks or proprietary technology; such assets becoming obsolete due to new technology or manufacturing processes entering the markets or an adverse change in legal factors; and the market capitalization of the Company’s common stock.
 
At
June 30, 2018
and
December 31, 2017,
the Company recorded valuation allowances against its deferred tax assets. The valuation allowances were recorded since the Company had
three
consecutive years of taxable losses and determined that its history of actual net losses was evidence that should be given more weight than future projections. The Company determined the recording of valuation allowances against deferred tax assets to be an indicator to test its long-lived assets, which consist solely of property, plant and equipment, for impairment. The Company assessed the specific recoverability of its property, plant and equipment using updated real estate appraisals and other data for its other fixed assets, mainly production equipment. Based upon this analysis, the Company believes its property, plant and equipment carrying value was recoverable and depreciable lives were appropriate as of
June 30, 2018.
Therefore
no
impairment was recorded in
2018.
If the Company experiences a significant reduction in future sales volume, further average selling price (“ASP”) reductions, lower profitability, a cessation of operations at any of its facilities, or negative changes in U.S. or Spain real estate markets, the Company’s property, plant and equipment
may
be subject to future impairment or accelerated depreciation.
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 7 - Assets Held for Sale
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Long-lived Assets Held for Sale Disclosure [Text Block]
NOTE
7—ASSETS
HELD FOR SALE
 
In
July 2015,
the Company announced a restructuring plan that included the closure of its Johor, Malaysia facility effective
August 2, 2015.
Subsequent to the announcement, the Company engaged advisors and was actively trying to sell its land-use right, building and other fixed assets located at the facility. During
2016,
the Company entered into a definitive Purchase and Sale Agreement for the land-use right and the building for a purchase price of
RM25,000.
Closing of the transaction was subject to customary conditions to closing of transactions of this type, including the approval of the Johor Port Authority (“JPA”). On
July 31, 2017,
the Company received a notice from the purchaser purporting to terminate the agreement, alleging that the JPA was seeking to impose certain conditions on the approval of the transfer of the facility to the purchaser that it found unacceptable. The Company was
not
successful in removing those conditions, and the agreement terminated. The Company has re-launched the sale process for its Malaysia facility.
 
In accordance with ASC
360
-Property, Plant and Equipment, the Company assessed the asset group attributed to the sale for impairment. Based upon the Company’s assessment of the status of the Malaysia property, plant and equipment, all of the requirements (including the held for sale requirements) set forth in ASC
360
-
10
-
45
-
9
were met and the assets were classified on the Condensed Consolidated Balance Sheet as of
June 30, 2018
and
December 
31,
2017
as assets held for sale. An impairment loss of
$267,
related to the foreign currency fluctuation of the Ringgit, was recorded in the Company’s Condensed Consolidated Statement of Comprehensive (Loss) Income in other expense, net during the
first
half of
2017.
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 8 - Accrued Liabilities
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
NOTE
8—ACCRUED
LIABILITIES
 
Accrued liabilities consist of the following:
 
    June 30,
2018
  December 31,
2017
Salaries and wages   $
323
    $
239
 
Accrued bonus    
210
     
258
 
Professional fees    
285
     
319
 
Restructuring severance and benefits (see Note 10)    
102
     
87
 
Environmental (see Note 9)    
57
     
57
 
Accrued franchise tax    
79
     
90
 
Client deposits    
179
     
1,157
 
Other    
114
     
100
 
Total accrued liabilities   $
1,349
    $
2,307
 
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 9 - Commitments and Contingencies
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Commitments and Contingencies Disclosure [Text Block]
NOTE
9—COMMITMENTS
AND CONTINGENCIES
 
The Company is a party to claims and litigation in the normal course of its operations. Management believes that the ultimate outcome of these matters will
not
have a material adverse effect on the Company’s financial position, results of operations, or cash flows.
 
Product Performance
 
The Company provides a short-term warranty that it has manufactured its products to the Company’s specifications. On limited occasions, the Company incurs costs to service its products in connection with specific product performance matters that do
not
meet the Company’s specifications. Anticipated future costs are recorded as part of cost of sales and accrued liabilities for specific product performance matters when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated.
 
On isolated occasions, the Company has also offered limited short-term performance warranties relating to its encapsulants
not
causing module power loss. The Company’s encapsulants are validated by long-term performance testing during product development prior to launch and during customer certification prior to mass production. The Company has operated its solar business since the
1970s
and over
20
GW of solar modules incorporating its encapsulants have been installed in the field with
no
reported module power performance issues caused by the Company’s encapsulants and
no
related warranty claims to date. Based on this fact pattern, the Company has
not
accrued any warranty liability associated for this potential liability as its occurrence is deemed to be remote. If the Company was to ever receive a warranty claim for such matter, the Company would assess the need for a warranty accrual at that time.
 
The Company’s product performance liability that is recorded in accrued liabilities in the Condensed Consolidated Balance Sheets was
$
0
as of each
June 30, 2018
and
December 31, 2017.
 
Environmental
During
2010,
the Company performed a Phase II environmental site assessment at its
10
 Water Street, Enfield, Connecticut location. During its investigation, the site was found to contain a presence of volatile organic compounds. The Company has been in contact with the Department of Environmental Protection and has engaged a licensed contractor to remediate this circumstance. Based on ASC
450
-Contingencies, the Company has accrued the estimated cost to remediate. The Company’s environmental liability that is recorded in accrued liabilities in the Condensed Consolidated Balance Sheets was
$
57
as of
June 30, 2018
and
December 31, 2017.
 
Solaria
 
In
October 2016,
a complaint was filed by Solaria Energia y Medio Ambiente S.A.U. (“Solaria”) against the Company and its Spanish subsidiary, Specialized Technology Resources España S.A.U. (“STR Spain”), in the Court of the First Instance
No.
8
in Oviedo, Spain, relating to a product quality claim in connection with a non-encapsulant product that STR Spain
 
purchased from a vendor in
2005
and
2006
and resold to Solaria. The Company stopped selling this product in
2006.
Solaria is seeking approximately
€3,300,
plus interest, in damages.
 
A trial was held on
April 6, 2017
in Oviedo, Spain, and the Company is currently awaiting a ruling from the court. The Company believes that it has product liability insurance coverage for claims of this nature, excluding the original product cost but including defense costs. The Company believes it has meritorious defenses and does
not
believe a loss is probable or can be reasonably estimated. As such,
no
accrual relating to this complaint was recorded as of
June 30, 2018
and
December 31, 2017.
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 10 - Cost Reduction Actions
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Restructuring and Related Activities Disclosure [Text Block]
NOTE
10—COST
-
REDUCTION ACTIONS
 
In
March 2017
the Company made the decision to wind down its China manufacturing operations substantially by the end of the
second
quarter of
2017.
 The decision was consistent with ongoing efforts to reorganize its encapsulant business to better align with customer geography, to reduce losses related to unprofitable locations and to convert assets to cash for potential redeployment into more profitable endeavors. In connection with the restructuring, the Company does
not
expect any significant asset impairment charges and recorded
$93
of severance charges and benefits in cost of sales and
$48
of severance charges and benefits in selling, general and administrative expenses during the
first
six
months of
2017
and
$67
of severance charges during the
first
six
months of
2018.
The Company sold certain production and testing equipment from the China facility to its tolling partner in India during the
third
quarter of
2017.
 
In
June 2018,
the Company eliminated certain positions at its Spain facility, effective
June 18, 2018.
The Company recorded
$588
of severance and benefits in cost of sales and
$67
of severance and benefits in selling, general and administrative expenses during the
second
quarter of
2018.
 
The restructuring accrual consists of
$102
for severance and benefits as of
June 
30,
2018.
A rollforward of the severance and other exit cost accrual activity is as follows:
 
    June 30,
2018
  June  30,
2017
Balance as of beginning of year   $
87
    $
269
 
Additions    
722
     
143
 
Reductions    
(707
)    
(177
)
Reversals    
     
(120
)
Balance as of end of period   $
102
    $
115
 
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 11 - Fair Value Measurements
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Fair Value Disclosures [Text Block]
NOTE
11—FAIR
VALUE MEASUREMENTS
 
The Company measures certain financial assets and liabilities at fair value on a recurring basis in the financial statements. The hierarchy ranks the quality and reliability of inputs, or assumptions, used in the determination of fair value
and requires financial assets and liabilities carried at fair value to be classified and disclosed in
one
of the following
three
categories:
 
·
Level
1
-quoted prices (unadjusted) in active markets for identical assets and liabilities;
·
Level
2
-unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are
not
active, or inputs other than quoted prices that are observable for the asset or liability; and
·
Level
3
-unobservable inputs that are
not
corroborated by market data.
 
The following table provides the fair value measurements of applicable financial assets and liabilities as of
June 
30,
2018:
 
    Financial assets and liabilities at fair value
as of June 30, 2018
    Level 1   Level 2   Level 3
             
Money market funds (1)   $
7,605
    $
    $
 
Bank acceptance notes (2)    
     
     
 
Non-recurring fair value measurements (3)    
     
     
6,155
 
Total   $
7,605
    $
    $
6,155
 
 
The following table provides the fair value measurements of applicable financial assets and liabilities as of
December 
31,
2017:
 
    Financial assets and liabilities at fair value
as of December 31, 2017
    Level 1   Level 2   Level 3
             
Money market funds (1)   $
6,688
    $
    $
 
Bank acceptance notes (2)    
904
     
     
 
Non-recurring fair value measurements (3)    
     
     
6,155
 
Total   $
7,592
    $
    $
6,155
 
________________________
(
1
)
Included in cash and cash equivalents on the Company’s Condensed Consolidated Balance Sheets. The carrying amount of money market funds is a reasonable estimate of fair value due to the short-term maturity.
(
2
)
Refer to Note
4
for further information
(
3
)
Included in assets held for sale on the Company’s Condensed Consolidated Balance Sheets. Refer to Note
7
for further information.
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 12 - Factoring Arrangement
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Factoring Arrangement Disclosure [Text Block]
NOTE
12—FACTORING
ARRANGEMENT
 
In
October 2015,
the Company’s wholly owned Spanish subsidiary, STR Spain, entered into a factoring agreement to sell, with recourse, certain European, U.S. and other foreign company-based receivables to Eurofactor Hispania S.A.U., who was later acquired by Credit Agricole Leasing and Factoring Sucursal en España during the
first
quarter of
2017.
Under the current terms of the factoring agreement, the maximum amount of outstanding advances at any
one
time is
€1,500
(approximately
$1,752
as of
June 30, 2018),
which is subject to adjustment based on the level of eligible receivables, restrictions on concentrations of receivables and the historical performance of the receivables sold. The annual discount rate is
2%
plus EURIBOR for Euro denominated receivables and
2%
plus LIBOR for all other currencies. The term of the agreement is for
one
year, which will be automatically extended unless terminated by either party with
90
days prior written notice. As of
June 30, 2018
and
December 31, 2017
the Company has recorded
$397
and
$454,
respectively, as due to factor on the Condensed Consolidated Balance Sheets.
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 13 - Income Taxes
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
NOTE
13—INCOME
TAXES
 
On
December 22, 2017,
the Tax Cuts and Jobs Act (“TCJA”) was enacted into law in the United States. The legislation contains several key tax provisions including the reduction of the corporate income tax rate to
21%
effective
January 1, 2018,
a
one
-time transition tax on foreign earnings which have
not
previously been subject to tax in the United States, as well as a variety of other changes, including limitation of the tax deductibility of interest expense, limitations for the deduction for net operating losses, new taxes on certain foreign-sourced earnings, and modification or repeal of many business deductions and credits.
 
The SEC staff issued SAB
118
which allows companies to record provisional amounts during a
one
-year measurement period. At
December 31, 2017,
the Company has
not
completed its accounting for the tax effects of the
 
enactment of the TCJA; however, the Company estimated what it believes to be the effects of the TCJA on its existing deferred tax balances and the
one
-time transition tax, and recorded a provisional estimate for these tax effects.
 
During the
three
and
six
months ended
June 30, 2018,
the Company did
not
record any measurement period adjustments to the provisional estimates recorded at
December 31, 2017.
Final accounting for these impacts is expected in the
third
quarter of
2018
subsequent to the Company’s completion of the
2017
tax return.
 
The TCJA subjects a U.S. shareholder to tax on global intangible low-taxed income (GILTI) earned by certain foreign subsidiaries for which an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or provide for the tax expense related to GILTI in the year the tax is incurred. Given the complexity of the GILTI provisions, the Company is still evaluating the effects of the GILTI provisions and has
not
yet determined its accounting policy. As of
June 30, 2018,
the Company does
not
anticipate a GILTI inclusion for the taxable year. The Company will continue to assess forthcoming guidance and accounting
interpretations on the effects of the TCJA and expects to complete its analysis within the measurement period in accordance with the SEC guidance.
 
During the
three
and
six
months ended
June 30, 2018,
the Company recorded an income tax expense of
$172
and
$271
resulting in an effective tax rate of (
5.9%
) and (
10.9%
), respectively. This effective tax rate for the
three
months ended
June 30, 2018
differs from the U.S. statutory tax rate primarily due to the effect of taxes on foreign earnings.
 
There was
no
provision or benefit for federal, foreign or state income taxes for the
three
and
six
months ended
June 30, 2017
other than income tax benefit of
$125
and
$143,
respectively, resulting from an intra-period tax allocation between operations and other comprehensive income.
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 14 - Stockholders' Equity
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
NOTE
14—STOCKHOLDERS’
EQUITY
 
Changes in stockholders’ equity for the
six
months ended
June 
30,
2018
are as follows:
 
    Common Stock   Treasury Stock   Additional
Paid–In
  Accumulated Other
Comprehensive
  Accumulated   Total
Stockholders’
    Issued   Amount   Acquired   Amount   Capital   Loss   Deficit   Equity
Balance at December 31, 2017    
19,532,573
    $
195
     
1,240
    $
(57
)   $
232,149
    $
(5,355
)   $
(199,072
)   $
27,860
 
Stock-based compensation    
505,648
     
5
     
     
     
166
     
     
     
171
 
Net loss    
     
     
     
     
     
     
(2,755
)    
(2.755
)
Foreign currency translation, net of tax    
     
     
     
     
     
(88
)    
     
(88
)
Balance at June 30, 2018    
20,038,221
    $
200
     
1,240
    $
(57
)   $
232,315
    $
(5,443
)   $
(201,827
)   $
25,188
 
 
Common Stock
 
The Company’s Board of Directors has authorized
200,000,000
shares of common stock,
$0.01
par value. At
June 30, 2018,
there were
20,039,461
shares issued and
20,038,221
shares outstanding of common stock. Each share of common
stock is entitled to
one
vote per share.
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 15 - Stock-based Compensation
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE
15—STOCK
-BASED COMPENSATION
 
On
November 
6,
2009,
the Company’s Board of Directors approved the Company’s
2009
Equity Incentive Plan (the
“2009
Plan”), which became effective on the same day. Effective
May 
14,
2013,
the
2009
Plan was amended to increase the number of shares subject to the
2009
Plan. As a result, a total of
4,133,133
shares of common stock were reserved for issuance under the
2009
Plan. The
2009
Plan is administered by the Board of Directors or any committee designated by the Board of Directors, which has the authority to designate participants and determine the number and type of awards to be granted, the time at which awards are exercisable, the method of payment and any other terms or conditions of the awards. The
2009
Plan provides for the grant of stock options, including incentive stock options and nonqualified stock options (collectively, “options”), stock appreciation rights, shares of restricted stock, or “restricted stock,” rights to dividend equivalents and other stock-based awards (collectively, the “awards”). The Board of Directors or the committee will, with regard to each award,
 
determine the terms and conditions of the award, including the number of shares subject to the award, the vesting terms of the award, and the purchase price for the award. Awards
may
be made in assumption of or in substitution for outstanding awards previously granted by the Company or its affiliates, or a company acquired by the Company or with which it combines. Options outstanding generally vest over a
three
or
four
-year period and expire
ten
years from the date of grant. There were
431,131
shares available for grant under the
2009
Plan as of
June 30, 2018.
 
The following table summarizes the options activity under the Company’s
2009
Plan for the
six
months ended
June 
30,
2018:
 
 
    Options Outstanding
    Number
of
Shares
  Weighted–
Average
Exercise
Price
  Weighted–
Average
Remaining
Contractual
Term
(in years)
  Weighted–
Average
Grant–Date
Fair Value
  Aggregate
Intrinsic
Value(1)
Balance at December 31, 2017    
1,121,332
    $
1.52
     
    $
0.99
    $
(1,402
)
Options granted    
    $
     
    $
    $
 
Exercised    
    $
     
    $
    $
 
Canceled/forfeited    
    $
     
    $
    $
 
Balance at June 30, 2018    
1,121,332
    $
1.52
     
6.61
    $
0.99
    $
(1,402
)
Vested and exercisable as of June 30, 2018    
1,121,332
    $
1.52
     
6.61
    $
0.99
    $
(1,402
)
Vested and exercisable as of June 30, 2018 and expected to vest thereafter    
1,121,332
    $
1.52
     
6.61
    $
0.99
    $
(1,402
)
 _________________
(
1
)
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of
$0.27
of the Company’s common stock on
June 
30,
2018.
 
As of
June 30, 2018,
there was
$0
of unrecognized compensation cost related to outstanding stock option awards. The Company did
not
receive any proceeds related to the exercise of stock options for the
six
months ended
June 30, 2018.
 
The following table summarizes the restricted common stock activity of the Company for the
six
months ended
June 
30,
2018:
 
    Unvested
Restricted Shares
    Number of
Shares
  Weighted–
Average
Grant–Date
Fair Value
Unvested at December 31, 2017    
385,716
    $
 
Granted    
119,932
    $
 
Vested    
(505,648
)   $
0.28
 
Unvested at June 30, 2018    
    $
 
Expected to vest after June 30, 2018    
    $
 
 
Stock-based compensation expense was included in the following Condensed Consolidated Statements of Comprehensive Loss categories for operations:
 
    Three Months Ended
June 30,
  Six Months Ended
June 30,
    2018   2017   2018   2017
Selling, general and administrative expense   $
88
    $
132
    $
161
    $
252
 
Total stock-based compensation expense   $
88
    $
132
    $
161
    $
252
 
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 16 - Geographical Information
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
NOTE
16—GEOGRAPHICAL
INFORMATION
 
ASC
280
-
10
-
50
Disclosure about Segments of an Enterprise and Related Information establishes standards for the manner in which companies report information about operating segments, products, geographic areas and major customers. The method of determining what information to report is based on the way that management organizes the operating segment within the enterprise for making operating decisions and assessing financial performance. The Company focuses on the manufacturing, sale and licensing of highly engineered plastic sheet and film products to customers throughout the world. The Company procures raw materials from multiple similar vendors and expects similar long-term economic characteristics for its products.
 
Operations by Geographic Area
 
    Three Months Ended
June 30,
  Six Months Ended
June 30,
    2018   2017   2018   2017
Net Sales                                
Spain   $
1,906
    $
2,042
    $
3,382
    $
3,754
 
China    
     
983
     
30
     
2,974
 
India    
478
     
     
904
     
 
United States    
131
     
32
     
1,945
     
42
 
Total Net Sales   $
2,515
    $
3,057
    $
6,261
    $
6,770
 
 
Long-Lived Assets by Geographic Area
 
    June 30,
2018
  December 31,
2017
Long-Lived Assets                
United States   $
1,237
    $
1,311
 
Spain    
6,454
     
7,141
 
China    
76
     
276
 
Total Long-Lived Assets   $
7,767
    $
8,728
 
 
Foreign sales are based on the country in which the sales originated. Net sales to
four
of the Company’s major customers that exceeded
10%
of the Company’s consolidated net sales for the
three
months ended
June 
30,
2018
were
$1,401.
Net sales to
two
of the Company’s major customers that exceeded
10%
of the Company’s consolidated net sales for the
six
months ended
June 
30,
2018
were
$1,444.
Net sales to
one
of the Company’s major customers that exceeded
10%
of the Company’s consolidated net sales for the
three
and
six
months ended
June 
30,
2018
were
$683
and
$1,330,
respectively. Accounts receivable from
two
customers amounted to
$1,072
and
$70
as of
June 
30,
2018
and
December 
31,
2017,
respectively.
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 17 - Related Party Transaction
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]
NOTE
17—RELATED
PARTY TRANSACTION
 
Huhui Supply Agreement
 
The Company’s Chinese subsidiary, Specialized Technology Resources Solar (Suzhou) Co. Ltd. (“STR China”) entered into a supply agreement (the “Huhui Supply Agreement”) dated as of
December 31, 2014
with Zhangjiagang Huhui Segpv Co. Ltd ("Huhui"), a solar module manufacturer and an affiliate of Zhenfa. Pursuant to the Huhui Supply Agreement, STR China agreed to supply Huhui with the Company's encapsulant products and Huhui agreed (i) to purchase
not
less than
535
MW worth of encapsulants (the “Minimum Amount”) during each contract year, (ii) to pay the Company a deposit equal to
10%
of the Minimum Amount, and (iii) 
not
to purchase encapsulant products from other encapsulant manufacturers. The initial term of the Huhui Supply Agreement was for
one
year; however, such initial term was extended due to failure by Huhui to purchase the Minimum Amount at the end of the
first
year anniversary of the effective date of the Huhui Supply Agreement. The Huhui Supply Agreement further provided that Huhui’s obligations were contingent (unless otherwise provided in the agreement) upon (i) the delivery by STR China of an initial shipment of products in accordance with the specifications and (ii) the qualification of the products by Huhui during a sample production run of
not
less than
30
days. As of
December 31, 2017,
Huhui had
not
commenced the sample production run. The Huhui Supply Agreement automatically renewed for additional
one
year terms if either party failed to notify the other party at least
90
days prior to the
 
end of the then current term that it was electing to terminate the agreement. The Company believes that the terms and conditions set forth in the Huhui Agreement at that time were fair and reasonable to the Company. The Company received
$1,148
as a deposit from Huhui during the year ended
December 31, 2015,
which was included in accrued liabilities on the Condensed Consolidated Balance Sheets.
 
Huhui did
not
complete its
30
day production run as contemplated under the Supply Agreement and on
March 27, 2018,
following the approval of the Company’s Special Committee of Continuing Directors, STR China entered into an agreement to terminate the Supply Agreement (the “Termination Agreement”). Pursuant to the Termination Agreement,
Huhui agreed that STR China would retain the Deposit, and each of Huhui and STR China agreed to release the other from any liability or further obligations under the Supply Agreement. The Company recognized the full amount of the deposit as other income on the Condensed Consolidated Statement of Comprehensive Income (Loss).
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 2 - Recent Accounting Pronouncements and Adoption (Tables)
6 Months Ended
Jun. 30, 2018
Notes Tables  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]
      2018       2019(a)      
Total
 
Revenue expected to be recognized during the year ended December 31   $
1,750
    $
4,250
    $
6,000
 
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 3 - Loss Per Share (Tables)
6 Months Ended
Jun. 30, 2018
Notes Tables  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
    Three Months Ended
June 30,
  Six Months Ended
June 30,
    2018   2017   2018   2017
Basic and diluted net loss per share                                
Numerator:                                
Net loss   $
(3,074
)   $
(284
)   $
(2,755
)   $
(3,331
)
Denominator:                                
Weighted–average shares outstanding    
19,669,353
     
18,913,427
     
19,607,204
     
18,839,391
 
Add:                                
Dilutive effect of stock options    
     
     
     
 
Dilutive effect of restricted common stock    
     
     
     
 
Weighted–average shares outstanding with dilution    
19,669,353
     
18,913,427
     
19,607,204
     
18,839,391
 
                                 
Net loss per share:                                
Basic   $
(0.16
)   $
(0.02
)   $
(0.14
)   $
(0.18
)
Diluted   $
(0.16
)   $
(0.02
)   $
(0.14
)   $
(0.18
)
                                 
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 4 - Bank Acceptance Notes (Tables)
6 Months Ended
Jun. 30, 2018
Notes Tables  
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]
    June 30,
2018
  December 31,
2017
Balance as of beginning of period   $
904
    $
3,360
 
Received from customers    
     
1,985
 
Converted to cash    
(888
)    
(3,508
)
Paid to suppliers    
     
(1,162
)
Foreign exchange impact    
(16
)    
229
 
Balance as of end of period   $
    $
904
 
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 5 - Inventories (Tables)
6 Months Ended
Jun. 30, 2018
Notes Tables  
Schedule of Inventory, Current [Table Text Block]
    June 30,
2018
  December 31,
2017
Finished goods   $
365
    $
340
 
Raw materials    
996
     
829
 
Reserve    
(4
)    
(59
)
Inventories, net   $
1,357
    $
1,110
 
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 8 - Accrued Liabilities (Tables)
6 Months Ended
Jun. 30, 2018
Notes Tables  
Schedule of Accrued Liabilities [Table Text Block]
    June 30,
2018
  December 31,
2017
Salaries and wages   $
323
    $
239
 
Accrued bonus    
210
     
258
 
Professional fees    
285
     
319
 
Restructuring severance and benefits (see Note 10)    
102
     
87
 
Environmental (see Note 9)    
57
     
57
 
Accrued franchise tax    
79
     
90
 
Client deposits    
179
     
1,157
 
Other    
114
     
100
 
Total accrued liabilities   $
1,349
    $
2,307
 
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 10 - Cost Reduction Actions (Tables)
6 Months Ended
Jun. 30, 2018
Notes Tables  
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]
    June 30,
2018
  June  30,
2017
Balance as of beginning of year   $
87
    $
269
 
Additions    
722
     
143
 
Reductions    
(707
)    
(177
)
Reversals    
     
(120
)
Balance as of end of period   $
102
    $
115
 
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 11 - Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2018
Notes Tables  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
    Financial assets and liabilities at fair value
as of June 30, 2018
    Level 1   Level 2   Level 3
             
Money market funds (1)   $
7,605
    $
    $
 
Bank acceptance notes (2)    
     
     
 
Non-recurring fair value measurements (3)    
     
     
6,155
 
Total   $
7,605
    $
    $
6,155
 
    Financial assets and liabilities at fair value
as of December 31, 2017
    Level 1   Level 2   Level 3
             
Money market funds (1)   $
6,688
    $
    $
 
Bank acceptance notes (2)    
904
     
     
 
Non-recurring fair value measurements (3)    
     
     
6,155
 
Total   $
7,592
    $
    $
6,155
 
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 14 - Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2018
Notes Tables  
Schedule of Stockholders Equity [Table Text Block]
    Common Stock   Treasury Stock   Additional
Paid–In
  Accumulated Other
Comprehensive
  Accumulated   Total
Stockholders’
    Issued   Amount   Acquired   Amount   Capital   Loss   Deficit   Equity
Balance at December 31, 2017    
19,532,573
    $
195
     
1,240
    $
(57
)   $
232,149
    $
(5,355
)   $
(199,072
)   $
27,860
 
Stock-based compensation    
505,648
     
5
     
     
     
166
     
     
     
171
 
Net loss    
     
     
     
     
     
     
(2,755
)    
(2.755
)
Foreign currency translation, net of tax    
     
     
     
     
     
(88
)    
     
(88
)
Balance at June 30, 2018    
20,038,221
    $
200
     
1,240
    $
(57
)   $
232,315
    $
(5,443
)   $
(201,827
)   $
25,188
 
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 15 - Stock-based Compensation (Tables)
6 Months Ended
Jun. 30, 2018
Notes Tables  
Share-based Compensation, Stock Options, Activity [Table Text Block]
    Options Outstanding
    Number
of
Shares
  Weighted–
Average
Exercise
Price
  Weighted–
Average
Remaining
Contractual
Term
(in years)
  Weighted–
Average
Grant–Date
Fair Value
  Aggregate
Intrinsic
Value(1)
Balance at December 31, 2017    
1,121,332
    $
1.52
     
    $
0.99
    $
(1,402
)
Options granted    
    $
     
    $
    $
 
Exercised    
    $
     
    $
    $
 
Canceled/forfeited    
    $
     
    $
    $
 
Balance at June 30, 2018    
1,121,332
    $
1.52
     
6.61
    $
0.99
    $
(1,402
)
Vested and exercisable as of June 30, 2018    
1,121,332
    $
1.52
     
6.61
    $
0.99
    $
(1,402
)
Vested and exercisable as of June 30, 2018 and expected to vest thereafter    
1,121,332
    $
1.52
     
6.61
    $
0.99
    $
(1,402
)
Nonvested Restricted Stock Shares Activity [Table Text Block]
    Unvested
Restricted Shares
    Number of
Shares
  Weighted–
Average
Grant–Date
Fair Value
Unvested at December 31, 2017    
385,716
    $
 
Granted    
119,932
    $
 
Vested    
(505,648
)   $
0.28
 
Unvested at June 30, 2018    
    $
 
Expected to vest after June 30, 2018    
    $
 
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
    Three Months Ended
June 30,
  Six Months Ended
June 30,
    2018   2017   2018   2017
Selling, general and administrative expense   $
88
    $
132
    $
161
    $
252
 
Total stock-based compensation expense   $
88
    $
132
    $
161
    $
252
 
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 16 - Geographical Information (Tables)
6 Months Ended
Jun. 30, 2018
Notes Tables  
Revenue from External Customers by Geographic Areas [Table Text Block]
    Three Months Ended
June 30,
  Six Months Ended
June 30,
    2018   2017   2018   2017
Net Sales                                
Spain   $
1,906
    $
2,042
    $
3,382
    $
3,754
 
China    
     
983
     
30
     
2,974
 
India    
478
     
     
904
     
 
United States    
131
     
32
     
1,945
     
42
 
Total Net Sales   $
2,515
    $
3,057
    $
6,261
    $
6,770
 
Long-lived Assets by Geographic Areas [Table Text Block]
    June 30,
2018
  December 31,
2017
Long-Lived Assets                
United States   $
1,237
    $
1,311
 
Spain    
6,454
     
7,141
 
China    
76
     
276
 
Total Long-Lived Assets   $
7,767
    $
8,728
 
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 2 - Recent Accounting Pronouncements and Adoption 1 (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Mar. 31, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Revenue from Contract with Customer, Including Assessed Tax $ 2,515   $ 3,057 $ 6,261 $ 6,770
Price Report, Formula and Sample [Member]          
Revenue from Contract with Customer, Including Assessed Tax   $ 1,750      
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 2 - Recent Accounting Pronouncements and Adoption 2 (Details Textual) - USD ($)
$ in Thousands
Jun. 30, 2018
Jan. 16, 2018
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2018-07-01    
Revenue, Remaining Performance Obligation, Amount $ 1,750  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2018-07-01 | Delivery and Installation of Equipment and Training [Member]    
Revenue, Remaining Performance Obligation, Amount 2,000  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-01-01    
Revenue, Remaining Performance Obligation, Amount [1] 4,250  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-01-01 | License [Member]    
Revenue, Remaining Performance Obligation, Amount 2,250  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: (nil)    
Revenue, Remaining Performance Obligation, Amount $ 6,000 $ 6,000
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: (nil) | Price Report, Formula and Sample [Member]    
Revenue, Remaining Performance Obligation, Amount   1,750
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: (nil) | Delivery and Installation of Equipment and Training [Member]    
Revenue, Remaining Performance Obligation, Amount   2,000
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: (nil) | License [Member]    
Revenue, Remaining Performance Obligation, Amount   $ 2,250
[1] $2,000 upon installation of the Equipment and $2,250 upon acceptance and commencement of the License.
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 2 - Recent Accounting Pronouncements and Adoption - Expected Recognition of Revenue (Details) - USD ($)
$ in Thousands
Jun. 30, 2018
Jan. 16, 2018
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2018-07-01    
Revenue expected to be recognized during the year ended December 31 $ 1,750  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-01-01    
Revenue expected to be recognized during the year ended December 31 [1] 4,250  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: (nil)    
Revenue expected to be recognized during the year ended December 31 $ 6,000 $ 6,000
[1] $2,000 upon installation of the Equipment and $2,250 upon acceptance and commencement of the License.
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 3 - Loss Per Share (Details Textual) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Employee Stock Option [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 1,121,332 1,121,332 1,121,332 1,121,332
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 3 - Loss Per Share - Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Net loss $ (3,074) $ (284) $ (2,755) $ (3,331)
Weighted–average shares outstanding (in shares) 19,669,353 18,913,427 19,607,204 18,839,391
Weighted–average shares outstanding with dilution (in shares) 19,669,353 18,913,427 19,607,204 18,839,391
Basic (in dollars per share) $ (0.16) $ (0.02) $ (0.14) $ (0.18)
Diluted (in dollars per share) $ (0.16) $ (0.02) $ (0.14) $ (0.18)
Employee Stock Option [Member]        
Dilutive effect of share-based awards (in shares)
Restricted Stock [Member]        
Dilutive effect of share-based awards (in shares)
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 4 - Bank Acceptance Notes - Bank Acceptance Notes (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Balance as of beginning of period $ 904  
Balance as of end of period  
Bankers Acceptance [Member]    
Balance as of beginning of period 904 $ 3,360
Received from customers 1,985
Converted to cash (888) (3,508)
Paid to suppliers (1,162)
Foreign exchange impact (16) 229
Balance as of end of period $ 904
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 5 - Inventories - Inventories (Details) - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Finished goods $ 365 $ 340
Raw materials 996 829
Reserve (4) (59)
Inventories, net $ 1,357 $ 1,110
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 6 - Long-lived Assets (Details Textual) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Impairment of Long-Lived Assets to be Disposed of $ 0 $ 267
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 7 - Assets Held for Sale (Details Textual)
$ in Thousands, RM in Millions
6 Months Ended
Jun. 30, 2018
USD ($)
Jun. 30, 2017
USD ($)
Jun. 30, 2016
MYR (RM)
Proceeds from Sale of Property, Plant, and Equipment, Total $ 238  
Impairment of Long-Lived Assets to be Disposed of 0 $ 267  
Malaysia Facility [Member]      
Proceeds from Sale of Property, Plant, and Equipment, Total | RM     RM 25
Impairment of Long-Lived Assets to be Disposed of $ 267    
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 8 - Accrued Liabilities - Accrued Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Salaries and wages $ 323 $ 239
Accrued bonus 210 258
Professional fees 285 319
Restructuring severance and benefits (see Note 10) 102 87
Environmental (see Note 9) 57 57
Accrued franchise tax 79 90
Client deposits 179 1,157
Other 114 100
Total accrued liabilities $ 1,349 $ 2,307
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 9 - Commitments and Contingencies (Details Textual)
€ in Millions
1 Months Ended
Oct. 31, 2016
EUR (€)
Jun. 30, 2018
USD ($)
Dec. 31, 2017
USD ($)
Loss Contingency Accrual, Ending Balance   $ 0 $ 0
Solaria Energia y Medio Ambiente S.A. [Member] | Damages from Product Defects [Member]      
Loss Contingency Accrual, Ending Balance   0 0
Loss Contingency, Damages Sought, Value | € € 3.3    
Phase II Environmental Site Assessment [Member]      
Accrual for Environmental Loss Contingencies, Ending Balance   $ 57,000 $ 57,000
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 10 - Cost Reduction Actions (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2018
Jun. 30, 2017
Mar. 31, 2018
Mar. 31, 2017
Restructuring Reserve, Ending Balance $ 102 $ 102 $ 115 $ 87 $ 269
Facility Closing [Member] | Johor, Malaysia [Member] | Cost of Sales [Member]          
Severance Costs   $ 67 93    
Facility Closing [Member] | Johor, Malaysia [Member] | Selling, General and Administrative Expenses [Member]          
Severance Costs     $ 48    
Facility Closing [Member] | SPAIN | Cost of Sales [Member]          
Severance Costs 588        
Facility Closing [Member] | SPAIN | Selling, General and Administrative Expenses [Member]          
Severance Costs $ 67        
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 10 - Cost Reduction Actions - Schedule of Restructuring Costs (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Balance as of beginning of year $ 87 $ 269
Additions 722 143
Reductions (707) (177)
Reversals (120)
Balance $ 102 $ 115
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 11 - Fair Value Measurements - Fair Value Measurements of Financial Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Fair Value, Inputs, Level 1 [Member]    
Fair Value Assets $ 7,605 $ 7,592
Fair Value, Inputs, Level 1 [Member] | Fair Value, Measurements, Nonrecurring [Member]    
Non-recurring fair value measurements [1]
Fair Value, Inputs, Level 2 [Member]    
Fair Value Assets
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Nonrecurring [Member]    
Non-recurring fair value measurements [1]
Fair Value, Inputs, Level 3 [Member]    
Fair Value Assets 6,155 6,155
Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Nonrecurring [Member]    
Non-recurring fair value measurements 6,155 [1] 6,155
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member] | Fair Value, Measurements, Recurring [Member]    
Money market funds [2] 7,605 6,688
Money Market Funds [Member] | Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member]    
Money market funds [2]
Money Market Funds [Member] | Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Recurring [Member]    
Money market funds [2]
Bankers Acceptance [Member] | Fair Value, Inputs, Level 1 [Member] | Fair Value, Measurements, Recurring [Member]    
Bank acceptance notes [3] 904
Bankers Acceptance [Member] | Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member]    
Bank acceptance notes [3]
Bankers Acceptance [Member] | Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Recurring [Member]    
Bank acceptance notes [3]
[1] Included in assets held for sale on the Company's Condensed Consolidated Balance Sheets. Refer to Note 7 for further information.
[2] Included in cash and cash equivalents on the Company's Condensed Consolidated Balance Sheets. The carrying amount of money market funds is a reasonable estimate of fair value due to the short-term maturity.
[3] Refer to Note 4 for further information
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 12 - Factoring Arrangement (Details Textual)
$ in Thousands, € in Millions
1 Months Ended
Oct. 01, 2015
Oct. 31, 2015
Jun. 30, 2018
USD ($)
Jun. 30, 2018
EUR (€)
Dec. 31, 2017
USD ($)
Due To Factor, Current     $ 397   $ 454
Eurofactor Hispania S.A.U [Member] | Factoring Agreement to Sell with Recourse [Member]          
Factoring Agreement Maximum Outstanding Amount     $ 1,752 € 1.5  
Term of Agreement 1 year        
Written Notice Period Prior to End of Current Term   90 days      
Eurofactor Hispania S.A.U [Member] | Factoring Agreement to Sell with Recourse [Member] | Euro Interbank Offered Rate (EURIBOR) [Member]          
Loans Receivable, Basis Spread on Variable Rate   2.00%      
Eurofactor Hispania S.A.U [Member] | Factoring Agreement to Sell with Recourse [Member] | London Interbank Offered Rate (LIBOR) [Member]          
Loans Receivable, Basis Spread on Variable Rate   2.00%      
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 13 - Income Taxes (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent     21.00%  
Income Tax Expense (Benefit), Total $ 172 $ (125) $ 271 $ (143)
Effective Income Tax Rate Reconciliation, Percent, Total (5.90%)   (10.90%)  
Current Federal, State and Local, Tax Expense (Benefit), Total   0   0
Income Tax Expense (Benefit), Intraperiod Tax Allocation, Total   $ (125)   $ (143)
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 14 - Stockholders' Equity (Details Textual)
6 Months Ended
Jun. 30, 2018
$ / shares
shares
Dec. 31, 2017
$ / shares
shares
Common Stock, Shares Authorized 200,000,000 200,000,000
Common Stock, Par or Stated Value Per Share | $ / shares $ 0.01 $ 0.01
Common Stock, Shares, Issued, Total 20,039,461 19,919,529
Common Stock, Shares, Outstanding, Ending Balance 20,038,221 19,918,289
Common Stock, Voting Rights Number 1  
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 14 - Stockholders' Equity - Schedule of Changes in Stockholders' Equity (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Balance at December 31, 2017     $ 27,860  
Stock-based compensation     171  
Net loss     (2,755) $ (3,331)
Foreign currency translation, net of tax $ (542) $ 501 (88) $ 631
Balance at end of period $ 25,188   $ 25,188  
Common Stock [Member]        
Balance at December 31, 2017 (in shares)     19,532,573  
Balance at December 31, 2017     $ 195  
Stock-based compensation (in shares)     505,648  
Stock-based compensation     $ 5  
Net loss      
Foreign currency translation, net of tax      
Balance at end of period (in shares) 20,038,221   20,038,221  
Balance at end of period $ 200   $ 200  
Treasury Stock [Member]        
Balance at December 31, 2017 (in shares)     1,240  
Balance at December 31, 2017     $ (57)  
Stock-based compensation (in shares)      
Stock-based compensation      
Net loss      
Foreign currency translation, net of tax      
Balance at end of period (in shares) 1,240   1,240  
Balance at end of period $ (57)   $ (57)  
Additional Paid-in Capital [Member]        
Balance at December 31, 2017     232,149  
Stock-based compensation     166  
Net loss      
Foreign currency translation, net of tax      
Balance at end of period 232,315   232,315  
AOCI Attributable to Parent [Member]        
Balance at December 31, 2017     (5,355)  
Stock-based compensation      
Net loss      
Foreign currency translation, net of tax     (88)  
Balance at end of period (5,443)   (5,443)  
Retained Earnings [Member]        
Balance at December 31, 2017     (199,072)  
Stock-based compensation      
Net loss     (2,755)  
Foreign currency translation, net of tax      
Balance at end of period $ (201,827)   $ (201,827)  
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 15 - Stock-based Compensation (Details Textual) - USD ($)
6 Months Ended
May 14, 2013
Jun. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant   431,131
Share Price   $ 0.27
Proceeds from Stock Options Exercised   $ 0
Employee Stock Option [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 10 years  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total   $ 0
Employee Stock Option [Member] | Minimum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 3 years  
Employee Stock Option [Member] | Maximum [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 4 years  
Equity Incentive Plan 2009 [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 4,133,133  
XML 66 R53.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 15 - Stock-based Compensation - Summary of Stock Options Activity (Details) - Employee Stock Option [Member] - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2018
Dec. 31, 2017
Options Outstanding, Number of shares (in shares) 1,121,332  
Options Outstanding, Weighted–average exercise price (in dollars per share) $ 1.52  
Options outstanding, Weighted–average Grant–date fair value (in dollars per share) $ 0.99 $ 0.99
Options outstanding, Aggregate intrinsic value [1] $ (1,402) $ (1,402)
Options granted, Number of shares (in shares)  
Options granted, Weighted–average exercise price (in dollars per share)  
Options granted, Weighted–average Grant–date fair value (in dollars per share)  
Exercised, Number of shares (in shares)  
Exercised, Weighted–average exercise price (in dollars per share)  
Canceled/forfeited, Number of shares (in shares)  
Canceled/forfeited, Weighted-average exercise price (in dollars per share)  
Cancelled/forfeited, Weighted–average Grant–date fair value (in dollars per share)  
Options Outstanding, Number of shares (in shares) 1,121,332 1,121,332
Options Outstanding, Weighted–average exercise price (in dollars per share) $ 1.52 $ 1.52
Options outstanding, Weighted–average remaining contractual term (Year) 6 years 222 days  
Vested and exercisable as of December 31, 2017, Number of shares (in shares) 1,121,332  
Vested and exercisable as of December 31, 2017, Weighted–average exercise price (in dollars per share) $ 1.52  
Vested and exercisable as of December 31, 2017, Weighted–average remaining contractual term (Year) 6 years 222 days  
Vested and exercisable as of December 31, 2017, Weighted–average Grant–date fair value (in dollars per share) $ 0.99  
Vested and exercisable as of December 31, 2017, Aggregate intrinsic value [1] $ (1,402)  
Vested and exercisable as of December 31, 2017 and expected to vest thereafter, Number of shares (in shares) 1,121,332  
Vested and exercisable as of December 31, 2017 and expected to vest thereafter, Weighted-average exercise price (in dollars per share) $ 1.52  
Vested and exercisable as of December 31, 2017 and expected to vest thereafter, Weighted–average remaining contractual term (Year) 6 years 222 days  
Vested and exercisable as of December 31, 2017 and expected to vest thereafter, Weighted–average Grant–date fair value (in dollars per share) $ 0.99  
Vested and exercisable as of December 31, 2017 and expected to vest thereafter, Aggregate intrinsic value [1] $ (1,402)  
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $0.27 of the Company's common stock on June 30, 2018.
XML 67 R54.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 15 - Stock-based Compensation - Summary of Restricted Common Stock Activity (Details) - Restricted Stock [Member] - $ / shares
6 Months Ended
Jun. 30, 2018
Jun. 30, 2018
Unvested restricted shares, Number of shares (in shares) 385,716  
Unvested, Weighted-average grant-date fair value (in dollars per share)  
Granted, Number of shares (in shares) 119,932  
Granted, Weighted-average grant-date fair value (in dollars per share)  
Vested, Number of shares (in shares) (505,648)  
Vested, Weighted-average grant-date fair value (in dollars per share) $ 0.28  
Unvested restricted shares, Number of shares (in shares)  
Unvested, Weighted-average grant-date fair value (in dollars per share)  
Expected to vest, Number of shares (in shares) 385,716
Expected to vest, Weighted-average grant-date fair value (in dollars per share)  
XML 68 R55.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 15 - Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Total stock-based compensation expense $ 88 $ 132 $ 161 $ 252
Selling, General and Administrative Expenses [Member]        
Total stock-based compensation expense $ 88 $ 132 $ 161 $ 252
XML 69 R56.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 16 - Geographical Information (Details Textual)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
USD ($)
Jun. 30, 2017
USD ($)
Jun. 30, 2018
USD ($)
Jun. 30, 2017
USD ($)
Dec. 31, 2017
USD ($)
Revenue from Contract with Customer, Including Assessed Tax $ 2,515 $ 3,057 $ 6,261 $ 6,770  
Customer Concentration Risk [Member] | Sales Revenue, Net [Member]          
Number of Major Customers 4 1 2 1  
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Four Major Customers [Member]          
Revenue from Contract with Customer, Including Assessed Tax $ 1,401        
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Two Major Customers [Member]          
Revenue from Contract with Customer, Including Assessed Tax     $ 1,444    
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | One Major Customers [Member]          
Revenue from Contract with Customer, Including Assessed Tax 683   $ 1,330    
Customer Concentration Risk [Member] | Accounts Receivable [Member]          
Number of Major Customers     2    
Accounts Receivable, Gross, Current $ 1,072   $ 1,072   $ 70
XML 70 R57.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 16 - Geographical Information - Schedule of Operations by Geographic Area (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Net sales $ 2,515 $ 3,057 $ 6,261 $ 6,770
SPAIN        
Net sales 1,906 2,042 3,382 3,754
CHINA        
Net sales 983 30 2,974
INDIA        
Net sales 478 904
UNITED STATES        
Net sales $ 131 $ 32 $ 1,945 $ 42
XML 71 R58.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 16 - Reportable Segment and Geographical Information - Schedule of Long-lived Assets by Geographic Area (Details) - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Long-Lived Assets $ 7,767 $ 8,728
UNITED STATES    
Long-Lived Assets 1,237 1,311
SPAIN    
Long-Lived Assets 6,454 7,141
CHINA    
Long-Lived Assets $ 76 $ 276
XML 72 R59.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 17 - Related Party Transaction (Details Textual) - Huhui Supply Agreement [Member]
$ in Thousands
12 Months Ended
Dec. 31, 2015
USD ($)
Dec. 31, 2014
MWh
Related Party Transaction, Agreement Term   1 year
Related Party Transaction, Automatic Renewal Additional Term   1 year
Zhangjiagang Huhui Segpv Co Ltd [Member]    
Related Party Transaction, Minimum Square Meters Transaction | MWh   535
Related Party Transaction, Deposit Percentage on Minimum Amount   10.00%
Related Party Transaction, Notice Period Prior to End of Current Term   90 days
Zhangjiagang Huhui Segpv Co Ltd [Member] | Accrued Liabilities [Member]    
Related Party Transaction, Client Deposit Received from Related Party | $ $ 1,148  
EXCEL 73 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 74 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 75 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 77 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 144 215 1 true 48 0 false 7 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.strsolar.com/20180630/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.strsolar.com/20180630/role/statement-condensed-consolidated-balance-sheets-unaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Sheet http://www.strsolar.com/20180630/role/statement-condensed-consolidated-balance-sheets-unaudited-parentheticals Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited) Sheet http://www.strsolar.com/20180630/role/statement-condensed-consolidated-statements-of-comprehensive-loss-income-unaudited Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited) (Parentheticals) Sheet http://www.strsolar.com/20180630/role/statement-condensed-consolidated-statements-of-comprehensive-loss-income-unaudited-parentheticals Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited) (Parentheticals) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.strsolar.com/20180630/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Basis of Presentation Sheet http://www.strsolar.com/20180630/role/statement-note-1-basis-of-presentation Note 1 - Basis of Presentation Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Recent Accounting Pronouncements and Adoption Sheet http://www.strsolar.com/20180630/role/statement-note-2-recent-accounting-pronouncements-and-adoption Note 2 - Recent Accounting Pronouncements and Adoption Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Loss Per Share Sheet http://www.strsolar.com/20180630/role/statement-note-3-loss-per-share Note 3 - Loss Per Share Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Bank Acceptance Notes Notes http://www.strsolar.com/20180630/role/statement-note-4-bank-acceptance-notes Note 4 - Bank Acceptance Notes Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Inventories Sheet http://www.strsolar.com/20180630/role/statement-note-5-inventories Note 5 - Inventories Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Long-lived Assets Sheet http://www.strsolar.com/20180630/role/statement-note-6-longlived-assets Note 6 - Long-lived Assets Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Assets Held for Sale Sheet http://www.strsolar.com/20180630/role/statement-note-7-assets-held-for-sale Note 7 - Assets Held for Sale Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Accrued Liabilities Sheet http://www.strsolar.com/20180630/role/statement-note-8-accrued-liabilities Note 8 - Accrued Liabilities Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Commitments and Contingencies Sheet http://www.strsolar.com/20180630/role/statement-note-9-commitments-and-contingencies Note 9 - Commitments and Contingencies Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Cost Reduction Actions Sheet http://www.strsolar.com/20180630/role/statement-note-10-cost-reduction-actions Note 10 - Cost Reduction Actions Notes 16 false false R17.htm 016 - Document - Note 11 - Fair Value Measurements Sheet http://www.strsolar.com/20180630/role/statement-note-11-fair-value-measurements Note 11 - Fair Value Measurements Uncategorized 17 false false R18.htm 017 - Disclosure - Note 12 - Factoring Arrangement Sheet http://www.strsolar.com/20180630/role/statement-note-12-factoring-arrangement Note 12 - Factoring Arrangement Uncategorized 18 false false R19.htm 018 - Disclosure - Note 13 - Income Taxes Sheet http://www.strsolar.com/20180630/role/statement-note-13-income-taxes Note 13 - Income Taxes Uncategorized 19 false false R20.htm 019 - Disclosure - Note 14 - Stockholders' Equity Sheet http://www.strsolar.com/20180630/role/statement-note-14-stockholders-equity Note 14 - Stockholders' Equity Uncategorized 20 false false R21.htm 020 - Disclosure - Note 15 - Stock-based Compensation Sheet http://www.strsolar.com/20180630/role/statement-note-15-stockbased-compensation Note 15 - Stock-based Compensation Uncategorized 21 false false R22.htm 021 - Disclosure - Note 16 - Geographical Information Sheet http://www.strsolar.com/20180630/role/statement-note-16-geographical-information Note 16 - Geographical Information Uncategorized 22 false false R23.htm 022 - Disclosure - Note 17 - Related Party Transaction Sheet http://www.strsolar.com/20180630/role/statement-note-17-related-party-transaction Note 17 - Related Party Transaction Uncategorized 23 false false R24.htm 023 - Disclosure - Note 2 - Recent Accounting Pronouncements and Adoption (Tables) Sheet http://www.strsolar.com/20180630/role/statement-note-2-recent-accounting-pronouncements-and-adoption-tables Note 2 - Recent Accounting Pronouncements and Adoption (Tables) Uncategorized 24 false false R25.htm 024 - Disclosure - Note 3 - Loss Per Share (Tables) Sheet http://www.strsolar.com/20180630/role/statement-note-3-loss-per-share-tables Note 3 - Loss Per Share (Tables) Uncategorized 25 false false R26.htm 025 - Disclosure - Note 4 - Bank Acceptance Notes (Tables) Notes http://www.strsolar.com/20180630/role/statement-note-4-bank-acceptance-notes-tables Note 4 - Bank Acceptance Notes (Tables) Uncategorized 26 false false R27.htm 026 - Disclosure - Note 5 - Inventories (Tables) Sheet http://www.strsolar.com/20180630/role/statement-note-5-inventories-tables Note 5 - Inventories (Tables) Uncategorized 27 false false R28.htm 027 - Disclosure - Note 8 - Accrued Liabilities (Tables) Sheet http://www.strsolar.com/20180630/role/statement-note-8-accrued-liabilities-tables Note 8 - Accrued Liabilities (Tables) Uncategorized 28 false false R29.htm 028 - Disclosure - Note 10 - Cost Reduction Actions (Tables) Sheet http://www.strsolar.com/20180630/role/statement-note-10-cost-reduction-actions-tables Note 10 - Cost Reduction Actions (Tables) Uncategorized 29 false false R30.htm 029 - Disclosure - Note 11 - Fair Value Measurements (Tables) Sheet http://www.strsolar.com/20180630/role/statement-note-11-fair-value-measurements-tables Note 11 - Fair Value Measurements (Tables) Uncategorized 30 false false R31.htm 030 - Disclosure - Note 14 - Stockholders' Equity (Tables) Sheet http://www.strsolar.com/20180630/role/statement-note-14-stockholders-equity-tables Note 14 - Stockholders' Equity (Tables) Uncategorized 31 false false R32.htm 031 - Disclosure - Note 15 - Stock-based Compensation (Tables) Sheet http://www.strsolar.com/20180630/role/statement-note-15-stockbased-compensation-tables Note 15 - Stock-based Compensation (Tables) Uncategorized 32 false false R33.htm 032 - Disclosure - Note 16 - Geographical Information (Tables) Sheet http://www.strsolar.com/20180630/role/statement-note-16-geographical-information-tables Note 16 - Geographical Information (Tables) Uncategorized 33 false false R34.htm 033 - Disclosure - Note 2 - Recent Accounting Pronouncements and Adoption 1 (Details Textual) Sheet http://www.strsolar.com/20180630/role/statement-note-2-recent-accounting-pronouncements-and-adoption-1-details-textual Note 2 - Recent Accounting Pronouncements and Adoption 1 (Details Textual) Uncategorized 34 false false R35.htm 034 - Disclosure - Note 2 - Recent Accounting Pronouncements and Adoption 2 (Details Textual) Sheet http://www.strsolar.com/20180630/role/statement-note-2-recent-accounting-pronouncements-and-adoption-2-details-textual Note 2 - Recent Accounting Pronouncements and Adoption 2 (Details Textual) Uncategorized 35 false false R36.htm 035 - Disclosure - Note 2 - Recent Accounting Pronouncements and Adoption - Expected Recognition of Revenue (Details) Sheet http://www.strsolar.com/20180630/role/statement-note-2-recent-accounting-pronouncements-and-adoption-expected-recognition-of-revenue-details Note 2 - Recent Accounting Pronouncements and Adoption - Expected Recognition of Revenue (Details) Uncategorized 36 false false R37.htm 036 - Disclosure - Note 3 - Loss Per Share (Details Textual) Sheet http://www.strsolar.com/20180630/role/statement-note-3-loss-per-share-details-textual Note 3 - Loss Per Share (Details Textual) Uncategorized 37 false false R38.htm 037 - Disclosure - Note 3 - Loss Per Share - Earnings (Loss) Per Share (Details) Sheet http://www.strsolar.com/20180630/role/statement-note-3-loss-per-share-earnings-loss-per-share-details Note 3 - Loss Per Share - Earnings (Loss) Per Share (Details) Uncategorized 38 false false R39.htm 038 - Disclosure - Note 4 - Bank Acceptance Notes - Bank Acceptance Notes (Details) Notes http://www.strsolar.com/20180630/role/statement-note-4-bank-acceptance-notes-bank-acceptance-notes-details Note 4 - Bank Acceptance Notes - Bank Acceptance Notes (Details) Uncategorized 39 false false R40.htm 039 - Disclosure - Note 5 - Inventories - Inventories (Details) Sheet http://www.strsolar.com/20180630/role/statement-note-5-inventories-inventories-details Note 5 - Inventories - Inventories (Details) Uncategorized 40 false false R41.htm 040 - Disclosure - Note 6 - Long-lived Assets (Details Textual) Sheet http://www.strsolar.com/20180630/role/statement-note-6-longlived-assets-details-textual Note 6 - Long-lived Assets (Details Textual) Uncategorized 41 false false R42.htm 041 - Disclosure - Note 7 - Assets Held for Sale (Details Textual) Sheet http://www.strsolar.com/20180630/role/statement-note-7-assets-held-for-sale-details-textual Note 7 - Assets Held for Sale (Details Textual) Uncategorized 42 false false R43.htm 042 - Disclosure - Note 8 - Accrued Liabilities - Accrued Liabilities (Details) Sheet http://www.strsolar.com/20180630/role/statement-note-8-accrued-liabilities-accrued-liabilities-details Note 8 - Accrued Liabilities - Accrued Liabilities (Details) Uncategorized 43 false false R44.htm 043 - Disclosure - Note 9 - Commitments and Contingencies (Details Textual) Sheet http://www.strsolar.com/20180630/role/statement-note-9-commitments-and-contingencies-details-textual Note 9 - Commitments and Contingencies (Details Textual) Uncategorized 44 false false R45.htm 044 - Disclosure - Note 10 - Cost Reduction Actions (Details Textual) Sheet http://www.strsolar.com/20180630/role/statement-note-10-cost-reduction-actions-details-textual Note 10 - Cost Reduction Actions (Details Textual) Uncategorized 45 false false R46.htm 045 - Disclosure - Note 10 - Cost Reduction Actions - Schedule of Restructuring Costs (Details) Sheet http://www.strsolar.com/20180630/role/statement-note-10-cost-reduction-actions-schedule-of-restructuring-costs-details Note 10 - Cost Reduction Actions - Schedule of Restructuring Costs (Details) Uncategorized 46 false false R47.htm 046 - Disclosure - Note 11 - Fair Value Measurements - Fair Value Measurements of Financial Assets and Liabilities (Details) Sheet http://www.strsolar.com/20180630/role/statement-note-11-fair-value-measurements-fair-value-measurements-of-financial-assets-and-liabilities-details Note 11 - Fair Value Measurements - Fair Value Measurements of Financial Assets and Liabilities (Details) Uncategorized 47 false false R48.htm 047 - Disclosure - Note 12 - Factoring Arrangement (Details Textual) Sheet http://www.strsolar.com/20180630/role/statement-note-12-factoring-arrangement-details-textual Note 12 - Factoring Arrangement (Details Textual) Uncategorized 48 false false R49.htm 048 - Disclosure - Note 13 - Income Taxes (Details Textual) Sheet http://www.strsolar.com/20180630/role/statement-note-13-income-taxes-details-textual Note 13 - Income Taxes (Details Textual) Uncategorized 49 false false R50.htm 049 - Disclosure - Note 14 - Stockholders' Equity (Details Textual) Sheet http://www.strsolar.com/20180630/role/statement-note-14-stockholders-equity-details-textual Note 14 - Stockholders' Equity (Details Textual) Uncategorized 50 false false R51.htm 050 - Disclosure - Note 14 - Stockholders' Equity - Schedule of Changes in Stockholders' Equity (Details) Sheet http://www.strsolar.com/20180630/role/statement-note-14-stockholders-equity-schedule-of-changes-in-stockholders-equity-details Note 14 - Stockholders' Equity - Schedule of Changes in Stockholders' Equity (Details) Uncategorized 51 false false R52.htm 051 - Disclosure - Note 15 - Stock-based Compensation (Details Textual) Sheet http://www.strsolar.com/20180630/role/statement-note-15-stockbased-compensation-details-textual Note 15 - Stock-based Compensation (Details Textual) Uncategorized 52 false false R53.htm 052 - Disclosure - Note 15 - Stock-based Compensation - Summary of Stock Options Activity (Details) Sheet http://www.strsolar.com/20180630/role/statement-note-15-stockbased-compensation-summary-of-stock-options-activity-details Note 15 - Stock-based Compensation - Summary of Stock Options Activity (Details) Uncategorized 53 false false R54.htm 053 - Disclosure - Note 15 - Stock-based Compensation - Summary of Restricted Common Stock Activity (Details) Sheet http://www.strsolar.com/20180630/role/statement-note-15-stockbased-compensation-summary-of-restricted-common-stock-activity-details Note 15 - Stock-based Compensation - Summary of Restricted Common Stock Activity (Details) Uncategorized 54 false false R55.htm 054 - Disclosure - Note 15 - Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details) Sheet http://www.strsolar.com/20180630/role/statement-note-15-stockbased-compensation-schedule-of-stockbased-compensation-expense-details Note 15 - Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details) Uncategorized 55 false false R56.htm 055 - Disclosure - Note 16 - Geographical Information (Details Textual) Sheet http://www.strsolar.com/20180630/role/statement-note-16-geographical-information-details-textual Note 16 - Geographical Information (Details Textual) Uncategorized 56 false false R57.htm 056 - Disclosure - Note 16 - Geographical Information - Schedule of Operations by Geographic Area (Details) Sheet http://www.strsolar.com/20180630/role/statement-note-16-geographical-information-schedule-of-operations-by-geographic-area-details Note 16 - Geographical Information - Schedule of Operations by Geographic Area (Details) Uncategorized 57 false false R58.htm 057 - Disclosure - Note 16 - Reportable Segment and Geographical Information - Schedule of Long-lived Assets by Geographic Area (Details) Sheet http://www.strsolar.com/20180630/role/statement-note-16-reportable-segment-and-geographical-information-schedule-of-longlived-assets-by-geographic-area-details Note 16 - Reportable Segment and Geographical Information - Schedule of Long-lived Assets by Geographic Area (Details) Uncategorized 58 false false R59.htm 058 - Disclosure - Note 17 - Related Party Transaction (Details Textual) Sheet http://www.strsolar.com/20180630/role/statement-note-17-related-party-transaction-details-textual Note 17 - Related Party Transaction (Details Textual) Uncategorized 59 false false All Reports Book All Reports stri-20180630.xml stri-20180630.xsd stri-20180630_cal.xml stri-20180630_def.xml stri-20180630_lab.xml stri-20180630_pre.xml http://xbrl.sec.gov/country/2017-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2018-01-31 http://fasb.org/us-gaap/2018-01-31 true true ZIP 79 0001171843-18-005976-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-18-005976-xbrl.zip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end